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Abstract
Lyme disease is the most prevalent arthropod-borne (tick) disease in North America. The
disease is more prevalent in some Eastern and Central states than in Western states. The
general problem is that, in southern California especially in Los Angeles County, both
patients and practitioners fail to recognize the disease, resulting in misdiagnosis and
delayed treatment. Consequently, the patient may develop the long-term, chronic Lyme
disease (CLD). The purpose of this phenomenological study was to explore the impact of
CLD on the health-promoting behaviors of ethnically diverse young adults from similar
educational and socioeconomic backgrounds based on their lived experiences. The
geographical focus of this study was restricted to Los Angeles County, California,
because researchers have demonstrated a general lack of awareness of CLD as well as a
gap when it comes to representing CLD clients from diverse ethical and socio-economic
groupings. Data were collected from face-to-face semistructured interviews of 9
participants, based on the health belief model constructs on an ethnically diverse group of
young adults clinically diagnosed with CLD. Data were coded and explored for themes.
Key results of the study include the existence of excellent health prior to CLD, marked
declined in health status because of the disease not being recognized or properly treated,
and the use of various modalities of treatment including conventional antibiotic treatment
and complementary and alternative treatments to combat the disease. Social implications
of this study include increased awareness of physicians and the community in the Los
Angeles County of Lyme Disease as an emerging epidemic, development of preventive
measures against this disease, and generation of rich data and propositions regarding
CLD for further research.
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Chapter 1: Introduction to the Study
Introduction
Chronic Lyme disease (CLD) is a condition that describes a plethora of persistent
symptoms lasting more than six months which develops when Lyme disease (LD)
diagnosis is missed, or as results of inadequate length of antibiotic treatment
(Borgersmans, Goderis, Vandevoorde, & Devroey, 2014). CLD symptoms range from
fatigue and musculoskeletal pain to neurocognitive complaints placing those individuals
diagnosed with the disease with a substantial clinical burden (Ali et al., 2014). Little is
known about the health-promoting behaviors of young adults diagnosed with CLD. The
purpose of this his phenomenological study, based on lived experiences of young adults
from a diverse ethnic, educational, and socioeconomic background who reside in Los
Angeles County afflicted with CLD, was to gather insights about their experiences, to
bring awareness to the Los Angeles County community of the existence of the disease,
and to elucidate the impact CLD has on their health behaviors.
Social implications of this qualitative study include increased awareness of
physicians and the community in the Los Angeles County of LD as an emerging
epidemic (see Hui, 2008), development of preventive measures against this devastating
disease, and generation of rich data and hypotheses about CLD for further research
(Adrion, Aucott, Lemke, & Weiner, 2015). According to the California Lyme Disease
Association (2015), most residents in Los Angeles County do not know about LD’s
transmission, symptoms, and the danger of the presence of ticks. Subsequently, these
residents may also not take precautions, check for ticks and tick bites after visiting
mountain trails and parks, remove ticks properly, and are not informed to immediately

2

seek for health care assistance if the characteristic rash develops (California Lyme
Disease Association, 2015). The perspectives of this group of participants may give
healthcare providers and the public a deeper insight into the impact CLD has on the
personal and professional lives, as well as in decision-making.
In this chapter, I provide a detailed description of the background of the study and
clearly present the problem statement. In addition, I present the purpose statement,
research questions, theoretical framework, and nature of the study. I also provide concise
definitions of key concepts or constructs in this chapter to clarify the meaning as the
terms relate to CLD. In addition, I briefly discuss assumptions, scope, and delimitations,
as well as limitations of specific aspects of the research that are critical to the
meaningfulness of the study such as population’s boundaries, transferability, possible
weaknesses, and biases of the study. Finalizing the chapter; I discuss the significance of
the study section including potential contributions of the study to the individual, the
community, society, as well as the public health practice. To close the chapter, I present
the summary which highlights the main points covered in the chapter and provides a
transition to the study’s next chapter.
Background of the Study
The term CLD describes a constellation of persistent symptoms in patients
exposed to the bite of a tick infected with the bacterial spirochete Borrelia burgdorferi
(Bb; Ali et al., 2014). The symptoms lasting more than six months range from fatigue,
headache, back pain, myalgia, arthralgia, nausea, abdominal pain, and night sweats, to
cardiac (arrhythmia) and neurological involvement; cognitive dysfunction, peripheral
neuropathy and encephalomyelitis (Borgersmans et al., 2014). The Centers for Disease
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Control and Prevention (CDC) recommend antibiotic therapy in the early stage of the
disease, within 30 days of exposure, to hasten symptoms resolution and to prevent
development of CLD (Horowitz, 2013; Hu, 2012). However, approximately 10 to 20% of
patients treated with the recommended dose and duration of antibiotic therapy report
persistent symptoms described as Post-Treatment Lyme Disease Syndrome (PTLDS),
also referred to as CLD in this study (Adrion, Aucott, Lemke, & Weiner, 2015).
Failure of standard antibiotic therapy for LD may be due to the complex genetic
makeup of the causative organism with three times more plasmids than any other
organism and the so-called stealth pathology. Stealth pathology refers to mechanisms
used by Bb to evade immune response that include (a) immunosuppression; (b) genetic,
phase and antigenic variation; (c) physical seclusion; and (d) secretion of factor to engage
in autoresurrection becoming a dormant organism. These mechanisms suggest the need
for prolonged use of antibiotics (Stricker, 2007). In addition, tick borne coinfections such
as Babesia, Anaplasma, Ehrlichia, or Bartonella exacerbate LD symptoms and cause a
low-grade infection that can increase the duration and severity of LD (Stricker, 2007). In
a study conducted by Johnson, Wilcox, Mankoff, and Stricker (2014), using the CDC
health-related quality of life (HRQoL) indicators to identify health needs, determine the
burden of disease, and direct public health policy; patients with CLD compared to the
general population reported a significant symptom disease burden, lower health quality
status, more bad physical and mental days, and greater activity limitations. CLD patients
also reported increased utilization of health care services, greater out of pocket expenses
in medical cost, impairment in their productivity and ability to work, and limited
recreation activities. The study findings also suggested that the CDC should include in
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national population surveys questions regarding LD that will allow researchers to
accurately characterize prevalence, annual incidence, and demographic distribution of the
disease.
Adrion, Aucott, Lemke, and Weiner (2015) utilized retrospective data on medical
claims from 547,993 LD diagnosed cases between 2006 and 2010 on persons ages
ranging from 0 to 64-year-old enrolled in commercial health insurance plans to examine
the impact of PTLDS on health care cost and utilization. Over a 12-month period those
patients having one or more PTLDS-related diagnosis were associated with $3,798 higher
total health care cost, 66% more outpatient and management visit, and 89% more
emergency department visits than those with no PTLDS related diagnosis. The estimated
cost for patients with neurological involvement associated with late stage LD was $6,007,
while those with PTLDS uncomplicated or complicated cases estimated cost is $10,000.
The study found patients with PTLDS to be 5.5 times more likely to suffer from
debilitating and undue fatigue so severe as to affect the health-related quality of life. The
researchers concluded that by extrapolating, the data there are approximately 240,000 to
400,000 cases of LD annually in the United States with a LD and PTLDS total direct
medical cost of $712 million to $1.3 billion each year. The implications of this study on
public health policy are enormous as LD spreads to non-endemic areas such as Southern
California. Increased awareness of the disease and the potential for complications from
misdiagnosis, late diagnosis, or inappropriate treatment is crucial to provide costeffective and compassionate management of patients with CLD.
The number of phenomenological approach studies conducted to understand
patients’ diagnosis of CLD that explore the lived experiences of becoming diagnosed are
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limited. Previous qualitative studies on CLD included purposive samples of 10 to 12
participants diagnosed with the disease, face-to-face interviews were conducted and tape
recorded, the interviews were transcribed and emerging themes and topics were
categorized and analyzed. Drew and Hewitt (2006) found six themes that emerged from
the interviews. Theme one, feelings of frustration on long process of diagnosis due to
high rate of false-negative results, lack of “bull’s eye” rash erythema migrans (EM)
presentation, and nature of the symptoms. Theme two, long road to diagnosis. Theme
three, financial stress, patients have lost their jobs and medical expenses not covered by
medical insurance. Theme four, self-advocacy, participants researched the internet, social
support groups and other means to consider LD as differential diagnosis and educate
others about the disease. Theme five, validation of their symptoms once diagnosed as
relief and explanation of the multiple symptoms; and Theme six, sense of hopefulness
once treatment began despite nature of the illness. Another study conducted by Ali et al.
(2014) found four major themes. Theme one, changes in health status and social impact
of CLD. Theme two, doubts about recovery and the future. Theme three, contrasting
doctor-patient relationship in which participants characterized doctors as either uncaring
and dismissive or exceptionally supportive. And theme four, unconventional therapies to
treat CLD; besides receiving oral or intravenous antibiotic therapy for longer periods than
the established guidelines with symptomatic relief while in the treatment, many patients
in this study reported seeking out other health care providers such as neuropathic doctors
or complementary and alternative medicine providers and therapies. According to Ali et
al. (2014), there is a gap in the current literature when it comes to representing CLD
clients from diverse ethical groupings with attention given to those in a higher socio-
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economic stratum, more education, and medical insurance coverage. This study will fill
in the gap described by Ali et al. (2014). This research was achieved by selecting a group
of participants who were not just middle-aged whites with high a socioeconomic status,
and who can afford full medical insurance coverage, but focused on a diverse ethnic,
racial, educational, and socioeconomic group of participants.
Problem Statement
Lyme disease falls in the category of Emerging Infectious Diseases (EID), which
comprises of a list of human pathogens that have emerged or remerged in the last three
decades (Parks et al., 2005). The impact of EID on human society is enormous causing
nearly 15 million deaths, suffering, and costing billions of dollars (Ostfeld, 2011). The
annual incidence of LD has steadily increased more than 25-fold since 1982 when
national surveillance began in the United States (Drew & Hewitt, 2006). Cases reported
to the CDC in 2013 yielded a national incidence of 8.6 per 100,000 people (CDC, 2013).
Extrapolations estimate annual cases to be from 240,000 to 440,000 cases (Gardner,
2012). However, this number is underestimated due to inconsistency in reporting by
physicians and laboratories, number of undiagnosed cases (Borgermans, et al., 2014) and
lack of standard diagnostic practices in the states (Drew & Hewitt, 2006). LD is a
multisystem zoonotic disease caused by Bb (Margos, et al., 2012). This bacterial
organism has evolved by gene expression and adapted to various environments, the
transmitting vector, and the mammalian host (Anguita, Hedrick, & Fikrig, 2003). LD is
the most-prevalent arthropod-borne (tick) disease in North America and one of the fastest
growing infectious diseases (Levi, Kilpatrick, Mangel, & Wilmers, 2012). The incidence
has approximately doubled between 1991 and 2012 from 3.74 to 7.01 reported cases per
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100,000 people (CDC, 2013). In some Eastern and Central states, the disease is more
prevalent than in Western states (CDC, 2013). The general problem is that all the way to
Southern California, both patients and practitioners fail to recognize the disease, resulting
in misdiagnosis and delayed treatment (Hui 2008; Swei, Ostfeld, Lane, & Briggs, 2011).
If diagnosis is missed or is treated inadequately the patient may go on to develop
devastating long-term CLD or PTLSD consisting of many non-specific symptoms
affecting various body systems (Drew & Hewitt, 2006; Stricker, 2007; Borgermans et al.,
2014). The annual burden of disease for CLD in the year 2000 was $17,580 per patient
broken down into $1,380 direct medical, $389 indirect medical, $6,703 non-medical, and
$9,108 loss of productivity (Adrion et al., 2015). Currently, the average annual cost of
CLD exceeds $20,000 per patient (Adrion et al., 2015). Patients bear 88% of the cost,
while insurers bear just 12% (Johnson, 2013; Horowitz, 2013). Total healthcare cost of
CLD per patient is $3,798 higher for a 12-month-period relative to those who do not
develop CLD (Adrion et al., 2015).
The specific problem is that there exists a misconception that there is no LD and
subsequently no CLD in Southern California (Hui, 2008). Therefore, primary care
physicians and most individuals may not even be aware that the disease exists in their
area (Sharlach, 2015). In California, the risk of encountering infected ticks is
concentrated in national recreational parks and other wooded areas (Sharlach, 2015). In
Los Angeles County, urban areas are located next to wilderness areas (Hollywood Bowl,
Rose Bowl, and the Greek Theatre). Blacklegged ticks found throughout Hollywood
Bowl (Hollywood Hills), Griffith Park, Angeles National Forest, Santa Monica
Mountains, Los Padres National Forest, San Gabriel Mountains, Santa Monica
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Mountains, Whittier Hills, La Puente Hills, and Palos Verdes (Woolford, 2015)
constitutes a serious risk. The lack of early diagnosis, awareness, and prevention
measures pose a great danger (Hui, 2008). Statistical figures indicate that from 1,561 LD
total reported cases in a period of ten years from 1992 to 2001 there were 200 cases
(13%) from Southern California mainly from San Diego, Los Angeles, and San
Bernardino County (Hui, 2008; CDPH, 2014). The California Department of Public
Health reported 120 cases of LD in 2013 of which 17 confirmed cases where from Los
Angeles County (CDPH, 2014).
According to Ali et al. (2014), there is a gap in the current literature when it
comes to representing CLD clients from diverse ethical groupings with attention given to
those in a higher socioeconomic stratum, more education, and medical insurance
coverage. Little is known about CLD patient’s experiences and the impact on young
adults’ health behaviors in the Los Angeles County, an ethnic, educational, and socioeconomic diverse population area (Hui, 2008; CDPH, 2013; California LD Association,
2015). In his study, I addressed the gap found in Ali et al. (2014) by conducting a
qualitative, descriptive study in which face to face semistructured interviews based on the
health belief model (HBM) constructs of perceived susceptibility, severity, benefits,
barriers, cues to action, and self -efficacy was conducted on an ethnically diverse group
of young adults 18 to 40-year-old clinically diagnosed with CLD.
Purpose of the Study
The purpose of this phenomenological study was to explore the impact of chronic
Lyme disease on the health-promoting behaviors of ethnically diverse, insured, young
adults from similar educational and socioeconomic backgrounds based on their lived
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experiences. The geographical focus of this study was restricted to Los Angeles County,
California, because there is a general lack of awareness of LD and CLD on the West
Coast of the United States (see Hui 2008; Swei, Ostfeld, Lane, & Briggs, 2011). The
perspectives of this group of participants gave healthcare providers and the public a
deeper insight into the affect CLD has on the personal and professional lives of affected
clients and its impact on their decision-making processes.
Research Questions
RQ1: Qualitative: To what degree do different ethnic groups with average levels
of socioeconomic status, education, and third-party coverage, perceive the likelihood of
acquiring comorbidities related to CLD?
RQ2: Qualitative: To what degree does the perceived severity of CLD impact the
lives and decision-making processes of different ethnic groups with average levels of
socio-economic status, education, and third-party coverage?
RQ3: Qualitative: To what degree does the perceived benefits of treatment impact
the lives and decision-making processes of different ethnic groups with average levels of
socio-economic status, education, and third-party coverage?
RQ4: Qualitative: To what degree do perceived barriers impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
RQ5: Qualitative: To what degree does the cues to action impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
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RQ6: Qualitative: To what degree does self-efficacy impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
Theoretical Framework
The HBM was used as the framework for the study to explain and predict health
behaviors of CLD by focusing on the attitudes and beliefs of the individuals afflicted
with the disease. The HBM has its origins in Lewin’s theory in 1947 which indicated that
“behavior change is determined by how people value a particular outcome and the
assumption that certain actions will facilitate that outcome” (Becker, Rosenstock, &
Slack, 1974, p. 328). It is from Lewin’s hypotheses that social psychologists Hochbaum,
Rosenstock, and Kegels in the 1950s popularized the HBM while working in the U.S.
Public Health Services to better understand the widespread failure of people to participate
in programs to diagnose or prevent disease (Crosby, DiClemente, & Salazar, 2006;
Schiavo, 2007). The dimensions of the HBM constructs; perceived susceptibility,
severity, benefits, barriers, cues to action, and self-efficacy (Crosby et al., 2006; Hayden,
2013; Schiavo, 2007) aided to understand the illness presentations, health care choices,
treatments options, and the individual’s beliefs and expectations of the disease (Ali et al.,
2014).
The theoretical model explains individual perceptions in a disease being
influenced by modifying factors such as age, sex, ethnicity, personality, insurance status,
educational level, socio-economic, and knowledge which, in turn, influence the
likelihood of action and perceived threat of disease modified by education, symptoms,
and media information directly affecting likelihood of behavioral change which is
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discussed in depth in chapter two (Crosby, DiClemente, & Salazar, 2006; Redding, Rossi,
Velicer, & Prochaske, 2000). The HBM relates to this study approach and research
questions in that it examined the impact that the experiences and perceptions of the Los
Angeles County, California young adults diagnosed with CLD have on their health
promoting behaviors; therefore, the HBM constructs (see Figure 1) provided the
dimensions to focus on the perceptions and lived experiences of patients, including
diagnostic methods, health benefits, perceived efficacy, and therapeutic regimens used.
More details regarding the HBM and its value in framing the study design and execution
are discussed in Chapter 2.

Individual Perceptions

Perceived Susceptibility/
Seriousness of Illness

Modifying Factors

Likelihood Action

Age, sex, ethnicity,
personality, socioeconomics, knowledge

Perceived
benefits versus
barriers to
behavioral change

Perceived threat of
disease

Likelihood of
behavioral change

Cues to action:
education, symptoms,
media information
Figure 1. Conceptualizing the HBM. Adapted from Glams, K., Rimer, B. and Lewis, M.
(2002). Health Behavior and Health Education: Theory, Research and Practice. Wiley
and Sons, San Francisco. Copyright 2003 by The American Psychological Association.
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Nature of the Study
I used a qualitative, hermeneutical phenomenology research design. Qualitative
inquiry provided the means to examine the nature and scope of CLD through the lived
experiences and perceptions of those afflicted by the disease in the natural setting (Baxter
& Jack, 2008; Drew & Hewitt, 2006). Hermeneutical phenomenology, a descriptive style
of qualitative research, provided the strategy of inquiry in which I identified and
interpreted the essence of human experiences about CLD in language that was loyal to
the lived experiences of the participants (Creswell, 2009; Rudestam & Newton, 2015). In
addition, hermeneutical phenomenology research is a descriptive style of qualitative
inquiry that permits the researcher to use introspective reflection as well as observation,
listening, and empathetic alliance with the study participants (Drew & Hewitt, 2006;
Rudestam & Newton, 2015). Qualitative inquiry and more precisely a phenomenological
design was the most appropriate method since it allowed me to draw upon lived
experiences of the participants to gain a deeper understanding and appreciation of how
CLD impacts their lives and decision-making processes. This approach uniquely
supported my goal to examine the experiences of an ethnically diverse, young adult
segment of the Los Angeles County population afflicted with CLD. It also allowed me to
gather insights about the impact of CLD on daily lives of the participants by exploring
the full nature of the phenomenon and describing the human experience as it was lived
(Drew & Hewitt, 2006; Rudestam & Newton, 2015).
I used semistructured interview questions for this qualitative study based on the
HBM constructs focused on the experiences and perceptions of patients clinical
diagnosed CLD as the main source of data. The purposive sample I used for this study
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consisted of voluntary participants in the age range from 18 to 40 years old recruited
from the social media (Facebook) group “Los Angeles County Chronic Lyme Disease
Support and Discussion” as well as CLD patients known by the researcher. Participants
continued to be recruited and interviewed until emerging patterns appeared and
theoretical saturation was achieved indicated by well-characterized and differentiated
categories (see Ali et al., 2014). Prior to the interview, approval from the Institutional
Review Board was obtained as well as informed consent from the participants to collect
demographic data such as age, sex, marital status, years of education, race/ethnicity,
socio-economic and employment status, and health insurance coverage.
The primary sources of data were demographic data from the study participants,
transcripts of the tape-recorded interview sessions, and field notes taken during the
interview sessions. Relevant documents were used a secondary source of data as needed
to verify information gathered during the study (Creswell, 2009). Transcripts were
analyzed using content analysis standard methods to determine emergent themes and
categories assigned with codes by using the qualitative software QSR NVivo.
Definitions
Anaplasma: a genus of organisms transmitted by ticks that parasitize erythrocytes,
thrombocytes, and leukocytes causing of human granulocytic anaplasmosis (HGA). The
infection can be mild causing anemia, low white blood cell count, low platelet count, and
elevated liver enzymes or severe causing respiratory insufficiency, kidney failure, and
eventually death (Krakowetz, Dibernardo, Lindsay, & Chilton, 2014, CLDA, 2015).
Babesia: protozoan parasite transmitted by ticks that infect the blood and cause a
parasitic, hemolytic disease known as babesiosis presenting itself with fever and chills
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then fatigue, headache, drenching sweats, muscle aches, chest pain, hip pain and
shortness of breath as the disease progresses. Documentation in the literature of Babesia
transmission cases from mother to unborn child or through a contaminated blood
transfusion exist. Currently, most blood banks do not screen donated blood for Babesia
(CDC, 2014).
Bartonella: are bacteria that live primarily inside the lining of the blood vessels
that can infect humans, mammals and a wide range of wild animals. The organism
transmitted by fleas, ticks, animals, even spiders cause Bartonellosis. The infected patient
may experience fever, fatigue, and loss of peripheral vision, bouts of muscle and joint,
numbness of the hands, headaches, memory loss, and hallucinations (CLDA, 2015).
Cognitive dysfunction: is the loss of intellectual functions such as remembering,
thinking, and reasoning of sufficient severity to interfere with daily functioning. Also
known as brain fog in which the patients have trouble with concentration, verbal recall,
and basic arithmetic (Medalia & Revheim, 2012).
Ehrlichia: bacterial organisms transmitted to humans by the bite of an infected
tick. The lone star tick (Amblyomma americanum) is the primary vector in the United
States. Symptoms of ehrlichiosis include fever, headache, fatigue, and muscle aches
within one to two weeks following a tick bite (CDC, 2015).
Encephalopathy: a term for a diffuse disease of the brain that alters brain function
or structure that may be caused by bacteria, virus, brain tumor, malnutrition, chronic
progressive trauma, pressure in the skull, prolonged exposure to toxic chemicals, or lack
of oxygen or blood flow to the brain. The condition results in altered mental state causing
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lethargy, progressive loss of memory, inability to concentrate and subtle personality
changes (NIH, 2010).
Neuropathic: describes a problem with the nerves, mainly the peripheral nerves
which can be sensory (numbness, tingling, increase or decrease ability to feel pain, heat
or cold), motor (muscle weakness, twitching, crumps) or autonomic (dizziness, fainting,
bloating, constipation, diarrhea, raising heart) caused by certain diseases, infection,
vitamin B12/folate deficiency and drugs (Logigian & Steere, 2012).
Complementary and alternative medicine: abbreviated as CAM treatment of LD
refers as a combination of different intravenous antibiotics therapy, herbal remedies
administration, and nutritional supplements, to stimulate and enhance the immune
system's ability to fight Bb an intracellular microorganism (Vojdani, Hebroni, Raphael,
Erde & Raxlen, 2009).
Phenomenology: is the direct investigation and description of phenomena as
consciously experienced, without theories about their causal explanations. In a
phenomenological research design, the researcher attempts to understand the participant’s
perspectives and perceptions and tries to answer questions such as; what is it like to
experience CLD? then generalize from the insider’s perspective (Creswell, 2009).
Zoonotic disease: a disease transferred between animals and humans; caused, by
viruses, bacteria, parasites, and fungi. Estimates indicate, “more than six out of every 10
infectious diseases in humans are spread from animals” (CDC, 2013, p. 5).
Assumptions
I chose a qualitative research design for this study because the health promoting
behaviors of young adults in the Los Angeles County afflicted with CLD needed to be

16

explored and their voices needed to be heard rather than to use predetermined
information from the literature or relay on other studies. My first assumption was the
paradigm assumption that patterns and theories can be explicated to develop a significant
understanding of how young adults cope with CLD through the interview questions to get
to the heart of the problem.
The second philosophical assumption was that reality for the group of participants
is the result of individual interactions in their social worlds; therefore, meaning is
determined by their experiences, an assumption that was mediated through my own
perception (Creswell, 2009). Lastly, the study relied on the responses the participants
provided through interview questions, I assumed that the participants answered honestly
and truthfully. In addition, given the fact that the study was a phenomenological study;
the lived experiences of individuals were important to the study, the meaning of these
experiences was best given by the people who experienced them, and one should not be
preoccupied with method and the traditional concerns of reliability, generalization, or
validity (Golafshani, 2003). For the study to progress, I provided reassurance to the
participants by explaining how confidentiality will be preserved for the entire duration of
the study and in the future. The participants were also informed that they might withdraw
at any time without any ramifications.
Scope and Delimitations
Lyme disease (LD) is a controversial illness which has created battles for years
between opposing views in the prevalence of the infection, the accuracy of diagnosis,
effective modes of treatment, and the existence of a chronic form of the disease (Ostfeld,
2011). On one side of the argument are physicians and researchers who state that chronic
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Lyme disease (CLD) is difficult to contract, easy to diagnose, and effectively treated with
conventional oral antibiotics (Horowitz, 2013). On the other side of the controversy, are
groups of patients and health care practitioners who assert that LD is more severe and
common than presented by the CDC’s statistics, unrecognized, undiagnosed, and if left
untreated results in chronically infected patients (Horowitz, 2013).
Failure to investigate and address the size of the problem by the public health
community and health care providers has limited the development of sensitive diagnostic
tools, modes of treatment, and effective disease management (Ostfeld, 2011). This study
explored health promoting behaviors of male and female young adult’s ages 18-40 from
diverse racial/ethnical background, various levels of education as well as socio-economic
status, which did or did not have health care coverage. The participants were residents of
the Los Angeles County who had been clinically diagnosed with CLD and had received
or were receiving medical treatment or intervention including antibiotic therapy or
complementary and alternative medicine treatment. The age group chosen for this study
(18-40 years-old) was determined based on the level of activity, independence, and busy
lifestyle often demonstrated by this age group under normal healthy circumstances.
Persons excluded from the study included those who lacked medical diagnosis of CLD
either by clinical disease definition or confirmatory laboratory diagnostic tests, selfdiagnosed, patients with diagnosed CLD who had received any treatment, and those
outside the determined age group. Participants were recruited from social media groups;
the Facebook page “Chronic Lyme Disease” and the “California Lyme Disease
Association Los Angeles Chapter Support Group and Advocacy.”
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The HBM was selected as the theoretical framework for this study after careful
consideration was given to other theories and models frequently used in health promotion
such as Stages of Change (Transtheoretical model) and the theory of reasoned action.
Even though these models and theories relate to behavior change, they did not provide
the dimensions this study focused on which included the perceptions and lived
experiences of patients, including diagnostic methods, health benefits, perceived efficacy,
and therapeutic regimens used (Redding, Rossi, Velicer & Prochaske, 2000). The results
of this study may not produce transferability data to other CLD young adults in other
counties in California or other communities in the nation.
Limitations
Phenomenology, the nature of this qualitative research design, and data
subjectivity leads to difficulties in the following areas: establishing reliability and
validity, preventing or detecting researcher induced bias, interpreting data, and presenting
the results in a manner that is usable to health care and public health practitioners
(Shenton, 2004). In addition, there is no formula to determine sample size as in
quantitative studies and phenomenology does not generate generalizable data (Patton,
2002).
Potential weaknesses in the study included: first, achieve adequate participants’
enrollment to obtain theoretical saturation. Theoretical saturation is defined as “the phase
of qualitative data analysis in which the researcher has continued sampling and analyzing
data until no new data appear and all concepts in the theory are well-developed” (Morse,
2015). To achieve theoretical saturation, theoretical concepts were verified, conceptual
borders were marked, verification of no further need for additional data was ensured, and
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confirmation that the data analysis was data driven was performed. Second, introduction
of the researcher’s induced bias. Introduction of my bias were considered as a method of
dealing with them (see Rajendran, 2001). As the data “went through” my mind, I
confronted opinions and prejudices using a flexible approach which entailed talking
about myself, my choices, experiences, presuppositions, and actions during the research
process allowing the reader to visualize the choices and decisions I experienced during
the research inquiry (Ortlip, 2008).
Third, establish credibility as means on internal validity. I strived to promote
confidence, trust, and openness of the participants by developing early familiarity with
the participant’s culture before the data collection took place. Open ended questions were
posed during the interview process allowing the participants to articulate their
experiences dealing with CLD. A form of triangulation was used which involved the use
of a wide range of participants racial/ethnically, culturally, and financially diverse
viewpoints and experiences verified against each other (Patton; 2002; Rajendran, 2001;
Shenton, 2004).
Participant’s checks were performed at various times during data collection. The
participants had opportunities to read any transcripts of the dialogues and interviews they
participated in to ensure the information captured was indeed their intended words (Guba
1981; Patton, 2002). I used frequent debriefing sessions with the dissertation chair to
discuss the study approach, identify flaws, develop ideas, and recognize bias (Shenton,
2004) as well as peer scrutiny of the research by peers and colleagues.
The fourth and last potential weakness of the study discussed here as with any
qualitative research design is transferability or external validity. Since the findings of the
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study were specific to a small group of individuals in a geographical area it is impossible
to demonstrate applicability to other populations. The interpretation that the results of the
research can be applied to a wider population like Los Angeles County study population
affected by CLD are left up to the reader. My responsibility was to provide accurate
description of the phenomenon and sufficient contextual information of health promoting
behaviors of young adults with CLD, to enable the reader to make such a transfer
(Shenton, 2004).
Significance of the Study
I uniquely addressed in this study the need for a deeper understanding of the
impact of CLD on the health promoting behavior of ethnically diverse, young adults
residing in Los Angeles County through a qualitative examination of their lived
experiences. Results from this study may positively impact individuals, the community,
and society by shedding light on the nature and scope of this disease from the perspective
of those infected. I probed into the perceived effectiveness of conventional and
nonconventional treatment modalities, which may lay the foundation for re-examining
the care planning process. If treatment approaches are designed to meet the holistic needs
of CLD clients, this may erode perceived barriers and foster health promoting and
seeking behaviors.
In addition, this study was intended to increase awareness of the scope and nature
of CLD in a community with limited but growing infection rates (Hui, 2008; CDPH,
2014), so that providers and the public can work collaboratively to retard the spread of
this disease and safeguard the health and safety of society. This study may also serve as a
positive catalyst for societal change by altering health promoting behaviors of the public
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based, in part, of the lived experiences of the participants. Finally, it is the researcher’s
sincerest desire to see this study lay the foundation for future qualitative inquiry in the
nature and scope of CLD in the U.S. and abroad.
Summary
In this chapter, I provided a detailed description of the background of the study
and the problem statement. The purpose statement, research questions, theoretical
framework, and nature of the study were presented. Definitions of terms used were
provided to clarify the meaning as the terms relate to CLD. Assumptions, scope and
delimitations, as well as limitations of specific aspects of the research that were critical to
the meaningfulness of the study such as population’s boundaries, transferability, possible
weaknesses, and biases of the study were discussed. Significance of the study identified
potential contributions to the individual, the community, society, and public health
practice. The following chapter, the literature review, provides backing for the proposed
study; the problem serving as the catalyst for the study; and finally, the theory that
underpinned the study’s design and execution.
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Chapter 2: Review of the Literature
Introduction
Lyme disease (LD), a globally emerging infectious disease caused by the
spirochete bacteria Borrelia burgdorferi (Bb), is classified as the most common vectorborne (tick) infectious disease in North America and Europe (Aucott, Rebman, Crowder,
& Korte, 2013; Feng, Shi, Zhang, & Zhang, 2015) and one of the fastest growing
infectious diseases (Levi, Kilpatrick, Mangel, & Wilmers, 2012). The LD burden to the
individual and society remain high despite the knowledge and availability of prevention
measures (Cameron, Johnson & Maloney, 2014).
The incidence of LD ranges from 240,000 – 440,000 new cases a year (Gardner,
2012; Adrion, Aucott, Lemke, & Weiner, 2015; CDC, 2013) making LD at least twice as
common as breast cancer and six times more prevalent than HIV/AIDS (Stricker &
Middelveen, 2015; The Lyme Times, 2015). However, this number is underestimated due
to inconsistency in reporting by physicians and laboratories, number of undiagnosed
cases (Whitmont, 2012; Borgermans et al., 2014), and lack of standard diagnostic
practices in the states (Drew & Hewitt, 2006).
In some Eastern and Central states, LD is more prevalent than in Western states
(CDC, 2013). All the way to Southern California, both patients and practitioners fail to
recognize the disease, resulting in misdiagnosis and delayed treatment (Hui 2008; Swei,
Ostfeld, Lane, & Briggs, 2011). If diagnosis is missed or is treated inadequately the
patient may go on to develop devastating long-term chronic Lyme disease (CLD) or PostTreatment Lyme Disease Syndrome (PTLDS) consisting of many non-specific symptoms
affecting various body systems (Drew & Hewitt, 2006; Stricker, 2007; Borgermans et al.,
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2014). The purpose of this study was to explore the effect that CLD has on the health
promoting behaviors of ethnically diverse, insured, young adults from similar educational
and socio-economic backgrounds based on their lived experiences. The geographical
focus of this study was restricted to Los Angeles County, California, because there is a
general lack of awareness of LD and CLD on the West Coast of the United States (Hui
2008; Swei, Ostfeld, Lane, & Briggs, 2011).
In this chapter, I present a synthesis of the research literature relevant to LD and
CLD, coinfections, treatments, and associated issues affecting health promoting
behaviors of young adults with CLD. The specific literature search strategies and terms,
library databases, and search engines are presented to facilitate finding articles for future
reference and achieve reproducibility of the research. Previous and current application of
the HBM are reviewed and the ways the model constructs support this research are
discussed. Finally, the major themes elucidated in the literature review are summarized
and the ways this study addressed gaps found in the body of literature are presented.
Literature Search Strategy
Literature research was conducted using various sources to retrieve information.
Medline, PubMed, Google Scholar, Microsoft Academic Research, PLoS ONE, Bio One,
and Science Direct were searched using Internet Explorer and Google Chrome as search
engines. The Walden online library Health Sciences Research databases which included
in addition to Medline, PubMed, and Scientific Direct; CINAHL Plus, ProQuest,
PsycINFO, and evidence based and clinical resources such as Cochrane, Health
Technology Assessments, and Annual Reviews (Walden, 2015). All databases were
searched with the terms Lyme Disease, Chronic Lyme Disease, Lyme Disease in
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California, or neuroborreliosis, in combination with case definition, statistics, diagnosis,
treatment, prevention, climate change, ecology, epidemiology, prevention controversies,
health promoting behaviors, young adults, or specific vector-borne infections associated
with LD for reports published after January 2010. I conducted many searches. Inquiry
using the words CLD in Google Chrome search engine produced an unbelievable
7,540,000 results. Narrowing the inquiry with the words Lyme Disease in California
produced 1,100,000 results that significantly decreased in articled to 330 when using
Google Scholar search engine. When searching with much more specific words related to
the topic of this study, health promoting behaviors in young adults with CLD I obtained
594 results by using Google scholar engine of which only two articles were relevant to
my topic of study. I obtained similar results when using the different databases available
at Walden University Library.
I conducted a review of the reference list of reports identified by the searches and
selected articles as a strategy to locate additional relevant articles. Familiarity with CLD
and the scientific literature was relied upon to search Lyme Disease Associations Journals
available through memberships and Lyme Literate Medical Doctors’ offices. Non-peerreviewed publication, narratives, opinions, magazines, and newspaper articles provided
lead to other sources that ultimately lead to systematic investigations, evidence based
studies, and scientific data.
I selected reports from the past 5 years, but I did not exclude older publications
that were unique in its informational content and deemed useful. I selected books and
reviews on LD, CLD treatments, ecology of LD, medicinal plants, and alternative and
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complementary medicine chapters to be cited as additional and comprehensive sources of
references.
Selected articles and resources that I included in this study were full text, peerreviewed publications, evidence based scientific data, research, and information
pertaining and affecting health promoting behaviors of young adults with CLD. Articles
and literature resources focusing on the aforementioned LD and CLD themes affecting
children under 18 years of age or over 40 years old, as well as those articles that
concentrated on the East and Central states LD etiological agents and disease presentation
were excluded. Exclusion took place to maintain the focus on research findings and
disease presentation in California, which directly affect LD spreading to Southern
California specifically to Los Angeles County’s active, young adult communities in the
age group 18 to 40 years old.
Articles, Master’s theses, or PhD dissertations relating directly with health
promoting behaviors of young adults affected with CLD were limited. As I mentioned, a
total of two closely related qualitative phenomenological studies using the HBM as
theoretical framework were found and one PhD dissertation which focused mainly on the
ecology of LD and the global pending epidemic to be acknowledged by the medical and
public health community. I used databases and search engines since the preliminary
stages of the study; from the initial drafting of the study prospectus and such practice
continued to submission of the revised and final version of the study.
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Theoretical Foundation
The Health Belief Model
The aim of public health practitioners is to achieve the mission of the
multidisciplinary field of public health; prevent disease and death, promote a better
quality of life, and create environmental conditions and interventions geared to healthy
individuals, the community, and the society at large (Behavioral Change Models, 2012;
Schiavo, 2007). For public health practitioners to achieve the public health mission, a set
of skills and qualities as described in the following sentence are essential. In addition to
possessing the skills to define and identify public health problems, assess causes of the
problem, identify population at risk, implement interventions, and evaluate outcomes; the
public health practitioner must know how to apply theories, basic principles, research
findings, and methods to inform their efforts (Crosby, DiClemente & Salazar, 2006;
Schiavo, 2007).
The HBM mainly derived from social and behavioral sciences, as is the case with
other behavioral change models, allows practitioners to assess public health problem
fundamental causes and develop public health interventions to address those problems
(Behavioral Change Models, 2012; Burke, 2013). The origin of the HBM dates to 1947
with Kurt Lewin’s theory who stated, “Behavior change is determined by how people
value a particular outcome and the assumption that certain actions will facilitate that
outcome” (Becker, Rosenstock, & Slack, 1974, p. 328).
According to his theory, perceptions of reality, not objective reality is what
influences behavior; is the world of the perceiver that determines what an individual will
and will not do (United States Department of Health and Human Services [DHHS],
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2002). The developers of the HBM were United States Public Health Services research
psychologist Godfrey Hochbaum, behavioral scientist Stephen Kegels, and psychologist
Irwin Rosenstock greatly influenced by Kurt Lewin’s theory (DHHS, 2002). The purpose
of the model was to explain and predict human behavior using a systematic method
focused on the relationship of health behaviors, practices, and utilization of health
services.
Currently, scientist consider the HBM as the beginning of systematic, theorybased research in health behavior and include general motivation to distinguish health
behavior from illness and sick-role behavior (DHHS, 2002). The professional training
and background of the HBM originators and the health settings of the 1950s, mainly
disease prevention and not treatment or concern for symptoms and medical regimen’s
compliance, were leading factors to the development of the HBM (DHHS, 2002; NICE
2007). Hochbaum, Kegels, and Rosenstock popularized the HBM to better understand the
widespread failure of people to participate in programs to diagnose or prevent disease
(Crosby, DiClemente, & Salazar, 2006; NICE 2007; Schiavo, 2007).
The Health Belief Model Brief Description
The hypothesis of the HBM states that health related action depends upon three
different factors occurring simultaneously. First, general health values: sufficient health
concern or motivation to make health issues relevant or salient. Second, specific health
values about vulnerability to a health threat: belief of one’s susceptibility or vulnerability
to a serious health problem, illness, condition or its sequelae (perceived threat). Third,
beliefs about the consequences of the health problem: the belief that following a health
recommendation at a subjectively accepted cost (perceived barrier) would reduce the
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perceived threat (Behavioral Change Models, 2012; Rosenstock, Strecher, & Becker,
1988).
Motivation to undertake a specific health behavior would then be based on
individual perceptions dealing with the importance of health to the individual, perceived
susceptibility, perceived severity and modifying behaviors and demographic variables
would influence perceived threat that directly influences likelihood of action (Behavioral
Change Models, 2012). The conceptual model explains individual perceptions in a
disease. It is influenced by modifying factors such as age, sex, ethnicity, personality,
insurance status, educational level, socio-economic, and knowledge which, in turn,
influence the likelihood of action and perceived threat of disease modified by education,
symptoms, and media information directly affecting likelihood of behavioral change
(Crosby et al., 2006; Redding, Rossi, Velicer, & Prochaske, 2000,).
Dimensions of the Health Belief Model
The HBM consists of six constructs (NICE, 2007). The first four constructs are
the original tenets developed by Hochbaum, Kegels, and Rosenstock. The last two
constructs were added later as research on the HBM evolved (Behavioral Change
Models, 2012; NIH, 2010).
1. Perceived susceptibility: refers to the individual’s subjective perception of the
risks involved in contracting a disease or condition (Janz & Becker, 1984;
Rosenstock, 1974). This construct considers the individual’s vulnerability and
wide variation in feelings regarding belief in the diagnosis, estimates of
susceptibility to a disease or condition, and susceptibility to illness in general
(Behavioral Change Models, 2012).
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2. Perceived severity: refers to the individual’s feelings concerning the seriousness
of contracting the disease, leaving the disease untreated, and clinical, medical, and
social consequences of the choices made. This dimension includes how the illness
affects family life, work, social relations, disability, pain, and death (Behavioral
Change Models, 2012; Janz & Becker, 1984; Rosenstock, 1974). The
combination of perceived susceptibility and perceived severity is termed
perceived threat (Janz & Becker, 1984).
3. Perceived benefits: this dimension refers to the individual perception of the
effectiveness to reduce or cure the illness. When individual considers the
available action to take based on the perceived susceptibility and severity. The
threatened individual would be expected to accept the recommended health action
when such action is perceived as efficacious and feasible (Behavioral Change
Models, 2012; Janz & Becker, 1984).
4. Perceived barriers: refers to the individual’s feelings on the obstacles present
when performing a recommended health action (Behavioral Change Models,
2012). Possible negative aspects considered by the individual regarding the
recommended health action may include cost, dangerous side effects, unpleasant
outcomes, painful, difficult, time consuming, and inconvenient (Janz & Becker,
1984).
5.

Cues to action: refers to anything that triggers a decision to change

behavior (Burke, 2013) the individual’s motivation to external or internal cues
triggers action to take place regarding a recommended health action. Cues to
action include physician’s advice, a change in health, wheezing, chest pains, death
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of a friend, illness of family member, advice from others, newspaper article, and
fleeting events elusive to record (Behavioral Change Models, 2012; Rosenstock,
1974).
6. Self-efficacy: Efficacy is directly affected by the level of the individual’s
confidence in their ability to perform a behavior successfully (Behavioral Change
Models, 2012). The most influential source of efficacy is performance
accomplishment, followed by vicarious experience obtained through observation
of other’s performance both successfully or unsuccessfully. Less powerful sources
of efficacy include verbal persuasion or exhortation and physiological states of
the individual (Rosenstock, Strecher, & Becker, 1994).
Limitations of the Health Belief Model
The HBM being more descriptive than explanatory does not suggest specific
strategies to produce change in health-related actions. Several limitations exist which
limit the HBM’s utility in public health. The model does not consider the individual’s
beliefs, attitudes, habitual behaviors, environmental, cultural factors, socioeconomic
status, and previous experiences that promote or inhibit the recommended health action
(Behavioral Change Models, 2012). The model also assumes that every person possesses
the same amount of information on the disease, illness, or condition and that “health”
action is the main goal in the individual’s decision-making process (Behavioral Change
Models, 2012; DHHS, 2002). Even though the HBM may be useful to derive information
leading to interventions designed to change health behaviors and health beliefs, the model
fails to inform decision making how to best structure those interventions (NIH, 2007).
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Applications of the Health Belief Model
The HBM since is development has been used as a conceptual formulation in
predicting health behaviors to understand the reason individuals engage or do not engage
in a wide variety of health-related actions; preventive health behaviors, sick role
behaviors, and clinic utilization (Janz & Becker, 1984). A critical review of 46 HBM
related studies carried by Janz and Becker (1984) consisting of preventive health
behavior studies (influenza vaccine, genetic screening, risk factors), sick-role behavior
(antihypertensive, diabetic, end-stage renal disease, mother’s compliance for child’s
condition regimens, and physician visit for symptoms), and clinic utilization, provided
substantial empirical support for the HBM.
Across the study designs, both prospective and retrospective, the perceived
susceptibility dimension was a strong contributor to understand preventive health
behaviors than sick role behaviors. Perceived barriers proven the most powerful of the
HBM dimensions, and perceived severity had the lowest overall significance ratio with a
weak association with preventive health behaviors and strongly related to sick-role
behaviors. On current studies, King, Vidourek, English, and Merianos (2014) obtained
the same results when applying the HMB: “Vigorous physical activity among college
students: using the HBM to assess involvement and social support.” In addition, in
studies such as “Comparing Theory-Based Condom Interventions: HBM Versus Theory
of Planned Behavior” (Montanaro & Bryan, 2014), or “An Empirical Study to explore the
adoption of Telehealth: HBM Perspective” (Hsieh, & Tsai, 2013); the results have
indicated that theory based interventions and research are superior to those not guided by
theory.
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Jones, Jones, and Katz, (1991) evaluated the HBM as a method to increase
compliance among acute and chronic patients visiting the Emergency Department. The
HBM suggests that a patient’s adherence to professional advice depends upon perceived
susceptibility, perceived severity, benefits, and cost after evaluating an estimate of what
barriers might be involved in undertaking the recommended health action (Behavioral
Change Models, 2012). In chronic diseases in which an illness episode represents flareups, compliance decreases with the treatment complexity and regimen’s duration. Jones,
Jones, and Katz, (1991) found that positive treatment experience, demographic variables
such as age, and knowledge of the illness affects a HBM intervention on compliance.
Using the dimensions of the HBM, Ali, Vitulano, Lee, Weiss, and Colson (2014)
conducted a qualitative, phenomenological study in 12 adult participants with CLD. The
HBM dimensions provided insights into the health beliefs and lived experiences of CLD
individuals in the health care system and their beliefs and expectations. By discussion
with each study participant on the HBM dimensions which included their perceptions of
susceptibility to CLD, severity of symptoms, benefits of treatment, barriers to treatment,
cues to action, and self-efficacy; Ali, Vitulano, Lee, Weiss & Colson (2014) formulated
emerging themes. Based on the participants perceptions and descriptions of their
experiences four distinct themes emerged: changes in health status and social impact of
CLD, doubts about recovery and the future, contrasting doctor-patient relationships, and
unconventional therapies to treat CLD.
Rationale for Using the Health Belief Model
Review of the literature yielded applications of the HBM pertaining to studies on
diseases, illnesses, both acute and chronic conditions, health promoting behaviors, and
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implementation of interventions. The HBM provided theoretical constructs to carry this
study on health promoting behaviors of young adults with CLD in a designated
geographical area. In addition, the model supported the current study by providing a
framework for the formulation of research questions and the questions for the semistructured interview based on each of the HBM dimensions. The model fit the study
foundation to explain and predict health behaviors of CLD by focusing on the attitudes
and beliefs of the individuals afflicted with the disease. Since the HBM is an
intrapersonal theory used in health promotion to design intervention and prevention
programs, the model aligned with the significance of the study to increase awareness,
promulgate prevention, retard the spread of the disease, and safeguard the health and
safety of society.
Literature Review Related to Key Variables and/or Concepts
A Brief History of Lyme Disease
Lyme disease (LD), caused by the Borrelia burgdorferi sensu lato complex, is the
most prevalent and reported tick-borne infection in the United States and Europe (Levi,
Kilpatrick, Mangel, & Wilmers, 2012; Stene et al., 2011) with increasing public health
importance (Aucott, Rebman, Crowder, & Kortte, 2013). The list of experiences, health
beliefs, and concerns of patients identified with CLD is extensive including the basic
validation of being sick, considerable limitation of daily life’s activities, decline in health
status, long-term debilitation, severe and varied symptomology, and psychological stress
(Ali, Vitulano, Lee, Weiss & Colson, 2014). In addition, apparent stigma and bias
perception within the medical community attached to chronic Lyme disease have resulted
in diagnosis and treatment delay (Aronowitz, 2011). Many patients see 15 to 20
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physicians searching for answers for diagnosis and treatment before correct diagnosis is
achieved (Horowitz, 2013). CLD patients’ negative experiences with physicians and
insurance companies have led to mixed feelings and opinions on the health care system,
public health practitioners, and health care policy makers (Ali, Vitulano, Lee, Weiss &
Colson, 2014; Aronowitz, 2011; Horowitz, 2013). Some of those experiences include
disallowance for longer antibiotic therapy than 30 days as standard of care for Lyme
disease, ineffective treatments, fruitless testing, and unsatisfying explanations (Johnson,
2013; Lantos, 2011). The following in depth literature review describes studies related to
the methods consistent with the scope of the study and the research questions, explores
basic case definition of CLD, history of the disease, epidemiology and ecology,
transmission, symptoms and disease presentation, characteristics of the LD etiologic
agent Bb, diagnosis, treatment, and prevention of LD.
To understand the roots of the decline in health status associated with the disease
impacting health promoting behaviors of young adults in California, what is controversial
and what remains to be studied are also reviewed. Researchers in the field of
epidemiology have just recently began involvement in studies to explore the lived
experiences of those diagnosed with CLD as evidenced by the limited numbers of studies
found in the literature. In a study conducted by Ali, Vitulano, Lee, Weiss & Colson,
2014) the authors used a qualitative phenomenological study on 12 patients with CLD to
gain insights on the participants experiences with the disease, perceptions of CLD
burden, and changes in the health and social status using the dimensions of the HBM.
Based on 60 – 90-minute semi-structured interviews the authors could recognize the
emergence of four major themes from the participant’s perceptions and experiences with
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CLD: “changes in health status and social impact of CLD,” “doubts about recovery and
the future,” “contrasting doctor-patient relationships,” and “unconventional therapies to
treat CLD.” Another qualitative approach to understanding patients diagnosed with CLD
was carried by Drew & Hewitt (2006) on a sample of 10 participants diagnosed with
CLD. Drew & Hewitt (2006) also used interviews to discover six emerging themes:
frustration, long road to diagnosis, financial stress, self-advocacy, validation and
explanation of symptoms, and sense of hopefulness. The strength found in these two
studies approaches is the methodology used to obtain a deep understanding of the lived
experiences of becoming diagnosed with CLD that will allow health care practitioners to
develop new strategies and interventions as well as advocate for CLD patient’s policy
development in the public health care environment.
Ali, Vitulano, Lee, Weiss, and Colson (2014) and Drew and Hewitt (2006)
qualitative studies on CLD were both conducted on Caucasian participants ranging from
20 - 69 years old, a weakness in their approach and application of the study as it relates to
the current racial/ethnic diversity and age of those affected with CLD in California. The
severity of CLD compared to other chronic conditions quality of life survey carried by
Johnson, Wilcox, Mankoff, and Stricker (2014) using the CDC health related quality of
life (HRQoL) indicators (used to identify health needs, determine the burden of disease,
and direct public health policy in the nation) found that CLD patients reported: increased
utilization of health care services, impairment in their ability to work, lower health
quality status, more bad physical and mental health days, greater activity limitations,
significant burdens due to the disease symptoms, and more out of pocket medical
expenses compared to the general population. Aucott, Rebman, Crowder, and Kortte
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(2012) results of a prospective study of 63 participants with erythema migrans (EM)
complements the results found in the survey carried by Johnson, Wilcox, Mankoff, and
Stricker (2014). The authors found in the study that antibiotic treated EM patient’s signs
and symptoms disappeared. In addition, new onset of symptoms increased after six
months significantly lowering life functions compared to those who did not develop post
treatment LD or CLD. Statistically significant differences found in CLD patients
compared with non-CLD individuals included social functioning, vitality, and physical
and emotional health (Aucott, Crowder, & Kortte, 2013).
Diagnostic challenges and the lack of a concise case definition of CLD, essentials
for satisfactory disease management due to the non-specific nature of many of CLD
manifestations
(Aucott, Crowder & Kortte, 2013; Stanek et al., 2010) are part of the problem with the
disease. CLD diagnostic challenges stems from there being more than a dozen recognized
genomic groups or Geno species of the Borrelia burgdorferi sensu lato complex (Center
for Food Security and Public Health, 2011; Clark, Leydet & Threlkeld, 2014; Shapiro,
2014). Each genomic group may cause a somewhat different syndrome with somewhat
different clinical presentation depending of its geographical distribution, which in turn
makes clinical and laboratory diagnosis a challenge (Buhner, 2005; Center for Food
Security and Public Health, 2011). Genomic groups known to cause LD in humans
include Borrelia burgdorferi sensu stricto (Bb), B. garinii, B. afzelii and the recently
recognized species: B. lodestars, B. andersonii, B. japonica, B. spielmanii, B. bissettii, B.
Lusitanian, B. miyamotoi, and B. valaisiana (Center for Food Security and Public Health,
2011; Clark, Leydet & Threlkeld, 2014; Rizzoli, Hauffe, Carpi, Neteler, & Rosa, 2011;
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Shapiro, 2014). The “Epidemiology and Ecology” section of this literature review
discusses more details on the geographical distribution of Bb. Case definitions are of
critical value in clinical management for collection and analysis of laboratory data as
supporting or confirmatory evidence of the disease and a requisite for reliable
epidemiological studies (Stanek et al., 2011). The CDC (2011) uses case definition of LD
for reporting surveillance purposes only. The case definition not intended for diagnostic
purposes is described by the CDC (2011) as “a systemic, tick borne disease with protean
manifestations, including dermatologic, rheumatologic, neurologic, and cardiac
abnormalities.” The most common marker for the disease is EM, the initial skin lesion
that occurs in 60% - 80% of patients (CDC, 2011; EID, 2013). Laboratory criteria
established by the CDC (2011) for diagnosis for surveillance purposes only are:
•

Positive culture for Bb, or

•

Two-tier testing adhering to established criteria where Positive Immunoglobulin
M (IgM) is sufficient only when ≤ 30 days from symptom onset or Positive IgG is
sufficient at any point during illness

•

Positive Single tier IgG immunoblot

•

CSF antibody positive for Bb by Enzyme Immunoassay (EIA) or
Immunofluorescence Assay (IFA), when the titer is higher than it was in serum

The CDC criteria classify LD cases as suspected, probable, and confirmed (CDC, 2011).
On the other hand, the case definition of CLD is non-existing at the CDC website.
Instead, the CDC has given the term PTLDS to those cases that after four to six weeks of
antibiotic treatment have symptoms of fatigue lasting more than six months (CDC, 2015;
Ljostad & Mygland, 2013). The Infectious Disease Society of America (2011) case
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definition of PTLDS includes a documented episode of early or late LD, with resolution
of objective symptoms of LD, with subsequent onset of symptoms. Such symptoms
include of fatigue, musculoskeletal pain, and cognitive complaints severe enough to
affect the individual’s functional ability in daily life persisting more than six months after
treatment (Perrone, 2015; Rissenberg & Chambers 1998). However, in long-term
duration untreated LD patients whether in early or late phases of LD, experience the same
symptoms: fatigue, musculoskeletal pain, and cognitive dysfunction persisting for years
affecting quality of life of the individuals both physically and socially (Aucott, Crowder,
& Kortte, 2013). One may ask then what CLD is.
CLD is “considered a constellation of persistent symptoms in patients with or
without evidence of Bb infection” (Borgermans et al., 2014). The clinical definition of
CLD refers to the continuation of such symptoms such as fatigue, arthralgia, myalgia,
headache, and memory loss after antibiotic therapy for LD (Fallon, Petkova, Keilp, &
Britton, 2012; Hu, 2012). Fatigue is not uncommon after antibiotic treatment of LD that
persists for several months; however, CLD patients experience polarized symptoms like
those seen in chronic fatigue syndrome and fibromyalgia (Buhner, 2005; Horowitz, 2013;
Hu, 2012). There are currently no serological tests or specific biomarkers to define CLD
as antibiotic treatment may prevent seroconversion of seronegative early LD cases
(Aucott, Crowder, & Kortte, 2013). Therefore, PTLDS and CLD seem to be synonymous
even though the legitimate clinical entity of CLD, definition, and diagnosis has become
highly controversial (Ali, Vitulano, Lee, Weiss & Colson, 2014; Aronowitz, 2011;
Horowitz, 2013; Hu, 2012). As stated by Aronowitz (2011), although the definition of a
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disease is limited by biological processes, what counts as a new disease often depends on
values, interests, and contingent historical events.
Spirochetes (the causative agent of LD) are some of the most ancient bacteria on
Earth; they have been around billions of years and have evolved to develop separate
DNA strands or plasmids just for humans (Buhner, 2005). Ticks, the vector of Lyme
disease, are resilient, persistent in the environment, inhabit almost every continent with
over 850 species, and fossil evidence suggest that they originated 65 – 146 million years
ago (IOM, 2013). The earliest human case of LD was designated as Lyme borreliosis
(LB) and was found on a 5,300-year-old Copper age individual known as the Tyrolean
Iceman discovered by two hikers in the Tisenjoch Pass in the Alps (Italy) in 1991 (Keller
et al., 2012). The Bb genome was 60% characterized in this mummy by whole genome
sequencing indicative of LB (Keller et al., 2011). Scientist use as evidence of transfer
across Siberia into Alaska between 30,000 BCE and 10,000 BCE by the genomic variety,
presence, and complexity of the LB species in northern Asia (Ostfeld, 2011). In addition,
unique genome alterations of the American Bb in Europe suggest spread of the organism
by heavy European contact after 1492 (Ostfeld, 2011). In Europe, as early as 1910
clinicians recognized that following a tick bite a rash they called erythema chronicum
migrans (now referred to as erythema migrans) was connected to most likely a bacterium
probably a Rickettsia associated with meningitis (Aronowitz, 2011). In the United States,
the first reported case of erythema migrans (EM) occurred in 1970 in Wisconsin and the
first cluster of EM cases was in Groton, Connecticut in 1976 reported in the Journal of
the American Medical Association by a physician of the naval base in Groton
(Aronowitz, 2011). Around the same time, a Yale rheumatologist investigated a
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significant number of children and adults in the closely located communities of Lyme,
Old Lyme, and East Haddam, Connecticut. The practitioner found patients afflicted by an
undiagnosed illness consisting of swollen joints and other problems including a rash in
25% of the patients regarded as juvenile arthritis (Aronowitz, 2011; Buhner, 2005;
Ostfeld, 2011; Randolf, Caimano, Stenson, & Hu, 2012). While looking for rickettsia in
ticks from Shelter Island, New York, Willy Burgdorfer—a native from Switzerland
working at Rocky Mountain Laboratory in Montana—discovered the spirochete that
causes Lyme in 1981(Buhner, 2005; Mervine, 2015; Ostfeld, 2011). While dissecting
ticks, Burgdorfer noticed a nematode in the hemolymph or blood of two female ticks and
decided to check the digestive system for more worms. He made smears of the tick’s
midgut and discovered poorly stained, coiled, bacteria that he confirmed as spirochetes
by dark field microscopy (Mervine, 2015). The spirochetes reacted with the serum of
those individuals in Lyme, Connecticut afflicted with the undiagnosed illness (Ostfeld,
2011). The disease was renamed Lyme disease and the spirochete Borrelia burgdorferi in
honor of Willy Burgdorfer (Buhner, 2005; Ostfeld, 2011; Randolf, Caimano, Stenson, &
Hu, 2012). Borrelia burgdorferi sensu lato has been infecting humans for a very long
time, yet it was not until just recently that, the spirochete could be seen under a
microscope, isolated, and grown in laboratory specialized media (Randolf, Caimano,
Stenson, & Hu, 2012).
Ecology, Epidemiology and Transmission of Lyme Disease
Lyme disease (LD) is an emerging vector-borne disease of global importance
creating new challenges for public health (Kilpatrick & Randolph, 2012). The ecology of
LD is based on the interactions of Bb (the pathogenic agent), Ixodes ticks (the vector),
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and the vertebrate reservoir hosts (Rizzoli, Hauffe, Carpi, Neteler, & Rosa, 2011). LD
etiological agent Borrelia burgdorferi (Bb) is an exotic pathogen that has increased
incidence in endemic regions, causes serious impact when introduced to new regions
infecting local populations for the first time, and has increased number of infected people
each year (Ostfeld, 2011). The emergence of LD in the 20th century is believed to have
underpinnings to the reforestation in the northeastern region of North America which
caused recolonization by deer, a range-wide decline of the red fox, expansion of coyote
population, and subsequently multiplication of ticks effectively predicting the spatial
distribution of LD (Kilpatrick & Randolph, 2012; Levi, Kilpatrick, Mangel & Wilmers,
2012). Even though deer are an incompetent host of LD they supply good feeding for
adult ticks (Kilpatrick & Randolph, 2012) and are important in the maintenance of the
Ixodes tick population because the adult ticks mate on them (Randolf, Caimano, Stenson,
& Hu, 2012). Forest fragmentation and changes in predator communities have influenced
increased abundance of small mammals such as white-footed mice, shrews, and eastern
chipmunks that are the main transmission hosts of Bb in the eastern states (Ostfeld,
2011). The increase of available host’s results in increased numbers of Bb infected
nymphal ticks which the main biting vector stage infecting humans (Ostfeld, 2011). In
addition to change in geographic range, other factors that determine the expansion of
ticks and Bb population to expand and drive invasion include temperature and rainfall
affecting the climate, habitat, host species range and density and the presence/adaptation
of competent vector species (Anguita, Hedrick, & Fikrig, 2013; Ogden, Mechai &
Margos, 2013). Ticks spend majority of their life living free in the environment off hosts,
subject to weather and climatic conditions (Brunner, Killilea & Ostfeld, 2012). Direct
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regulation in abundance of transmitting vectors occurs by climate changes including
desiccation, overheating, and freezing while indirect regulation examples include climate
altering vegetation structure and type (Kessing et al., 2009; Medlock & Leach, 2015).
Ecological conditions must be just right to support this zoonotic illness (Kessing et al.,
2009; Shapiro, 2015). Loss of biodiversity affects the transmission of Bb by changing the
abundance of the vector or host; the loss of a species from an ecological community has
the potential to increase disease transmission (Devevey & Brisson, 2012). In the case of
LD in the eastern States the white-footed mouse (an ecological resilient host) is the most
abundant, most competent, and the highest quality host for immature ticks infecting high
proportion of ticks (Kessing et al, 2010; Ostfeld, 2012). The opossums, in contrast, are
poor hosts for Bb since it kills most of the ticks that try to feed on them; therefore, ticks
are absent from degraded forests and low diversity forest fragments (Ostfeld, 2011). As
biodiversity is lost the opossum disappears (strong buffering effect) and the mouse
remains (strong amplifying effect) (Bouchard et al., 2013; Kessing et al., 2010; Ostfeld,
2011).
Reports of LD and CLD have been documented in North America, Europe, Asia,
and Australia with recent acknowledgement of the disease in Mexico, Colombia, and
Brazil (Center for Food Security and Public Health, 2011). Scientists have reported that
Borrelia burgdorferi sensu stricto is the main cause of LD and the only genospecies
responsible for human disease in the United States. However, a novel Borrelia
burgdorferi sensu lato complex strain Borrelia carolinensis sp. has been isolated from
rodents and ticks in the southeastern states (Rudenko, Golovchenco, Grubhoffer &
Oliver, 2011). Borrelia kurtenbachii is widely distributed in North America (Margos,
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Piesman, Lane, Ogden, Sing, Straubinger, and Fingerle, 2014) and Borrelia americana
strains are isolated in California (Rudenko, Golovchenko, Tao Lin, Grubhoffer & Oliver,
2009) like B. bissettii which has been identified as causing human disease (Clark, Leydet
& Threlkeld, 2014). In a study conducted by Ogden et al. (2011), ticks infected with Bb
also carry Borrelia miyamotoi with no diagnostic methods available. The advancement in
bioinformatics and recent development of Next Generation Sequencing (NGS) methods
have made great advances in research epidemiology and proven to have enormous
potential to detect and survey Borrelia genotypes in vectors and various localities
(Vayssier-Taussat et al., 2013). Borrelia burgdorferi sensu stricto is endemic in
northeastern and mid-Atlantic states, northeastern U.S., and the Pacific coast (Center for
Food Security and Public Health, 2011) documented in 47 out of 50 states (McKechnie,
2016). B. burgdorferi sensu lato complex comprises over 20 genospecies (genotypes) of
which B. afzelii, B. garinii, B. burgdorferi sensu stricto, B. bavariensis, and B. spielmanii
(associated with skin disease) are pathogenic in Europe (Makhani, Morris, Page, Brophy,
Lindsay & Banwell, 2011; Stanek & Reiter, 2011). They are mainly transmitted by the
tick Ixodes ricinus, where B. afzelii and B. garinii are found to be the most common of
the genospecies (Rizzoli, Hauffe, Carpi, Voutch, Neteler, & Rosa, 2011; Randolf,
Caimano, Stenson, & Hu, 2012). Studies have reported B. afzelii, B. burgdorferi sensu
stricto, B. lusitaniae, B. spielmanii, and B. valaisiana in Russia. B. afzelii and B.
burgdorferi sensu stricto have been detected in Taiwan; while B. bissettii, B. valaisiana,
B. lusitaniae, and B, miyamotoi have also been found in Asian countries (Center for Food
Security and Public Health, 2011; Perrone, 2014; Randolf, Caimano, Stenson, & Hu,
2012). See Appendix A for a list of bacteria responsible for LD, Lyme like diseases, other
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Borrelia burgdorferi sensu lato complexes, and other tick-borne microorganisms isolated
in humans.
Europe considered endemic for LB has an incidence ranging from several to more
than 100 confirmed cases per 100,000 inhabitants (Lewandowska, Kruba & Filip, 2013).
In the United States, the total incidence is 7.9, with some states such as Maine,
Massachusetts, Connecticut, New Hampshire, Pennsylvania, and Rhode Island’s
incidence ranging from 50 to 89 confirmed cases per 100,000 population (CDC, 2015).
The average incidence rate in California of reported confirmed cases is 0.23 per 100,000
Californians (CDPH, 2011). Scientist attribute the geographical variation in LB incidence
to environmental factors that affect abundance, occurrence, activity of hosts and tick
vectors, regional variation of genotypes, the efficiency of transmission cycles, and /or the
behavior of humans (Margos et al., 2012).
B. burgdorferi sensu stricto is transmitted in North America primarily by the
blacklegged tick Ixodes scapularis east of the Rocky Mountains and by Ixodes pacificus
in the far Western states (Ostfeld, 2011; Margos et al., 2012). Bb has also been isolated in
mites (Russia), biting flies (Germany and Connecticut), fleas, and biting mosquitoes
(Ostfeld, 2011). Although Bb is thought not to be transmitted via the environment or
body fluids once an individual is infected, the spirochete can be found in breast milk,
blood, urine, tears, and semen (Buhner, 2005; CDC, 2014; Center for Food Security and
Public Health, 2011). Studies have also shown that babies contracted the infection in the
womb (Horovitz, 2013). Bb can survive up to 48 days in human blood processed for
transfusion and stored at 4°C (Center for Food Security and Public Health, 2011).
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Seventy percent ethanol and by 1% sodium hypochloride inactivate the organism (Center
for Food Security and Public Health, 2011).
Ixodes pacificus in California is known to infest more than 100 species of lizards,
birds, squirrels, and mammals including dogs, cats, horses, cows, goats, pigs, and sheep
(Hasle, 2013; Newman et al., 2015; Ostfeld, 2011). Reservoirs hosts are animals that can
carry a significant number of infected ticks without getting sick themselves (Center for
Food Security and Public Health, 2011). B. burgdorferi sensu lato primary reservoir hosts
in California are the dusky-footed woodrat, the western gray squirrel, and birds (Newman
et al., 2015). Salkeld, Leonhard, Girard, Hahn, Padgett & Lane (2008) investigated the
role of the western gray squirrel (Sciurus griseus) as a reservoir host for Bb by surveying
222 western gray squirrels in California showing an overall prevalence of Bb infection of
30% to 50% by polymerase chain reaction (PCR). Birds, because of the long distance
they travel, are an important host of the spirochete (Ostfeld, 2011; Sahagun, 2014). Birds
can easily cross barriers like fences, oceans, mountains, glaciers, and desserts that stops
mammals; birds are also much faster at transporting infected ticks and possibly serve as
hosts for Bb transfer through co-feeding between ticks (Hasle, 2013; Nanoka, Ebel, &
Wearing, 2010). Co-feeding must occur in close spatial and temporal proximity as
illustrated in the diagram below; Figure 2 (A) illustrates infected nymph to larva cofeeding transmission of Borrelia spirochetes in a mouse reservoir host in which “larva 1”
acquires spirochetes, but “larva 2” does not as it is too distant from the infected lymph.
Figure 2 (B) illustrates systemic transmission in which larva can acquire spirochetes
anywhere they bite the infected mouse (Voordouw, 2015). Co- feeding transmission may

46

facilitate contact between isolated Borrelia species, allow genetic exchange between
Borrelia, and contribute to mixed infections (Voordouw, 2015).

Figure 2. Co-feeding and Systemic Transmission of Borrelia. Voordouw, M. J. (2015).
Co-feeding transmission in LD pathogens. Parasitology 142, 290-302. Copyright 2014
Cambridge University Press.
The relapsing fever spirochete Borrelia miyamotoi transmitted by nymphal I.
pacificus tick causes an illness like Lyme disease and was identified by Chowdri et al.
(2013) by reversing the traditional approach to disease discover (Branda & Rosenberg,
2013). B. miyamotoi was first isolated in Japan. Scientist have detected the organism in
blacked legged ixodid ticks in Russia and North America (Branda & Rosenberg, 2013).
Chowdri et al. (2013) first identified the infectious agent by PCR in the vector then
searched for human disease correlation. This accelerated the discovery of the Borrelia
miyamotoi human infection that overlaps neurological symptoms experienced by chronic
Lyme disease patients (Branda & Rosenberg, 2013). Scientist added B. miyamotoi to the
California statewide tick-testing program to enhance understanding of this novel
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pathogen ecology, geographic range, and prevalence in California as well as its relation
to coinfections in CLD (Padgett et al., 2014).
Risk behaviors associated with exposure to nymphal stage of Ixodes pacificus
ticks in California in descending rank are: sitting on logs in deciduous hardwood forest,
gathering wood, sitting against trees, contact with leaf litter either by stirring, walking or
sitting on leaf litter (Lane, Steinlein, & Mun, 2014). The western fence lizards play a
unique role in LD ecology in California serving for blood meal hosts to larval and
nymphal ixodid ticks rather than mammals, but are non-competent host for reservoir of
Bb (Swei, Ostfeld, Lane & Briggs, 2011). The western fence lizard has a protein in their
blood that kills Bb; as a result, few adult ticks carry the organism (Klein, 2013). In a
study conducted by Swei, Ostfeld, Lane & Briggs (2011) it was found that an
incompetent host reservoir for Bb, such as the western fence lizard, may in fact increase
risk by maintaining a higher vector density and subsequently a high density of infected
vectors. Ticks are not insects; they belong to the phylum Arthropoda and the class
Arachnida. They do not fly; do not have a head, a thorax, or an abdomen (IOM, 2013).
Ticks can attach to any part of the body especially in hard to see places such as the scalp,
armpit, or groin area. It must remain attached feeding for 36 to 48 hours or more for
transmission of Lyme disease causing spirochetes to humans (CDC, 2014).
The Ixodes tick enzootic cycle depicted in Figure 3 consists of three stages of
growth: larva, nymph, and adult and feed only one blood meal per stage (Nonaka, Ebel &
Wearing, 2010; Randolf, Caimano, Stenson, & Hu, 2012). Once engorged the ticks drop
off the host and either molt in to the next stage or if adult, lay eggs for a new generation
(Ostfeld, 2011; Whitmont, 2012). The adult tick lays eggs that hatch into larvae in about
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a month when the temperature is warm. Borrelia infects only a small portion of the eggs.
Scientists use the term transovarian transmission when the eggs are lay already infected
with the Borrelia organism (Nonaka, Ebel & Wearing, 2010; Ostfeld, 2011).
Transovarian transmission occurs in about one percent of the larvae (Ostfeld, 2011).
Larval ticks are very small about the size of a period at the end of a sentence feeding right
after hatching on infected reservoir animal hosts such as mice, squirrels, and birds.
Scientists use the term trans-stadially transmission to larval ticks retaining the Borrelia
bacterium to subsequent stages nymph and adult (Randolf, Caimano, Stenson, & Hu,
2012). Transovarian transmission occurs in about one percent of the larvae (Ostfeld,
2011).

Figure 3. Enzootic Cycle Borrelia burgdorferi. Radolf, J. D., Caimano, M. J., Stevenson,
B., and Hu, L.T. (2012). Of ticks, mice and men: understanding the dual-host lifestyle of
LD spirochetes. National Review of Microbiology, 10, 2, 87-99.

49

Larval ticks are very small about the size of a period at the end of a sentence
feeding right after hatching on infected reservoir animal hosts such as mice, squirrels, and
birds. Scientists use the term trans-stadially transmission to larval ticks retaining the
Borrelia bacterium to subsequent stages nymph and adult (Randolf, Caimano, Stenson, &
Hu, 2012). Once the larval tick attaches and bites into the skin a substance of similar
composition of collagen and keratin in vertebrate skin from tick saliva cements its
attachment and prevents leakage of blood or tick saliva (Buhner, 2005). The tick saliva
containing hundreds of biochemical counteract host-immune defenses such as hemostasis
which includes blood coagulation, platelet aggregation/vasoconstriction, inflammation,
and immunity both innate (complement system) and acquired (immunoglobulins)
(Buhner, 2005; Lane, Moss, Nonaka, Ebel & Wearing, 2010; Wei, Mesirow, & Kuo,
1999). Once uninfected larval ticks start feeding on the reservoir host, spirochetes flow
through the blood stream into the tick larva and colonize the tick’s gut mediated by
receptors for the spirochete’s outer surface protein A (OspA) and spreading to the tick’s
salivary glands, ovaries, and connective tissue (Buhner, 2005; Ostfeld 2011). Larval ticks
are about the size of a poppy seed (CDC, 2014) and feed for about 72 hours before falling
off the host and molting into nymphs; a process that takes about 35 days (Buhner, 2005).
The Borrelia infection rate in larval ticks range from three percent to 100 percent
(Buhner, 2005). Nymphs feed about four to five days and when engorged fall off the host
and molt into adult ticks which are about the size of a sesame seed (CDC, 2014; Randolf,
Caimano, Stenson, & Hu 2012). When an infected larvae or nymph bites the animal or
human host, the changes in temperature and pH cause the spirochetes to leave the tick
and enter the host (Buhner, 2005). Transmission of infected humans to feeding larvae is
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not known and humans are considered incidental hosts and not part of the enzootic cycle
(Center for Food Security and Public Health, 2011; Randolf, Caimano, Stenson, & Hu
2012). Even though wild carnivores and dogs not considered reservoir hosts, they may
transmit Borrelia burgdorferi sensu lato to ticks. Domesticated animals such as dogs,
cats, horses, and cattle may develop LD confirmed by serological tests and with
symptoms ranging from the initial EM or “bull’s eye” rash to lameness, stiffness, chronic
weight loss, arthritis, Lyme nephritis, hypertension, and neurological signs (Center for
Food Security and Public Health, 2011; Halperin, 2014). However, there is little or no
evidence that under natural conditions Bb is communicable from domesticated animals to
other animals or humans (Center for Food Security and Public Health, 2011).
Lyme Disease in California
In California, the most incidences of reported Lyme disease (LD) ranges from
April to August coinciding with the tick nymphal peak activity rather than adult tick
activity from October through April (Eisen, Lane, Fritz & Eisen, 2006). LD accounts for
97% of the vector borne diseases in California (Hui, 2008). In a global imaging system
(GIS) approach study conducted by Eisen, Lane, Fritz & Eisen (2006) it was found that
LD and acarologic (tick) risk of tick exposure in Southern California depends on the zip
code of residence with elevated risk in zip codes adjacent to public lands. California
variety of geographic areas including the moist and cool redwood forest in the west, the
coniferous forest in the northeast, and the dry and hot woodlands or chaparral in the
southeast allows human population to cluster in public lands for various recreational
activities increasing the risk for exposure to tick vectors (Woolford, 2015). The
California Department of Health Services started surveillance for LD in California in
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1983 (Lane et al., 1999) and reported the presence of Bb in other ticks other than I.
pacificus known to bite humans include Dermacentor occidentalis—found in shrubs,
chaparral, and among trails—and D. variabilis—known as the American dog tick or
wood tick (CDPH, 2014). Diagnostic issues in California include; only 20 percent of
individuals recall a tick bite, only 56% have EM, 41% exposed outside the county of
residence, and 22% exposed outside the state. In addition, bloodsucking flies have also
been associated with Bb seropositivity (Diers, 2005; Lane et al., 1999). Even though 56
out of 58 counties in California have reported ticks infected with Bb, many health care
practitioners are unaware of the existence of LD in the area they serve (Kuykendall,
2013). The13 million people population of Los Angeles County share urban and
recreational areas next to wilderness. Such areas include: Griffith Park, Los Angeles
National Forest, Santa Monica Mountains, Los Padres National Forest, San Gabriel
Mountains, Whittier Hills, La Puente Hills, Palos Verde, Rose Bowl, and the Greek
theater, where black-legged ticks are found throughout (Healy & Lowery, 2013; Hui,
2008; Woolford, 2015).
Symptoms and Disease Presentation
Following the tick bite there is an incubation period that is usually seven to 14
days, but can be up to 36 days and no more than three months. The first sign is the
characteristic skin lesion erythema migrans (EM) and only appears in 60 to 80 percent of
infected people after incubation (Biesiada, Czepiel, Lesniak, Garlicki, & Mach, 2012;
Ljostad & Mygland, 2013). EM first takes the form of a painless but mildly itchy bull’seye with a central clearing frequently in the lower extremities (approximately 54%) or the
trunk (approximately 29%) averaging 15 centimeters in diameter or larger (Center for
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Food Security and Public Health, 2011; McKechnie, 2016). The typical EM starts as a
macula or papule that widens and develops into a red or bluish rash lasting for a few days
and may disappear even without treatment (Berghoff, 2012; Emerging Infectious
Diseases, 2013). In about 50% of untreated patients after a few days, multiple secondary
lesions may appear which are smaller without central induration anywhere in the body
except the palms and soles (McKechnie, 2016). EM may go unrecognized and confused
with an allergic rash or an insect bite (Perrone, 2014). Weeks or months later symptoms
may slowly appear and develop into a syndrome, which varies on the individual
depending on the genospecies of the Borrelia and the geographic locations that causes
different clinical presentations (Ljostad & Mygland, 2013; Shapiro, 2015). Three distinct
stages have been determined based on presenting symptoms:


Stage I (Primary Stage or Early Localized Stage): In addition to EM described
above, flu-like symptoms may develop, followed by fatigue, myalgia, polyarthralgia,
stiff neck, headache, fever, sore throat, lymphadenopathy, and chills. A small
percentage of patients, approximately 10% will develop nausea, vomiting, abdominal
pain, conjunctivitis, and urticarial (McKechnie, 2016; Miklossy; 2012). Properly
diagnosed and treated LD at this stage causes mild or no persistent symptoms occur
(Horowitz, 2013).



Stage II (Secondary Stage or Early Disseminated Stage): Neurological
manifestations and cerebrospinal fluid (CSF) inflammation occurs in about 10 to 15
percent of the cases and is the hallmark of this stage. It is evident about six months
after the EM has faded, (McKechnie, 2016; Miklossy; 2012). In addition, headache,
stiff neck, fever, fatigue, vomiting, myalgia, arthritis, and photophobia may be
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present (Miklossy; 2012). The neurological manifestations may occur in the absence
of Stage I of the disease (McKechnie, 2016). Patients with Lyme encephalopathy are
afflicted with problems of concentration, memory, thinking, and confusion referred as
“mental fogginess” (Halperin, 2010). Some of the neurological manifestations are:
o Lymphocytic meningitis (manifested with frontal or occipital headache,
eye pain, photophobia, and low-grade fever).
o

Cerebral symptoms, accompanied by emotional liability, somnolence,
hallucinations, confusion, paranoid psychosis, agitation, irritability,
disorientation, tremors, coma/seizures, myelitis symptoms, (which include
loss of superficial reflexes, Babinski signs, urine retention, and
bowel/bladder incontinence).

o

Cranial neuropathies (which develop on about 60% of LD patients with
involvement of the facial nerve and differentiated from Bell’s palsy by
summer onset, bilateral involvement, and history of tick bite or EM) and

o

Radiculopathy or spinal pain, resistant to analgesics and worse at night
(McKechnie, 2016). The pain is severe and described as stabbing, burning,
shock-like, persistent, and debilitating involving the trunk or a limb
(Halperin, 2010).



Stage III (Tertiary Stage or Late Chronic Disease Stage): This stage is
characterized by arthritis, that may develop weeks or years after initial onset of the
disease manifested with joint pain and swelling, and neuropsychiatric manifestations
(McKechnie, 2016; Miklossy; 2012). Lyme arthritis will develop in 50 to 80 percent
of untreated LD patients (Horowitz, 2013). Untreated patients are those patients who
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do not receive antibiotic therapy at the onset of the disease or presentation of EM
(McKechnie, 2016). Since on average only 37% of people present EM, considering
that about 240,000 – 440,000 cases of annually infected and 50% a year do not
receive antibiotics, approximately 120,000 – 220,000 people will develop Lyme
arthritis (Buhner, 2005; Horowitz, 2013; McKechnie, 2016). Bramwell, Teuscher
&Weis (2014) studied forward genetics; a genetic approach to determine a heritable
trait allele responsible for variability using genetic mapping. This study may soon
elucidate regulators of Lyme arthritis severity and develop approaches to counteract
heritable genetic risk factors. Some of the most common symptoms of tertiary stage
LD include: profound fatigue, sweats/skin flashes, sleep disturbances, severe
headaches, numbing/tingling sensation, language difficulties, impaired memory,
problems of concentration, thinking, mental fogginess (Bransfield, 2012; Halperin,
2010), and nervous system involvement referred to as neuroborreliosis or Lyme
encephalopathy with predominance of psychiatric symptoms (Holtore, 2015;
Logigian & Steere, 2012). Bb breaks down the blood-brain barriers that sequester the
brain for the periphery and activate immune cells; neutrophils attracted by
chemokines into the central nervous system (CNS) contributes to neuroborreliosis
early inflammatory associated events and neuronal damage (Aucott, Seifter &
Rebman, 2012; Brissette, Kees, Burke, Gaultney, Floden, & Watt, 2013).
When LD evaluation has not been conducted properly, key symptoms may be
overlooked and patients may be diagnosed with an array of conditions including chronic
fatigue syndrome, multiple sclerosis, Epstein-Barr virus, fibromyalgia, lupus, and
psychiatric conditions (Bransfield, 2012; Holtore, 2015; Horowitz, 2013). Anyone would
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consider CLD patients at this stage as “crazy” and “hypochondriac” driving the patients
to depression and anxiety from alienation of family, friends, and the health care system
(Bransfield, 2012; Ljostad & Mygland, 2013). Patients with CLD cognitive complaints
experience a significant and measurable decline in intellectual acuity interfering with all
aspects of normal living and functioning. Aspects affected include, but are not limited to
home life, marriage, family, employment, emotional well-being, and social interactions
(Bransfield, 2012; Medalia & Revhein, 2012). Lyme neuroborreliosis can mimic
psychiatric disorders and type of encephalopathies analogous to neurosyphilis (Holtorf,
2015; MacDonald, 2014). Bb can evade the host’s immune system and persist in tissue
maintaining a chronic inflammation and the infection has been isolated from tertiary
lesions in the brain and the CSF (Miklossy, 2012). Commonalities of neuroborreliosis
and neurosyphilis include caused by a spirochete, involving multiple systems, and
affecting neurological functions leading to cognitive symptoms and psychiatric illness
(Fallon & Nields, 2013; Holtorf, 2015). Stricker & Middelveen (2015) examined the
ability of the organism through enzymes to form cysts, round bodies, and L-form
structures, which can hide in biofilms, persist in hostile environments, resist antibiotic
treatment, and reach privileged areas such as the synovial fluid, the eye, and the brain
suggesting the infection can be harbored in the genital tract as well. The marked
propensity of antibiotic failure in treatment of CLD in sexually active couples speculated
to be the result of reinfection occurring by person- to person intimate contact. Bb is
known to be neurotropic, leaving the CSF and adhering to glial cells and other brain
tissue forming a membranous material (blebs) during growth that bind Bb-specific IgM
antibody enabling Borrelia to escape immune surveillance (Fallon & Nields, 2013). In
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many neuroborreliosis patients brain Magnetic Resonance Image (MRI) scans are
normal, but the use of CSF examination (microscopic, chemical, and serological), single
proton emission computed tomography (SPECT), and positron emission tomography
(PET) scans provide evidence to support the clinical diagnosis of neuroborreliosis
(Donta, Noto & Vento, 2012; Halperin, 2010; Perrone 2014). Neuroborreliosis in
children is manifested by difficulty in concentration, memory, learning, efficiency and
speed processing information, language expression, auditory response, and multitasking
significantly affecting learning, and school performance directly impacting self-esteem,
self-confidence, and quality of life (Rhee & Cameron 2012; Shea & Leventhal, 2015).
Psychiatric sequelae in the form of depression may occur in children and adults ranging
from 25 to 65 percent as well as panic attacks and panic disorders with 5.3% prevalence
with periods of hopelessness or suicidal thoughts lasting for months to years after
diagnosis and treatment of CLD (Bransfield, 2015; Garakani & Mitton, 2015). The
magnitude of the effects of Bb in the brain and central nervous system are still unknown.
In a study conducted by MacDonald (2014) of Alzheimer’s autopsy brain specimens,
“touch preparations” stained with silver stains and Barbour’s Borrelia-specific antibodies
confirmed the presence of Borrelia. Scientific organizations need to conduct further
studies and investigation to demonstrate the possible association of Alzheimer’s dementia
and CLD (The Lyme Times, 2015).
CLD patients are often co-infected with other tick-borne organisms and infections
that may increase the severity of the symptoms (Horowitz, 2013) and make diagnosis and
treatment more challenging (Hersh et al., 2014; Horowitz, 2013). Co-infections clinically
relevant in alphabetical order include Anaplasma, Babesia, Bartonella species,
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Chlamydia pneumoniae, Ehrlichia, Mycoplasma pneumoniae, Rickettsia, Yersinia
enterocolitica, and tick-borne encephalitis virus (Berghoff, 2015; Borgermans et al.,
2014; Horowitz, 2013; Perrone, 2015). Additionally, Morgellons disease or “fiber’
disease” associated with CLD and emerging skin syndrome characterized by skin lesions
with dermal filaments of different colors fluorescent under ultraviolet light (Wood’s
lamp) and specks or dots referred to as granules on or in the skin coming out from the
lesion with itchy or crawling feelings under the skin (Horowitz, 2013). Scientists have
detected Bb spirochetes in the dermatological specimens of patients with Morgellons
disease (Borgermans et al., 2014). Bb shares the same vector, the black legged tick with
Anaplasma phagocytophilum explaining the incidence increase of human granulocytic
anaplasmosis (HGA) (IOM, 2013; Berghoff, 2015). Borrelia miyamotoi a novel species
has been implicated also in HGA (CDPH, 2014; Chowdri, Berardi, Goethert, Molloy,
Sterling & Telford, 2013; Platonov et al., 2011). A. phagocytophilum causes anemia, low
white blood cell count, low platelet count, and elevated liver enzymes or it may have a
severe presentation causing respiratory insufficiency, kidney failure, and eventually death
by parasitizing the host’s blood formed elements such as red blood cells, white blood
cells, and platelets (CDPH, 2014; CLDA, 2015; Krakowetz, Dibernardo, Lindsay, &
Chilton, 2014).
Babesia is a protozoan parasite transmitted by ticks that infect the red blood cells
and cause a parasitic hemolytic disease known as babesiosis (CDC, 2014; Berghoff,
2015). Babesia and Bb share the same enzootic cycle; therefore, babesiosis is spreading
just like LD (CDC, 2013; Horowitz, 2013) but geographically slightly lagging due to a
lower efficiency of transmission between the mice reservoir hosts and ticks (Dunn et al.,
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2014). Babesia microti and Babesia duncani both found in United States are transmitted
by the nymphal stage of the tick. They can cause more persistent and severe symptoms in
CLD patients (CDC, 2014; Hersh et al., 2014). Babesia is one of the most dangerous and
tenacious coinfections exacerbating the symptoms of LD such as increase in fatigue,
headache, joint pain, and cognitive dysfunction, with malarial symptoms of fever,
shaking chills, weakness and sweating with unexplained cough and shortness of breath
(air hunger) that may lead into acute respiratory distress syndrome (Berghoff, 2015;
CDC, 2014; Horowitz, 2013). Babesiosis standard treatment is a combination of
antibiotics and antimalarial drug quinine proven very effective for CLD patients
(Berghoff, 2015; Horowitz, 2013). Babesia testing by microscopic exam is difficult to
find especially if the amount of parasite in the blood is less than five percent. Accurate
detection requires the use of more expensive tests and laboratory techniques such as
immunofluorescent antibody titers (IFA), PCR, fluorescent in situ hybridization (FISH),
and RNA testing performed only in highly specialized laboratories such as the CDC
laboratories and IGeneX in California (Horowitz, 2013). Mode of transmission of
Babesia include from mother to the fetus in the womb, from person to person, or through
contaminated blood transfusion (CDC, 2014). Bartonella on the other hand, a bacterium
difficult to grow in laboratory media, is relatively easy to diagnose by serological
methods (Berghoff, 2015; Horowitz, 2013; Maritsi, Zarganis, Metaxa, Papaioannou, &
Vartzelis, 2013). Bartonella bacteria live primarily inside the lining of the blood vessels,
and can infect humans, mammals and a wide range of wild animals. Fleas, ticks, animals,
even spiders, can transmit the bacteria. The infected patient may experience fever,
fatigue, lost their peripheral vision, bouts of muscle and joint pain, numbness of the
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hands, headaches, memory loss, and hallucinations (CLDA, 2015). Bartonella henselae is
common in children and responsible for a low-grade fever and subacute regional
lymphadenitis known as cat scratch disease (CDC, 2013; Maritsi, Zarganis, Metaxa,
Papaioannou, & Vartzelis, 2013). Cat scratch disease is self-limited and usually resolves
without antibiotics (Horowitz, 2013. However, when B. henselae accompanies LD in a
patient by unusual severe neurological manifestations occur including seizures and
ophthalmic problems (CDPH, 2014; Berghoff, 2012; Horowitz, 2013). One unusual
presentation of Bartonella in patients with LD is stretch marks found in the thighs, breast,
abdomen, and upper shoulders due to burrowing of Borrelia and Bartonella through the
subcutaneous fat, which are often confused with stretch marks due to weight loss
(Horowitz, 2013). Bartonella can also be transmitted to the fetus during pregnancy
(CLDA, 2015; Horowitz, 2013). Borrelia carrying ticks may also carry Mycoplasma
pneumoniae, Mycoplasma genitaliun, and Mycoplasma fermentans detected in some
cases of CLD by indirect fluorescent assay (IFA) or serial PCR (CDPH, 2014; Horowitz,
2013). Mycoplasma species may cause overstimulation of plasma cells and B cells
promoting autoimmune reactions and rheumatoid disease (Horowitz, 2013). Despite long
term treatment (about a year) of Mycoplasma with tetracycline, quinolones, and
macrolides antibiotics this intracellular organism persists in CLD patients evidenced by
joint pain, headaches, and cognitive difficulties (CLDA, 2015; Berghoff, 2015).
Chlamydia like Mycoplasma (not transmitted by ticks) is an intracellular organism
associated with arthritis in multiple joints (poly arthritis) can cause exacerbation of LD
symptoms (Berghoff, 2012; CDPH, 2014; Horowitz, 2013). Chlamydia pneumoniae
causes respiratory infections. LD can activate this organism when dormant (Berghoff,
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2015; Horowitz, 2013). Rickettsia like both Anaplasma and Mycoplasma live inside the
host cells (CDC, 2015; Berghoff, 2015). Rickettsia infections commonly found in CLD
patients are Rocky Mountain spotted fever and Q fever. Rocky Mountain spotted fever
caused by R. rickettsii. Various species of ticks such as Amblyomma americanum (lone
star tick), Dermatocentor andersoni (wood tick), and Dermatocentor variabilis (dog tick)
can transmit the organism. Coxiella burnetti is the organism that causes Q fever and
presents itself as a myriad of non-acute symptoms consisting of severe headache, fever,
sweats, and muscle pains which may affect CLD patient severely (Horowitz, 2013). Q
fever diagnosis consists of serological tests and treatment consists of a tetracycline
antibiotic regimen such as doxycycline (CDC, 2015; Berghoff, 2015). Ehrlichia
chaffeensis is also transmitted by ticks (such as the lone star tick Amblyomma
americanum) and causes ehrlichiosis with symptoms of fever, headache, fatigue, and
muscle aches within 1 – 2 weeks following a tick bite (CDC, 2015; Clark, Leydet &
Hartman. 2013). Ehrlichiosis diagnosis in the same way as anaplasmosis through a
combination of blood tests for cell blood count, liver function, and antibody titers (Levin
& Fish, 2000; Horowitz, 2013). Microscopic examination of Ehrlichia infected white
blood cells in blood, bone marrow, and CSF show intracellular colonies arranged in
clusters called “morulae” indicative of the infection (Horowitz, 2013; CDC, 2015). The
basis on the importance of Yersinia enterocolitica as an LD coinfection is on the
manifestation of reactive arthritis, gastroenteritis, urethritis, uveitis, thyroid involvement,
and autoimmune processes such in the case of Chlamydia experienced by CLD patients
with seropositivity for Yersinia (Berghoff, 2015). In addition to the parasitic and bacterial
infections that can affect CLD patients, there are vector-borne viral infections such as tick
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borne viral encephalitis and non-tick borne viral infections such as Epstein-Barr virus,
human herpes virus 6 (HHV-6), cytomegalovirus, and West Nile that can be reactivated
from previous infections responsible for significant fatigue, fibromyalgia, and
neurological symptoms (Horowitz, 2013). Chronic viral as well as parasitic infections
may explain some of the antibiotic resistant symptomology seen in CLD patients
(Berghoff, 2015; Horowitz, 2013). Lastly, candida and other fungal infections may be
encouraged to overgrow in CLD patients taking antibiotics for bacterial coinfections and
can cause chronic symptoms of fatigue, joint, and muscle pain, brain fog, headache, and
gastrointestinal complaints that can be confused with antibiotic resistant LD (CDC, 2013;
Horowitz, 2013).
Unique Biological Characteristics of the Organism
Borrelia burgdorferi (Bb) may be considered a postmodern organism given the
facts that the illness it causes varies in presentation, is likely to have a variable treatment
response, and the organism does not have a predictable incubation period (Stanek &
Reiter, 2011). Borrelia, a spirochete, belongs in a group of phylogenetically distinct
bacteria with motility by means of endoflagella, or axial filaments, within the periplasmic
space between a semi-rigid peptidoglycan helix and a flexible outer membrane (Charon et
al., 2012; Todar, 2015). Figure 4 depicts the longitudinal and the cross-section diagram of
Bb and its component parts. The corkscrew fashion motility of the organism is due to the
filaments rotation in this space, a movement developed by adaptation to viscous
environments such as biofilms, mucosal tissue, and intestinal tracts of animals allowing
the organism to hide the flagella from the immune defenses of the host (Charon, et al.,
2012; Todar, 2015). The corkscrew shape of the spirochete allows the organism to “drill’
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through tissue and embed itself in brain, CNS, heart, spleen, liver, and joints resulting in
a plethora of symptoms ranging from dizziness and fatigue to paralysis (Kingston, 2014).
Motility plays an important role in the organism’s chemotaxis (movement toward or
away from a chemical stimulus) (Motaleb & Wolgemuth, 2012). The infection process,
starting form survival in nature, completion of the host-vector cycle, transmission,
dissemination through the skin, migration to the target tissues such as joints and the
brain, persistence, and evasion to the host’s immune response (Charon et al., 2012).
Unlike the spirochete responsible for syphilis, the Lyme spirochete Borrelia has been
successfully grown in laboratory culture media called Barbour-Stoenner-Kelly (BSK)
medium. BSK is enriched with nutrients such as bovine serum, albumin, and other
ingredients dissolved in a rabbit serum base incubated in a microaerophilic environment
at least 32°C for 24 – 72 hours (Clark, Leydet & Hartman. 2013; Todar, 2015; Wang et
al., 2004).

Figure 4. Typical Spirochete. Charon, N.W., et al (2012). The unique paradigm of
spirochete motility and chemotaxis. Annual Review of Microbiology, 66, 349-370.
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Borrelia’s size is 20 – 30 µm length by 0.2 – 0.3 µm width (Todar, 2015). It
cannot be visualized using the conventional light microscope due to its width being
below the resolving power; therefore, to visualize the spirochete dark-field microscopy
must be used (Todar, 2015). New methodologies such as the cryoelectron microscopy
have allowed Bb optimal analysis (Charon et al., 2012). Bb is not classified as a Gram
negative or positive organism even though it stains Gram positive, its chemical
composition is of Gram negative organisms with an outermost lipid bilayer cell
membrane, inner membrane, and a periplasmic space with a layer of peptidoglycan
(Todar, 2015) lacking lipopolysaccharides, but containing cholesterol lipids unusual in
bacteria (Charon et al., 2012). The outer membrane of Bb is composed of various unique
outer surface proteins denominated OspA through OsPF, decorin binding protein (Dbp)
A and DbpB, and Borrelial persistence in ticks (Bpt) A are lipid modified (Todar, 2015)
and play a role in the Bb’s virulence, tropism, dissemination, and immune evasion
(Kennedy, Lenhart & Akins, 2012; Todar, 2015). Besides being the most abundant, OspA
and OspB along with OsPC found exclusively on the surface of the organism, also found
in the periplasm of the organism contribute to virulence by adaptation of the organism to
the tick or animal host environment as needed (Kennedy, Lenhart & Akins, 2012). OspA
mediates the attachment of Bb to the tick midgut, OspA and OspB downregulate to
produce OsPC mediated by temperature changes to bind a tick salivary protein playing a
role in transmission and survival during host colonization. OspE recruits complement
regulator factors to the Bb cell membrane to evade complement-mediated cell lysis of the
animal host immune response (Bhattacharjee et al., 2013). DbpA and DbpB bind to
decorin a proteoglycan that interacts with collagen fibers and connective tissue (Kennedy,
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Lenhart & Akins, 2012). OsPC genotypes were exclusively associated with Bb
dissemination in blood and CSF (Wormser et al., 2008) and OspF enables the Bb
spirochete to maintain chronic infection by evading the immune system (Vojdani,
Hebroni, Raphael, Erde & Raxlen, 2009). OspA surface protein of Bb was used to
develop a vaccine composed of three doses combined with an adjuvant (Steere et al.,
1998) which was approved and used for several years but discontinued production in
2002 and is no longer in use due to complaints of individuals getting the disease and
eventually developing CLD symptoms (Kennedy, Lenhart & Akins, 2012). The genome
of Bb is small requiring complex nutritional requirements. The genome consists of a very
stable linear chromosome of 950 kb with more than 1,500 gene sequences in at least 132
functioning genes (Stricker, 2007). The genome exhibits little variation among isolates
and a variable number of 7 – 21 linear and circular plasmids comprise one third of the
organism’s total genetic material (Munderloh, 2013; Todar, 2015) essential for survival
in ticks in the reservoir hosts as well as rearrangement on different genotypes (Schutzer et
al., 2011). In addition to the genetic diversity of Bb that provides the organism with
adaptive processes to evade the host defense mechanisms and achieve persistence
(Schutzer et al., 2011) Bb possess large and diverse adhesive surface proteins to promote
dissemination (Coburn, Leong & Chaconas, 2013), immunosuppression, mutation,
antigenic variation, and recombination (Perrone, 2015). In addition to mechanisms to
change antigenic structure, the LD spirochete borrows a practical coat from the saliva of
its tick vector introduced during attachment and feeding into the animal and human hosts
(Buhner, 2006; Vojdani, Hebroni, Raphael, Erde & Raxlen, 2007). Borrelia can survive
both extracellularly and intracellularly in a dormant state by formation of cysts that under
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favorable conditions convert into free new Borrelia spirochetes in tissues (Stricker &
Johnson, 2011; Perrone, 2015). In a study conducted by Wormser et al., (2008) based on
restriction fragment polymorphisms (RFLP) of the 16s and 23S rRNA, Bb was classified
in three distinct genotypes called ribosomal spacer type (RST) 1, RST2, and RST3. Each
genotypic strain is responsible for differential pathogenicity demonstrating that certain
Bb genotypes are more invasive resulting in different disease presentation and the need
for various detecting mechanisms and treatment modalities.
Laboratory Diagnosis of Lyme Borreliosis
LD is diagnosed based on clinical presentation, mainly EM considered to be
pathognomonic of the disease, epidemiology, and laboratory testing (Perrone, 2014;
Shapiro, 2014). The only standardized test approved by the US Food and Drug
administration (FDA) to support the diagnosis of LD in the USA is serology (Ang,
Notermans, Hommes, Simmons-Smit & Herremans, 2011; Johnson, 2011). The
serological tests available in the market detect IgM and IgG antibodies to Borrelia
burgdorferi sensu stricto that develop after a few weeks of infection (Lee, Vigliotti, Jones
& Shearer, 2014). Different test exists to detect Bb directly such as cultures; only
available in limited number of diagnostic laboratories, and Polymerase Chain Reaction
(PCR). PCR is used for detection of the organism genetic material in blood, synovial
fluid, urine, CSF, and skin that may confirm the clinical diagnosis in seronegative
patients, but are not sensitive enough and not available for routine testing (Lee, Vigliotti,
Jones & Shearer, 2014; Perrone, 2014). There are also tests not supported by the CDC or
not approved by the FDA for routine testing including antigen capture assays in urine,
lymphocyte transformations tests, immunofluorescent staining for cysts forms of Bb,
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quantitative CD57, and reverse Western blots assays to name a few (Johnson, 2011).
Figure 5 schematic illustrates the current two-tiered serology test used in North America
for surveillance and individual patient evaluation. This is the recommended protocol for
LD diagnosis by the FDA, the National Institute of Health, the Association of Public
Health Laboratories, the Council of State and Territorial epidemiologists, and The
Clinical Laboratory Standards Institute (Johnson, 2011: Perrone, 2014). First-tier testing
consists of enzyme immunoassays (EIA) such as enzyme-linked immunosorbent assay
(ELISA), or immunofluorescent assays (IFA). These tests use whole cell sonicate of the
tick derived in vitro culture strain of Bb designated B31 (Perrone, 2014; Vojdani,
Hebroni, Raphael, Erde & Raxlen, 2007), which if negative no more testing is needed,
but if positive or indeterminate (equivocal or borderline) would prompt tier-2 testing
(Ang, Notermans, Hommes, Simmons-Smit & Herremans, 2011; Johnsons, 2011). The
second tier consists of immunoblotting with purified antigens known as Western blot.
When the Western blot test is positive it is diagnostic of LD. LD is positive only if both
the EIA or IFA and the immunoblots, results are positive. A positive IgG result with
clinical history may be indicative of LD. A single positive IgM is not diagnostic since
IgM antibody levels may remain positive even after effective treatment (Johnson, 2011;
Lee, Vigliotti, Jones & Shearer, 2014).
The CDC criteria for Western blot positive results for IgG are five of 10 antigenic
bands measured in kilodalton (kDa) for molecular weight designation. The antigenic
bands are:18 kDa, 23 – 25 kDa (OsPC), 28 kDa, 30 kDa, 39 kDa, 41 kDa, 45 kDa, 58
kDa, 66 kDa, and/or 83 – 93 kDa (Johnson, 2011; Clark, Leydet & Hartman, 2013; Lee,
Vigliotti, Jones & Shearer, 2014). The criteria for a positive result using protocol from
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IGeneX Lyme specialty laboratory in California is an IgG Western blot is two of the
following six bands: 23 – 25 kDa, 31 kDa (OspA), the 34 kDa (OspB), 39 kDa, 41 kDa
and/or the 83 – 93 kDa. 31kDa and 34 kDa antigens are included to the criteria due to
their importance in the recurrent and/or persistent disease period (Haley, 2011; IGeneX,
2015; Schutzer, et al., 2013). For IgM, the CDC positive criteria are two of the three
bands 41 kDa, 39 kDa, and 23kDa with intensity equal or greater than the calibration
control (Johnson, 2011).
Tier 1: IgG or IgM EIAs (combined or
separate)

Positive or
Indeterminate

Negative

Tier 2: IgG and/or IgM immunoblots
(separate)

Either Blot Positive

IgG Positive

Reported as
Positive

Reported as Negative

Negative

IgM Positive

Reported as Negative

Reported as Positive but only
clinically relevant if disease
duration is less than one month
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Figure 5. Two-tiered Serology for Lyme Disease. Adapted from Johnson, J. B. (2011).
Laboratory Diagnostic Testing for Borrelia burgdorferi Infection. Manual of Molecular
and Clinical Laboratory Immunology, 7th edition. ASM Press, Washington, DC.
Figure 6 below is an example of Western Blot tests showing significant Lyme
disease antibodies (IGeneX, 2013; Johnson, 2011; Vojdani, Hebroni, Raphael, Erde &
Raxlen, 2007). The two-tiered serology test CDC diagnostic guidelines for IgM is two of
three bands and IgG is five out of 10 bands. The test may be negative a few weeks after
EM presentation. It may also be negative or non-diagnostic in up to 75% of clinically
suspected cases of early LD, but in cases of disseminated neurologic or cardiac disease
caused by B. burgdorferi sensu stricto it is reasonably sensitive more than 87% and
specific up to 99% in diagnostic testing (Hinckley et al., 2014; Lee, Vigliotti, Jones &
Shearer, 2014; Lee, Shapiro, 2014).

Figure 6. Examples of IgM and IgG Immunoblots. Courtesy of IGenex Inc. Retrieved
from https//www.google.com
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Limitations of the two-tiered test include high specificity and sensitivity only after
two weeks of Bb infection, insensitive during EM presentation and during early
neuroborreliosis, it is technically demanding, expensive, and it can be difficult to
determine disease onset for IgM testing (Johnson, 2011). In addition, the immunoblots
scoring criteria applies only to Borrelia burgdorferi sensu stricto and no other Borrelia
genotypes (Dattwyler & Arnaboldi, 2014; Johnson, 2011). It is possible that some
equivocal or negative EIA or Western blot test results interpreted by the current CDC
guidelines may not be not accurate. These interpretations are due to Borrelia burgdorferi
sensu lato strains, a problematic issue with those afflicted with CLD symptoms and
negative EIA, IgM, and IgG Western blot current serological test available that are falling
by the wayside (Clark, Leydet & Hartman, 2013; Johnson, 2011; Perrone, 2014; The
Lyme Times, 2015). The distribution of Borrelia burgdorferi sensu lato complex is
worldwide, yet the organism is not tested routinely; neither is Borrelia miyamotoi that
causes a disease like Lyme and does not cross react with Bb (Perrone, 2014). Failure to
diagnose neuroborreliosis by a clinician unaware of the difficulty in diagnosing CLD may
implicate the labeling of patients with erroneous diagnosis such as idiopathic, viral,
degenerative, autoimmune, psychosomatic or inflammatory (Auwaerter, 2015; Perrone,
2014) and delay in appropriate treatment leading to chronic neurologic problem and even
death (Perrone, 2014). Therefore, the situation demands the development of new
diagnostic methods. The methods may include immunoblot tests containing specific
epitopes of Borrelia strains that can improve specificity and sensitivity (Dattwyler &
Arnaboldi, 2014). Also, new PCR methods, new genomic techniques such as high
throughput sequencing, and most importantly closer collaboration between
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microbiologists, epidemiologists, geneticians, immunologists, entomologists,
veterinarians, environmental scientists, and health care practitioners in a multidirectional
approach to determine strain pathogenicity diagnosis (Perrone, 2014). Horowitz (2013) in
his book Why Can’t I Get Better: Solving the Mystery of Lyme & Chronic Disease
discusses how the health care system is not primed for chronic diseases affecting
humanity in the 21st century such as CLD and primed mainly for acute diseases such as
urinary tract infections and heart attack. Horowitz (2013) blames the disease postulate
one germ, one disease known as the “Pasteur postulate” thought in medical school.
Horowitz (2013) also addresses in his book the need for a “paradigm shift” in his
proposed 16-point differential diagnostic map which is an assessment of the various
contributors to chronic illness as well as a new term for the syndrome with infectious
involvement following a tick bite: “multiple systemic infectious disease syndrome” or
MSIDS.
Treatment of Lyme Disease
Borrelia burgdorferi’s complex background concerning its biology, diagnostic
problems, and testing difficulties continues with reported failures when attempting to
treat LD (Stricker, 2007). The standard recommended antibiotic regimen for LD
presentation of EM in early localized or early disseminated in the absence of specific
neurologic manifestations or cardiac involvement is doxycycline (100 mg twice per day
for 10-21 days), amoxicillin (500 mg 3 times per day for 14- 21 days), or cefuroxime
acetyl (500 mg twice per day for 14 to 21 days) (Klempner et al., 2013; Wormser et al.,
2006). For late neurologic LD in adult patients the recommended treatment is intravenous
ceftriaxone for 2 to 4 weeks, or as an alternative cefotaxime or penicillin G administered
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intravenously (Klempner et al., 2013; Ljostad & Mygland, 2013; Wormser et al., 2006).
Prophylactic treatment with a single dose of doxycycline in an endemic area after a tick
bite to prevent LD was effective in a study conducted by Warshafsky, Lee, Francois,
Nowakowsky, Nadelman & Wormser (2010). About 10 to 20 percent of the patients
treated with the recommended monotherapy of doxycycline, amoxicillin, or cefuroxime
report persisting symptoms such as fatigue, muscular pain, and neurological afflictions
even after six months following treatment where Bb can be detected in serological tests,
but it cannot be cultured in laboratory media (Feng, Shi, Zhang & Zhang, 2015). A
frequent event during beginning or prolonged antibiotic treatment is the acute
exacerbation of symptoms known as the Jarish-Herxheimer (JH) reaction (Perrone,
2015). JH is a temporary worsening of LD symptoms that occur as a combination of the
killed Borrelia spirochete and the body’s own immune defenses response by the
production of inflammatory molecules (CDC, 2013; CDPH, 2013; Horowitz, 2013). JH
reaction creates the treatment with antibiotics a difficult situation since the antibiotics are
working to kill the bacteria, but they temporarily making the patient feel worse
(Horowitz, 2013). Bb persisters were demonstrated in vitro after treatment with
antibiotics by Hodzic, Imai, Feng, and Barthold (2014) and by xenodiagnoses method
using non-infected ticks to feed in antibiotic treated mice with successful recovery of Bb,
a method that may be one day applicable to humans to confirm diagnosis of LD
(Maloney, 2014). Evidence from CLD trials followed by Fallon, Petkova, Keilp, &
Britton (2012) demonstrated that the effectiveness of the use of repeated or long-term
antibiotic treatment cannot be proven or disproven, and antibiotic regimens are not
robustly effective. Nevertheless, approximately 60% of patients with persistent fatigue
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symptoms after antibiotic treatment in the trials experienced minor clinical improvement
after retreatment. The work of Feng, Wang, Zhang, Shi & Zhang (2014) using an
optimized SYBR Green Iodide dye assay for antibiotic susceptibility testing of Bb in a
high throughput drug screen format, showed to be a rapid, sensitive, convenient, and
powerful method for identifying drugs against Bb persisters in biofilms that can be used
as a rapid antibiotic susceptibility test. Currently, there are no guidelines for antibiotic
treatment of CLD (Wormser et al., 2006). Despite the increased number of LD reported
nationwide, pharmaceutical companies have not taken the interest to develop new
treatment regimens; therefore, evidence based treatments are conflicting, sparse, and
emerging (Cameron, Johnson & Maloney, 2014).
Considering the current antibiotics side effects, length of treatment, and lack of
guidelines for treating CLD a novel approach used by Vojdani, Hebroni, Raphael, Erde &
Raxlen (2007) utilizing in vivo induced antigen technology (IVIAT) and ELISA that may
provide the data needed to justify CAM treatment of CLD. IVIAT’s technique identifies
Borrelia antigenic gene products and antibodies expressed in the patient during infection
(Bb lysate, OspA, OspC, OspE, C2 peptide, C6 peptide, complement regulator protein -1,
and decorin binding protein of Bb); cross reactive micro-organisms (T. pallidum, B.
microti, Ehrlichia, Bartonella, Y. enterocolitica, Mycoplasma, salmonella, Shigella,
Chlamydia, etc.); and the target tissue antigens in blood (thyroid stimulating hormone
receptor, plasmin, plasminogen, collagen, arthritis related protein glutathione, myelin,
ganglioside, etc.) before presentation of CLD symptoms (Vojdani, Hebroni, Raphael,
Erde & Raxlen, 2007).
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Figure 7. Complementary and Alternative Medicine Treatment and its Actions.
Vojdani, A., Hebroni, F., Raphael, Y., Erde, J., and Raxlen, B. (2009). Novel Diagnosis
of Lyme disease: Potential for CAM Intervention. Evidence Based Complementary
Alternative Medicine 6(3), 283-295.
CAM provides a different intervention strategy for health care and includes a
combination of antibiotics, herbal, and nutritional supplements summarized in Appendix
B. These herbs and supplements utilized by CAM work at different levels. Levels include
attachment of the ticks, inhibition of the inflammatory process, and reduction of bacterial
load; resulting in elimination of Bb from the cells and tissues while diminishing crossreactive antibodies in the blood leading to the repair of the blood brain barrier damage
caused by LB (Buhner, 2006; Vojdani, Hebroni, Raphael, Erde & Raxlen, 2007;
Weintraub, 2013). Figure 7 schematically depicts the different levels of CAM action.
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According to Gardner (2015), Zerbe (2015), and Whitmont (2012) there is
evidence to suggest that additional natural LD treatments help heal the body by getting
rid of the infection, reducing inflammation, and restoring the injured immune system.
Those additional natural ways to deal with Lyme include:


Acupuncture to help reduce or eliminate pain, homeopathy by individualized
disease disturbances removal (Whitmont, 2012).



Treatment with green tea with curcumin (a compound of turmeric) to reduce
oxidative stress and aid in antibiotic treatment (Whitmont, 2012).



Probiotics use to help replenish beneficial bacteria damaged by long-term use of
antibiotics and prevent yeast overgrowth (Harte, 2011).



Exercise to improve oxygen intake to help destroy the organism in the body
(Harte, 2011) and



The use of inflammation annihilators such as a low-glycemic-index healthy diet
(Harte, 2011).

Prevention
Education is the best prevention against LD and development of CLD (CDC,
2011; CDPH, 2014). Education on tick avoidance includes staying away of brush and
grassy areas when hiking, staying in the middle of trails, and dressing appropriately for
tick in habited areas. Appropriate dress includes wearing long pants, tucking those pants
into boots, as well as to pulling socks over pants, tucking the shirt into the pants, utilizing
a hat, and wearing light colored clothes so ticks are easily spotted (CDPH, 2014; CDPHLA Vector Management, 2015). Application of 0.5% Permethrin on clothing to repel the
ticks, insect repellants that contain up to 25% of DEET in adults and 10% in children, or
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lemon eucalyptus oil is effective (CDC, 2013). Recommendations of environmental
precautions to decrease the risk of tick are; mow grass along trails, buildings, and
camping areas; remove brush in recreational areas and trails, check pets, children, and
yourself for ticks, shower immediately after outdoors activities where ticks may be
present, and learning how to remove a tick properly (Britain, 2015; CDC, 2013). The
procedure on how to remove an attached tick include:
1. Firmly pull the tick.
2. No jerking or unscrewing the tick.
3. Do not attempt to remove the tick by cigarette or match burning or applying
Vaseline

or other product.

4. Wash the hands and bite site with soap and water applying antiseptic to the
area.
5. Save the tick in a container or bag for identification.
6. Contact the health department to submit tick for identification of LD
infectivity.
7. Consult your physician if the tick cannot be removed or any part remains
inside the bite site or if after 30 days of the bite flu symptoms develop
(Britain, 2015).
The Chronic Lyme Disease Controversy
As if the plethora of CLD associated symptoms was not already enough to deal
with, diagnosis of CLD brings along a handful of controversies for the affected
individuals to face (Borgersmans, Goderis, Vandevoorde & Devroey, 2014). Due to
absence of accurate data on annually diagnosed patients, solid cause, a clear case
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definition, diagnostic criteria, biological complexity of Borrelia, and treatment options;
CLD continues to be a poorly understood disease (Borgermans, et al., 2014). In addition
to the confusion, data on gender was compiled in a cross-sectional study by Wormser,
Eugene & Shapiro (2009) based on a systematic review of antibiotic treated patients with
CLD and it was found that patients with CLD were 69% female suggesting that illnesses
with female preponderance such as chronic fatigue syndrome, depression, and
fibromyalgia may be misdiagnosed. Patients who seek care for CLD have diverse
backgrounds, medical literacy, and perspectives, but soon become aware of concepts
about LD that are controversial and deemed inaccurate by opposed scientific views
(Lantos, 2011). On one side of the controversy are the claims of some scientific groups
who believe Lyme activists and Lyme literate doctors (LLMD) through political lobbying
and public appeal have managed to divert attention from evidence-based medicine to
redefine LD and its antibiotic therapy regimens (Auwaerter et al., 2011). The Infectious
Disease Society of America (IDSA) has been challenged and threatened with antitrust
litigation after the release of updated LD guidelines claiming the guidelines were “rife
with conflict of interest” resulting in the convening of an independent scientific panel to
review the appropriateness of the IDSA antibiotic guidelines (Auwaerter et al., 2011). On
the other side of the controversy are physicians represented by the International Lyme
and Associated Disease Society (ILADS) and patient advocate organizations such as the
Lyme Disease Association in New Jersey and the California Lyme Disease Association.
In addition, agencies that claim unjust sanctions of Lyme literate medical doctors by state
medical licensing boards in state and federal agencies about ethics and medical credibility
by using certain diagnostic laboratories and conflict of interest continue litigation
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(Auwaerter et al., 2011; Lantos et al., 2010). The heavy burden of illness associated with
CLD patients demands an end to the ongoing controversy associated with the disease.
Such controversy resolution can be accomplished by broader use of clinical diagnosis
tools available; development of new methodology with increased accuracy, specificity,
and sensitivity; novel treatment approaches; and an integrative multidisciplinary
approach needed to prevent and treat the disease effectively (Borgermans, et al., 2014;
Johnson, Aylward & Stricker, 2011). Patient-powered research approaches developed and
run by patients such as “MyLymeData”; a patient-powered research project developed by
CLD patients currently sick or who have recovered from the disease; tracks patients over
time using computer technology to privately pool diagnosis and treatment experiences.
MyLymeData (MLD) allows patients to learn from each other and provide data for
research and insights into the disease process and treatment effectiveness (The Lyme
Times, 2015). The MLD registry will allow researchers soon to gather and analyze large
amounts of health information on CLD patients to study LD providing a new tool in the
researcher’s toolbox.
Summary
The current literature on CLD provides extensive evidence to show that persistent
symptoms of LD are due to chronic infection with Bb spirochete, in conjunction with
other bacterial, parasitic, and viral tick-borne coinfections (Berghoff, 2015). Persister
forms of the bacterial organism, cysts, and biofilms enhanced by unique infection
mechanisms maintain the chronic status of the disease and exacerbate symptomology
leading to considerable decline in health status and debilitation despite extended use of
antibiotics (IOM, 2013) leading the CLD patient to search for CAM, private LLMD, and
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other modalities of treatment (Buhner, 2006; McKechnie, 2016; Vojdani, Hebroni,
Raphael, Erde & Raxlen, 2009). Use of qualitative studies to gather insights into the
health beliefs and lived experiences of young adults diagnosed with CLD provided an
opportunity to heighten understanding and sensitivity of the complexity and difficulty of
living with CLD (Ali, Vitulano, Lee, Weiss & Colson, 2014).
Few studies on CLD have focused on the perceptions of disease burden and lived
experiences of young adults diagnosed with CLD using the dimensions of the HBM.
Previous studies did not take into consideration other racial and ethnic backgrounds
besides Caucasians in a wide age range (Drew & Hewitt, 2006; Ali, Vitulano, Lee, Weiss
& Colson, 2014). In California, and specifically in the Los Angeles County where
recreational places are within urban settings the risk for Borrelia carrying ticks, is an
emerging public health problem (CDPH, 2014). Awareness of public health practitioners,
health care providers, and the population of the problem through education and a
multidisciplinary approach (Stricker & Johnson, 2011) is imperative. Guided by the
research questions, the focus of this qualitative study was to examine the impact CLD has
on the health promoting behaviors of ethnically diverse, insured, young adults from
similar educational and socioeconomic backgrounds based on their lived experiences in
the Los Angeles County, California. Using semi-structured interview questions based on
the dimensions of the HBM participants provided lived experiences insights of CLD life
after diagnosis of this mysterious disease and the impact on their personal, professional,
and decision-making processes.
In the following chapter, the methodology, I define and explain the role of the
researcher, provides detailed information on the study population, sampling strategy,

79

participant selection, number of participants, identification, and recruitment rationale that
take into consideration other racial and ethnic backgrounds besides Caucasians in a wide
age range identified as a gap in the literature. In addition, in the following chapter, data
collection instruments and source of each data are identified, issues of trustworthiness
such as content validity, transferability, and dependability are established, and ethical
procedures such as the Institutional Review Board documentation and treatment of data
description are provided.
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Chapter 3: Research Method
Introduction
The purpose of this phenomenological study was to explore the impact chronic
Lyme disease (CLD) has on the health promoting behaviors of ethnically diverse,
insured, young adults from similar educational and socioeconomic backgrounds based on
their lived experiences. The geographical focus of this study was restricted to Los
Angeles County, California, because there is a general lack of awareness of Lyme disease
(LD) and CLD on the West Coast of the United States (Hui 2008; Ostfeld, 2011; Swei,
Ostfeld, Lane, & Briggs, 2011). The perspectives of this group of participants’ gives
healthcare providers and the public a deeper insight into the impact CLD has on the
personal and professional lives of affected patients and its impact on their decisionmaking processes.
This chapter discusses the study design and rationale highlighting the research
questions and methodology, including the role of the researcher regarding personal and
professional relationships with the study participants. Any bias resulting from this
relationship and how it was handled are explained as well as any ethical issues.
Description of the study population, recruitment procedures, U.S. federal regulations and
measures followed to protect human subjects, processes to safeguard participant’s
information and maintain anonymity, data collection instruments, and data organization
plan are presented. The software used for data analysis is identified, method of data
analysis is presented, and approaches to the study’s rigor such as credibility,
transferability, dependability, and confirmability are discussed.
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Research Design and Rationale
The following research questions guided this study:
RQ1: Qualitative: To what degree do different ethnic groups with average levels
of socioeconomic status, education, and third-party coverage, perceive the likelihood of
acquiring comorbidities related to CLD?
RQ2: Qualitative: To what degree does the perceived severity of CLD impact the
lives and decision-making processes of different ethnic groups with average levels of
socio-economic status, education, and third-party coverage?
RQ3: Qualitative: To what degree does the perceived benefits of treatment impact
the lives and decision-making processes of different ethnic groups with average levels of
socio-economic status, education, and third-party coverage?
RQ4: Qualitative: To what degree do perceived barriers impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
RQ5: Qualitative: To what degree does the cues to action impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
RQ6: Qualitative: To what degree does self-efficacy impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
The qualitative research design, which investigates the why and how of the
process of a developed phenomenon (Sanjari et al., 2014), in this case health promoting
behaviors of young adults with CLD, was selected as the research method. The
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naturalistic approach of the qualitative research design is in real world settings where the
phenomenon of interest unfolds naturally, and the researcher does not attempt to
manipulate the phenomenon (Victor & Barnard, 2016; Sanjari et al., 2014). The
naturalistic approach was the most efficient and appropriate way to investigate the
research questions in this study.
Little is known about health promoting behaviors of young adults diagnosed with
CLD (Ali, Vitulano, Lee, Weiss, & Colson, 2014). In this study, the qualitative research
design provided me the means to help understand this situation that otherwise is
mysterious, enigmatic, or confusing (see Katz, 2015). The qualitative approach provides
a robust research method to use when little information exists about a subject (Creswell,
2012; Malagon-Maldonado, 2014)— this the case of young adults living with CLD. The
qualitative research approach is useful in the early stages of knowledge development
(Katz, 2015), as is in this case, with the aim to understand the participants’ perspective
and interpretations of the environment in which they live, work, or receive care (see
Creswell, 2012).
I chose the traditional phenomenological approach to achieve an understanding of
the everyday experience of young adults living with CLD and their health promoting
behaviors by exploring the human condition to gain a deep insight into the lifeworld and
lived experience of the participants (Creswell, 2012; Malagon-Maldonado, 2014).
Phenomenological research is a strategy of inquiry in which the researcher identifies the
essence of human experiences about a phenomenon as described by participants
(Creswell, 2012). The emphasis was on understanding the ways in which young adults
with CLD construct their realities or to reveal what perspective they hold and how they
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interpret events that happen (Crosby, DiClemente, & Salazar, 2006). A hermeneutic
approach to this phenomenological inquiry was carried out in which I brought to the
study; personal experience, insights, discoveries, and reflections because of mutual effort
with the participants to elucidate the nature, meaning, and essence (Victor & Barnard,
2016) of health promoting behaviors of young adults living with CLD.
Role of the Researcher
I was an integral part of the study process and I was directly involved in all stages
of the study from seeking participants, conducting interviews, participating in
transcription, performing analysis, carrying out verification, and reporting concepts and
themes found. I relate to young adults with CLD and hold membership to the Lyme
Disease Association of Los Angeles County Chapter, with no supervisory or instructor
relationships involving power over the prospective participants. I obtained informed
consent from the study participants and followed all the federal regulations and
requirements (DHHS, 2009). I also provided many opportunities to the participants to
consider participation to minimize undue influence (DHHS, 2009).
In the phenomenological qualitative method, the main task of the researcher is
transformation of data to the lived experiences (Sanjari et al., 2014). I used interpersonal
skills to make an appropriate human instrument that is of major importance in natural
settings and qualitative research study processes (Sanjari et al., 2014). The established
relationship between the participants and me during the inquiry in this qualitative study
can raise a range of ethical concerns such as respect for privacy, establishment of honest
and open interactions, and misinterpretations (Creswell, 2009). I managed ethically
challenging situations by preserving the participants’ confidentiality, minimizing the
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possibility of intrusion, and thoroughly explaining informed consent issues such as the
nature and objectives of the study, identity of the researcher, participant’s role, and how
the results were to be used and published (Patton, 2002; Sanjari et al., 2014).
Methodology
Population Sampling Method, Size, and Contingencies
Purposeful sampling was the most appropriate method for this study because it
enabled me to select in a nonrandom manner a sample of elements representative of the
target population based on the purpose of the study (Suri, 2011); a population consisting
of young adults living with CLD. I used stratified purposeful sampling (Suri, 2011) to
capture major variations in the manifestation of the phenomenon. The stratified
purposeful sampling provided the sampling methods to capture varied key factor
associated with CLD, as well as enabled me to identify distinct strata and clusters of key
health promoting behaviors within each stratum (Suri, 2011). Sampling was conducted
until theoretical saturation was obtained, that is when further evidence collection
provided little or no new insights, perspectives, or concepts in well characterized and
differentiated categories (Ali, Vitulano, Lee, Weiss, & Colson, 2014; Suri, 2011).
Purposeful sampling provided a higher likelihood of reaching data saturation (Suri,
2011).
As typically anticipated in phenomenological studies, a sample size consisting of
eight to 10 participants is sufficient to achieve saturation (Suri, 2011). I anticipated a
similar sample size (eight to 10 participants) for this study to achieve saturation, but I
also considered the possibility for a larger sample. Since the required sample size seemed
relatively small, it was possible that a larger sample might have been required. I pursued
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support and agreement from the Los Angeles Lyme Disease organization members that
attend social gatherings and that post on the online website to participate in the study. In
addition, as stated in the recruitment section below, I used social media as a recruitment
contingency.
Inclusion/exclusion Criteria
Participants’ inclusion criteria included being 18 to 40 years old, residing in the
Los Angeles County, signing the Internal Review Board (IRB) approved consent
document (Appendix C), being clinically diagnosed with CLD, and having received or
currently receiving medical treatment or intervention including antibiotic therapy and or
complementary and alternative medicine treatment (CAM). The age group I chose for
this study was determined based on the level of activity, independence, and busy lifestyle
often demonstrated by this age group under normal healthy circumstances. Persons
excluded from the study included those who did not reside in the Los Angeles County
area, persons who lacked medical diagnosis of CLD either by clinical disease definition
or confirmatory laboratory diagnostic tests, self-diagnosed patients, patients with
diagnosed CLD who had not received any treatment, and those outside the determined
age group (18-40 years old). I did not allow participation in the study by individuals who
did not meet the inclusion criteria.
Recruitment
I distributed an electronic recruitment flyer using the Facebook Los Angles Lyme
group site and personally handed a hard copy recruitment flyer (see Appendix D)
soliciting participants that fit the studies’ population criteria willing to complete an inperson one-hour interview at the Los Angeles County Lyme Disease Association’s social
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gathering. I secured explicit written permission from the organization for recruiting of
participants and distribution of the recruitment flyer (see Appendix E). In case not
enough participants were recruited from the L.A. County Lyme Disease group, I posted
an invitation to participate in the study on the social media sites Facebook and LinkedIn
(see Appendix F). Basic descriptive information in the recruitment flyers included: study
title, purpose of the study, basic eligibility criteria, study location, and my name and
contact phone number for providing further information if needed (UDHHS, 2005). Once
the respondents contacted me, a short on the phone interview documented in the
“Respondent Screening Form” (see Appendix G) was given to the respondents consisting
of basic screening questions and authorization to be recorded during the study interview
to ensure the sample criteria was met.
Screening
As mentioned above, when the respondent contacted me by email, the
“Respondent Screening Form” (see Appendix G) was completed by self-report as I
prompted the subjects for the information contained within the form. Inclusion and
exclusion criteria were contained in the form to determine eligibility to participate in the
study. Acceptance to the study granted the participants a permanent record number
(PRN). The PRN had no personal information linking to the participant. The PRN
consisted of six digits indicating date of acceptance and sequential order of recruitment.
For example, for the first participant accepted February 27, 2017; the PRN was 022701.
The PRN followed the participant in all the phases of the study: interview(s),
transcription, data analysis, results reporting, and publishing, thus providing
confidentiality of personal identifiers in all the records. I am the only person who has
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access to the participant’s identification data matched with the PRN and stored in a
locked drawer at my desk. I notified the respondents determined to be ineligible by email
thanking them for the interest to participate on the study and reminding them the
importance of the eligibility requirements on the outcome of the study.
Informed Consent
Eligible participants received the informed consent form (Appendix C) from me
via email as well as the interview core questions (Appendix H). Providing the interview
core questions enhanced the informed consent process and prepared the respondents for a
successful interview. The informed consent form met all the general requirements as
determined by the DHHS (2009) which include: a statement that the study involves
research, purpose of the research, expected duration of the informant’s participation,
description of any benefits from the research to the participant or others, description of
the extent of time confidentiality of records, identification of the participant will be
maintained, the researcher’s contact information to answer pertinent questions about the
research and participant’s rights, and a statement that participation is voluntary and
withdraw from the study may be done at any time without any penalty.
In addition, I provided sufficient opportunity to consider whether to participate in
the study to minimize any possibility of coercion or undue influence. Once the qualified
participant had read and agreed upon the consent form’s contents and to be interviewed,
the words “I Consent” were e-mailed to my email address listed on the informed consent
(patricia.bolivar@waldenu.edu) by eligible participants. The “Respondent Screening
Form” (Appendix G) and the Informed Consent Participant Log (see Appendix I)
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containing the participant demographic information and eligibility criteria, the only
records linking the participant to the research, are maintained in my custody (DHHS,
2009); locked in a desk drawer designated “research study records” and kept for five
years after completion of the study, upon which time all records will be destroyed by
shredding. I conducted all the interviews. Interviews took place at a private place such as
the local library individual study rooms reserved prior to the interview. Upon the
participants’ request, few interviews took place at the privacy of the participant’s home.
Instrumentation
Data collection instruments consisted of a semistructured interview using a series
of open-ended questions asked to all participants in a pre-determined order (Crosby,
DiClemente, & Salazar, 2006; Patton, 2002; Turner, 2010). Open-ended questions
allowed the participants to elaborate and contribute as much additional details on their
experiences as desired (Giacomini & Cook, 2000; Turner, 2010). The core interview
questionnaire consisted of 35 directive questions (see Appendix H) used to ascertain the
research questions based on the Health Belief Model (HBM) constructs (Delgado-Rico,
Carretero-Dios, & Ruch, 2012). I read the questions exactly as they were worded to avoid
changing the intent of the question, in addition I was prepared to ask follow-up questions
to ensure optimal responses from the participants (Heckemann et al., 2016; Turner,
2010). A semistructured interview format allowed me to engage in dialogue with the
participant whereby modification of the initial question took place in the light of the
participant’s responses (Smith & Osborn, 2013). Although I was encouraged to use
probes, the probes were as neutral as possible to avoid introducing bias into the process
(Crosby et al., 2006; Denzin & Lincoln, 2008). Prior to scheduling the participants for the
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interview process, I confirmed that informed consent response with the words “I
Consent” was on file by reviewing the Informed Consent Participant Log (see Appendix
I). The existence of the informed consent on file was also documented in the interview
sheet notes, and my study journal. I kept a study journal to document how the study
progressed from initial forays of the research to the conclusion’s arrival (Bazeley &
Jackson, 2014). All interviews as previously authorized by the participants were recorded
using an Olympus WS-321M digital voice recorder.
Instrument Content Validity
Content validity has been defined as “the degree to which an instrument has an
appropriate sample of items for the construct being measure” (Polit & Tatano Beck,
2006). To establish the content validity of the core questions (Carretero-Dios, & Ruch,
2012; Delgado-Rico), I assembled a content validity panel. Four professionals with
expertise in a variety of areas including study design, qualitative research, public health,
human behavior, education, research ethics, and microbiology, were assembled (See
Appendix J). I contacted these professionals by phone and asked about their willingness
to participate. All four individuals agreed to serve on the content validity panel. I sent
everyone by email the 35 interview questions and the Survey/Interview Validation Rubric
for Expert Panel - VREP© (Simon & White, 2016) to grade the questionnaire (Appendix
K). I did not need explicit permission directly from the author to use the
Survey/Interview Validation Rubric. A statement of permission by the authors to use this
survey and include it for dissertation manuscripts was given to the public as stated in the
Internet (Simon & White, 2016). The Survey/Interview Validation Rubric provides a
Likert scale at the top of the page and instructs to rate the interview questions for clarity,
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wordiness, negative wording, overlapping responses, balance, use of jargon,
appropriateness, use of technical language, application to praxis, and relationship to
problem as well as relevance of the questions to the underlying construct as follow. The
grades are as follows: 1= not acceptable (major modifications needed), 2= below
expectations (some modifications needed), 3= meets expectations (no modification
needed, but could be improved with minor changes), and 4= exceeds expectations (no
modification needed).
Once the panel members graded the questions and returned them to me (Appendix
L) I calculated the average congruency percentage (ACP). The ACP indicates whether
each item on a scale is congruent or relevant to the construct (Polit & Tatano Beck,
2006). I computed then the percentage of items rated by each expert, and calculated the
average of the percentages across experts. An ACP percentage of 90 percent or higher is
considered acceptable (Polit & Tatano Beck, 2006). The ACP I calculated from the
content validity panel’s grading of the interview questionnaire for this study was 93.84%
(Appendix M).
The Survey/Interview Validation Rubric for Expert Panel - VREP© is designed to
measure face validity, construct validity, and content validity (Simon & White, 2016).
Face validity refers as how reasonable the questions are to gain the information the
researcher is attempting to obtain (Moores, Jones, & Radley, 2012). Construct validity
requires agreement between definitions and concepts and the measuring device for all
constructs being measured (Sackett, 2012), and content validity determines if an
instrument measures the specific domain of content (Sackett, 2012).
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Calculation of the content validity ratio (CVR) described by Lawshe (1975) as
CVR= n – N/2 ÷ N/2; where n represents the number of panelists that rated the questions
3 or 4 and N is the total number of panel members; this readily demonstrates whether the
level of agreement among panel members was greater than 50% (Polit & Beck, 2006;
Ayre & Scally, 2014). The entire panel gave a score of 3 or 4 to all the questions giving a
CVR of 1.0 indicating perfect agreement in a one-tailed test (α = 0.05) based on exact
binomial probabilities at which concurrence of the panel would not be considered to have
occurred by chance (Ayre & Scally, 2014). Therefore, agreement of the two validity
methods was demonstrated concluding inclusion of all the questions with minor
modifications.
The interview questions recommended for review by the content validity panel
(see Appendix L) were Questions 22, 25, 27, and 35. Original interview core questions
are included in appendix N. In Question 22, I explained to clarify the word literate and
what a Literate Lyme disease doctor entails, in Question 25 I changed the word failure
for inadequacy, and reworded Question 27 from What will it take for you to overcome
CLD? to What tactics do you think will be most beneficial to you to overcome CLD? and
in Question 35 I explained the word community to include what the community
encompass; neighbors, church, businesses, health care practitioners, etc.
After I implemented questions based on the validity review panel’s comments and
recommended revisions I carried a practice interview session with a colleague on April
27, 2016. The interview duration was one hour. Participants were reminded upon
eligibility of the length of the interview and the possible need to schedule additional
follow up interviews if clarification of the questions remained. Participants were
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informed when the entire interview process had been completed and encouraged to ask
questions to inquire of the study progress via a telephone call. I hired a professional
dissertation transcriber to transcribe the recordings of the interview within 48 to 72 hours
of finalizing the interview process. The PRN assigned upon confirmed eligibility was the
only identifier provided to the transcriber. The entire interview was transcribed to the
semantic level, including the interview questions, all words spoken, significant pauses,
and other features leaving a left-hand margin wide enough to make analytical comments
pin two separate columns (Smith and Osborn, 2007). I gave the participants the
opportunity to review the transcription of their interview, ask questions, and make
comments before data analysis and documented the activity in the “Participants Activity
Log” (Appendix O). The study protocol (Appendix P) summarizes all the central
elements involved in the study participants’ recruitment and interview process (WHO,
2016) as described above.
A small pilot study consisting of 10 to 20 percent of the sample size is
recommended to pretest or try out the research instrument (Simon, 2011). I used one
participants to conduct a pilot study as a trial run to address several logistic issues in the
research instrument, transcription, and documentation. This small pilot study provided an
opportunity to make sure the instructions were comprehensible, the wording was
adequate, validity and reliability were met, and to assure efficacy is achieved.
Data Analysis Plan
The process of data analysis began with the process of data collection discovering
the when, what, and where of experiences (Sandelowski, 2000) of young adults living
with CLD and their health promoting behaviors during the interviewing process and data
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documentation (Kim, Ju, & Khatun, 2015). Documentation of the data analysis process
was carefully and thoroughly executed to enhance the ability of subsequent investigators
to verify the findings and to follow the researcher’s decisions (Shenton, 2004). The
analytic strategy consisted of utilizing the concepts of content analysis such as latent
content, labels, meaning units, codes, themes, and unit of analysis (Graneheim &
Lundam, 2004). I utilized these tools to proceed with the analysis following a detailed
review of the transcripts as the process to recognize important themes, create a coding
system to identify those themes, and finally, to interpret the data (Ulin, Robinson, &
Tolley, 2005). To achieve this task, I immersed myself into the data by reading and
rereading the transcripts and becoming familiar with the content (Ulin, Robinson, &
Tolley, 2005). During the process, I sat aside preconceptions, pre-existing personal
experiences, attitudes, and beliefs to view and understand the phenomenon in a pure and
clear form (Drew & Hewitt, 2006) and became familiar with the responses (Creswell,
2012).
I followed the process by organization and characterization of the data into a list
of significant statements grouped into “meaning units” or themes condensed into
categories and codes to finally arrive to the interpretation of the phenomenon (Creswell,
2012). The data analysis process that I followed is summarized in Table 1. The aim of
analyzing the data is to try to understand or make sense of the content and the complexity
of those meanings instead of the mere measuring of their frequency (Creswell, 2009;
Sanjari et al., 2014). The study protocol (Appendix P) describes a summary of the steps
to follow in data analysis and data interpretation.
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Table 1
Data Analysis in Phenomenology
Data Management

Create and organize files for data

Reading

Read through text, make margin notes

Describing

Describe the essence of the phenomenon

Classifying

Develop significant statements, group statements into meaning units, codes

Interpreting

Develop a description of the “essence” experience

Representing

Present narration of the experience in discussion

I requested that the transcripts of the interview were written in such a way as to
provide sufficient space to contain two columns. The first column of the transcript was
used for commentary and to note significant and/or interesting details of what the
participant said and the second margin column to document emerging theme titles in the
form of concise phrases through the interpretative process (Snelgrove, 2014). I continued
this process for the entirety of the first transcript. A theme captures the experience
meaning and brings identity, intensity, and depth to the participant’s recurrent
experiences (Drew & Hewitt, 2006). I listed the emergent themes first chronologically in
a separate data sheet where I looked for connections between the emerging themes in
order to arrange them in a more analytical and theoretical order making connections
between the emerging themes (Denzin & Lincoln, 2008). Some of the themes clustered
together, while others emerged as subordinate concepts (Smith & Osborn, 2007). I
created then a table of the themes and arranged them in a coherent order as well as the
subordinate cluster themes, documenting the page number of where in the transcript each
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of them were found. I put aside the theme table from the first participant’s transcription
and worked on the next transcript from scratch. I used the theme tables to identify
repeating patters as well as new issues emerging respecting divergences and
convergences in the data acknowledging which participant’s accounts was similar but
also different (Smith & Osborn, 2007; Denzin & Lincoln, 2008). After analysis of all the
transcripts in the described fashion and revision of the emergent themes tables multiple
times, I constructed a table of superordinate themes or categories (Smith & Osborn,
2007). I assigned codes to the specific categories in each transcript. Then, I identified
codes as marked sections of the data and assigned labels towards the development of
themes, subthemes, categories, or major constructs (Denzin & Lincoln, 2008; MalagonMaldonado, 2014). Next, I condensed themes and codes into categories. I accomplished
condensation of similar coded text by utilizing a coding sort (Ali, Vitulano, Lee, Weiss,
& Colson, 2014). The qualitative data analysis software package NVivo from QSR
International set of tools assisted me in analyzing, managing, and shaping the data
(Bazeley & Jackson, 2014; Creswell, 2012). NVivo software also provided security by
sorting the database in a single file and enhanced rigor to the research by providing a
comprehensive “trail” of decisions made during data collection and analysis (Creswell,
2012; Houghton, Casey, Shaw, & Murphy, 2013). Upon completion of all the data
collection and the coding process, I performed data reduction followed by data synthesis,
and finally, interpretation of the data which explained how all the different themes and
subthemes fit together and the overall meaning of the responses given by the participants
(Ulin, Robinson, & Tolley, 2005).
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I obtained verbal commitment of independent qualitative researchers analyzing
the data and interpreting the results to produce dependable results which allowed for
percentage of agreement comparisons. The verification panel consisted of the San
Bernardino County Public Health Laboratory Director Linda Ward, a scientific research
writer and analyst; and Alexander Del Rosario, a graduate student. Once the independent
researchers had concluded the analysis, then I was ready to engage in the iterative process
to control some of the bias that are naturally inherent when only one researcher examines
data.
Issues of Trustworthiness
One of the most critical aspects of qualitative research is achieving and
maintaining rigor during the study (Loh, 2013; Thomas & Magilvy, 2011). Rigor is
defined by the Oxford dictionary (2007) as the quality of being extremely thorough,
accurate, or exhaustive. In other terms, rigor refers to various ways of establishing trust
or confidence by providing details to replicate the results and findings of a research study
with a different research sample (Thomas & Magilvy, 2011). Lincoln and Guba (1985)
naturalistic investigators in their classic work proposed a model of how to build trust in a
qualitative research or a model of trustworthiness. The authors explained the basic
question of qualitative rigor, “How can an inquirer persuade his or her audiences
(including self) that the finding of an inquiry are worth paying attention to, worth taking
account of?” (Lincoln & Guba, 1985, p. 297). Positivist investigators on the other hand,
often question the trustworthiness of qualitative researchers, perhaps because their
concepts of reliability and validity cannot be addressed in the same way in naturalistic
work (Shenton, 2004). Lincoln and Guba’s work addressed similar issues in four
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constructs corresponding to the positivists investigators criteria as follow: credibility (in
preference of internal validity); transferability (in preference to external
validity/generalizability); dependability (in preference to reliability); and confirmability
(in preference to objectivity) (Loh, 2013; Malterud, 2001; Shenton, 2004; Whittemore,
Chase, & Mandle, 2001). I used the strategies to determine rigor based on the four criteria
proposed by Lincoln and Guba (1985) for ensuring rigor and determining trustworthiness
in this qualitative research are described in more detail as follows.
Credibility (Internal Validity)
I ensured the study measured what was intended by remaining sensitive to the
relationship between the emerging data, the research questions, and the theoretical
framework; therefore, maintaining methodological coherence (Kramer-Kile, 2012;
Morse, Barret, Mayan, Olson, & Spiers, 2002; Shenton, 2004). I promoted confidence
that health promoting behaviors of young adults living with CLD were accurately
recorded by adhering to the following provisions. First, prolonged engagement between
myself and the participants to gain a full understanding of the phenomena: health
promoting behaviors of young adults living with CLD, and to establish a relationship of
trust (Shenton, 2004). Second, I practiced persistent observation by spending sufficient
time and prolonged engagement in the field until there was lack of any new emerging
data as evidence that saturation had been achieved (Creswell & Miller, 2000; Houghton,
Casey, Shaw, & Murphy, 2013; Simon, 2011). Third, triangulation across data provided
by the participants in the interviews and my detailed observations and documentation to
confirm data and to ensure data were complete (Houghton, Casey, Shaw, & Murphy,
2013; Kim, Ju, & Khatun, 2015). I searched for convergence among the participant’s
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information to form themes or categories in the study eliminating overlapping areas
(Creswell & Miller, 2000).
Fourth, review of the data and the research process by the dissertation committee
members, peer review by the verification panel and debriefing (Shenton, 2004; Simon,
2011). The verification panel as stated previously consisted of two members: a scientific
research writer and analyst, and a graduate student. The interview transcripts and my
interpretations were reviewed and put under scrutiny for accuracy of the methods and the
interpretations (Simon, 2011) by the verification panel. Finally, described by Lincoln and
Guba (1985) as “the most critical technique for establishing credibility” is member
checking. I took the data and its interpretations back to the study participants so that they
could confirm the credibility of the findings and had an opportunity to react to both the
data and its interpretation (Creswell & Miller, 2000; Morse, Barret, Mayan, Olson, &
Spiers, 2002). I documented this activity in the “Participants Activity Log” (Appendix
O).
Transferability (External Validity)
Transferability, defined by Malterud (2001, p. 484), is “the range and limitations
for applications of the study findings, beyond the context in which the study was done”.
It is understood that no study can provide information in its findings that are universally
transferable, regardless of the method used (Malterud, 2001). The aim of the researcher is
to produce enough information that could be shared and applied beyond the study settings
(Sharma, 2016). Since the findings of this study are specific to a small group of young
adults living with CLD in Los Angeles County, it will be impossible to demonstrate that
the findings and conclusions will be applicable to other populations and environments
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(Shenton, 2004). I provided thick, rich description and detail of the setting, the
participants’ accounts, perceptions, ideas, events, situations, and the themes in order to
create verisimilitude; defined by the Oxford Advanced Learner Dictionary (2005) as “the
quality of seeming to be true or real,” transporting the readers into the world of young
adults living with LD and enabling them to make decisions about applicability and
transferability of the findings to similar contexts or other settings (Creswell & Miller,
2000; Houghton, Casey, Shaw, & Murphy, 2013; Log, 2013; Malagon-Maldonado, 2014;
Noble & Smith, 2015; Sharma, 2016; Shenton, 2004).
Dependability (Reliability)
To achieve dependability of the study, I reported in detail the processes within the
study and provided an in-depth coverage of the research practices enabling future
researchers to be able to repeat the work and allow readers to gain a thorough
understanding of the methods and their effectiveness (Shenton, 2004). I established an
audit trail by keeping a research log of clear and comprehensive documentation of
activities, chronology of data collection, data contextual background, and methodological
decisions (Creswell & Miller, 2000; Houghton, Casey, Shaw, & Murphy, 2013). In
addition, the audit trail I included: a) Description of the specific purpose of the study, b)
Discussion of how and why the participants were selected, c) Description of how the data
were collected and how long the data collection lasted, d) Explanation of how the data
were transformed or reduced for analysis, e) Discussion of the interpretation and
presentation of research findings, and f) Communication of the specific techniques used
to determine the credibility of the data (Thomas & Magilvy, 2011). NVivo query tools in
conjunction with the researcher’s reflective diary was used to keep a comprehensive trail
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of decisions made during data collection and data analysis. I used NVivo tools to search
for specific words in the interview transcripts and observational field notes for important
terms, codes, and themes for analysis to ensure findings were not the perception of one
person, but of several participants sharing the same perception or experience (Bazeley &
Jackson, 2014; Houghton, Casey, Shaw, & Murphy, 2013). I ensured reflexivity by selfdisclosing personal beliefs, values, assumptions, and biases that may shape the research
inquiry as well as reflecting on social, historical, and cultural forces affecting personal
contributions that shape the interpretations (Creswell & Miller, 2000).
I elicited the support of at least one qualitative researcher to examine the raw data
and interpret its findings to establish inter rater reliability. The qualitative independent
researcher used the protocols I had previously established which outline the data collection
process, data analysis process, and the process used to interpret the findings (Appendix P).
The independent qualitative researcher used the established protocols to theme and code
the data and come up with interpretations. I then determined the percentage of agreement
where the higher the percentage of agreement, the greater the interrater reliability.
Confirmability (Objectivity)
Once I had established credibility, transferability, and dependability, confirmability then
took place (Thomas & Magilvy, 2011). In addition to triangulation and admission of my
beliefs and assumptions, I took the following steps to ensure as far as possible that the
study findings were the results of the participants’ ideas and experiences rather than my
preferences and characteristics. After I interviewed every participant, I wrote personal
feelings, insights, and biases; I made a conscious effort to follow rather than lead; and I
created an audit trail represented using data oriented diagrams. The diagrams showing
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how data led to the formation of recommendations and how it was processed during the
study’s course allowed the readers to trace the course of the research step by step of the
procedures I followed and decisions I made (Shenton, 2004; Thomas & Magilvy, 2011).
The in-depth methodological description allowed integrity of the results to be scrutinized
(Thomas & Magilvy, 2011). Table 2 below summarizes the strategies I followed to
establish rigor to the study.
Table 2
Summary of Strategies to Determine Rigor
Approaches to Rigor

Strategies

Credibility

Prolonged engagement and persistent observation
Triangulation
Peer debriefing
Member checking

Transferability

Thick description

Dependability

Audit trail
Reflexivity
Inter rater reliability

Confirmability

Audit trail
Reflexivity

Ethical Procedures
I did not begin the study until all the comments, guidance, and approvals were
received from the research ethics committee (USDHHS, 2005). I followed all the laws
and regulations that establish the principles of ethical conduct: do not harm, protect the
privacy and anonymity of the participants, and maintain confidentiality of information. I
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obtained informed consent of participants, assured that participation was voluntary
providing ample opportunity to withdraw from the research, avoided any inappropriate
behavior, and interpreted data honestly without distortion (Creswell, 2009; Patton, 2002;
USDHHS, 2005; World Medical Association; 2005). I obtained approval of the research
plan and all research materials from the Walden University IRB. Approval was obtained
on 02/17/2017 11:34:47 -06’00’. The IRB is responsible for ensuring that all research
conducted by Walden University’s students complies with the university’s ethical
standards as well as U.S. federal regulations and any applicable international guidelines
(Walden, 2016). The following documents were submitted to the IRB for review and
approval: the research plan or dissertation proposal (Chapter 1, 2 and 3), Informed
Consent Form (see Appendix C), Recruitment Flyer (see Appendix D), Approval letter to
recruit participants from the Los Angeles County Lyme Disease Association (see
Appendix E), Social Media Invitation to Study Participation to Facebook and LinkedIn
Chronic Lyme Disease Study Invitation (see Appendix F), Respondent Screening Form
(see Appendix G), Interview Core Questions (see Appendix H), Informed Consent
Participant Log (see Appendix I), Content Validity panel (see Appendix J),
Survey/Interview Validation Rubric for Expert Panel - VREP© (see Appendix K),
Completed VRP by Validation Panel (see Appendix L), Content Validity Panel and
Results (see Appendix M), Original Core Interview Questions Sent to Validation Panel
for Review (see Appendix N), Participants Activity Log (see Appendix O), Study
Protocol (see Appendix P), and proof of recent human subjects protection training (see
Appendix Q). The IRB approval period for conducting the study, guidelines, established

103

policies and procedures, reporting of any deviation from the procedures, and submission
of continuing review approval applications was respected and strictly followed as
required.
Summary
This chapter included a discussion of the research design and rationale
highlighting the research questions and methodology. My role as the researcher was
clearly defined and explained. Detailed information of the study population, sampling
strategy, recruitment procedures, participant selection, data collection instruments, and
the process of validating the semistructured interview questions that validated the
research questions were presented. The data analysis plan was elucidated, including a
brief description of NVivo (the software that was used to enhance the process). Measures
to protect human subjects following U.S. federal regulations, processes to safeguard
participant’s information and maintain anonymity, and issues of trustworthiness such as
credibility, transferability, dependability, and confirmability were established. Finally,
ethical procedures such as the IRB documentation and treatment of data description were
also provided. The following chapter includes a description of the results of the study by
addressing each research question, presenting data to support findings, and illustrating
results as appropriate.
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Chapter 4: Results
Introduction
The lack of qualitative phenomenological research studies on the impact that
chronic Lyme disease (CLD) has on the health promoting behaviors of ethnically diverse
groups has been affirmed by Ali et al., (2014). I explored this gap in the literature by
selecting a group of participants who were not just middle-aged whites with high
socioeconomic status, and who can carry full medical insurance coverage. The purpose of
this study was to explore the impact chronic Lyme disease (CLD) has on the health
promoting behaviors of ethnically diverse, insured, young adults from similar educational
and socio-economic backgrounds based on their lived experiences. The
phenomenological research design was used in this study to elicit CLD affected
participants to share their day to day experiences living with the disease.
This study was guided by a series of closely related questions (Simon, 2011)
based on the Health Belief Model constructs (Rosenstock, Strecher, & Becker, 1988;
Behavioral Change Models, 2012) that helped me to avoid being distracted by interesting,
but irrelevant digressions and to stay on target (Simon, 2011). The research questions
were as follow:
RQ1: Qualitative: To what degree do different ethnic groups with average levels
of socioeconomic status, education, and third-party coverage, perceive the likelihood of
acquiring comorbidities related to CLD?
RQ2: Qualitative: To what degree does the perceived severity of CLD impact the
lives and decision-making processes of different ethnic groups with average levels of
socio-economic status, education, and third-party coverage?
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RQ3: Qualitative: To what degree does the perceived benefits of treatment impact
the lives and decision-making processes of different ethnic groups with average levels of
socio-economic status, education, and third-party coverage?
RQ4: Qualitative: To what degree do perceived barriers impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
RQ5: Qualitative: To what degree does the cues to action impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
RQ6: Qualitative: To what degree does self-efficacy impact the lives and
decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage?
In this chapter, I describe the conduct of the pilot study, report any impact of the
pilot study on the main study, describe the setting and how the proposed plan was
performed, and present the study’s purposive sample population demographics and
characteristics relevant to the study. I describe in detail all the processes of data
collection including where the participants were interviewed and how the data was
transcribed and analyzed. The data analysis process is explained describing the specific
codes, categories, and themes that emerged from the data using quotations as needed to
emphasize its importance.
I also discuss how I used the NVivo from QSR International set of tools program
in analyzing, managing, and shaping the data. Measures used to establish evidence of
trustworthiness are also described. Finally, I present the data to support each finding by
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addressing each research question with the actual candid and rich descriptions of CLD
affected individuals’ experiences to demonstrate the relationship of thematic patterns and
the research questions.
Pilot Study
A small pilot study consisting of one individual as recommended by Simon
(2011) was recruited to try out the research instrument. I used a pilot study as a trial run
to address several logistic issues in the research instrument, transcription, and
documentation. This small pilot study provided an opportunity to make sure the
instructions were comprehensible, the wording was adequate, validity and reliability were
met, and to assure efficacy was achieved (Simon, 2011). The participant was recruited as
described in the methodology section, where informed consent was obtained for the
interview process and a permanent record number (PRN) was issued to indicate that
inclusion criteria was met and that confidentiality was maintained during the transcribing
and the data analysis processes.
The pilot interview took place March 6, 2017 at the public library in Pasadena,
California; duration 32 minutes. The transcriber received the interview 3 days later, and
returned its transcript back to me 4 days after submission. The process of data analysis
started immediately after I received the transcript. The process consisted of immersion
into the data by reading and re-reading the data and becoming familiar with the content
(Ulin, Robinson, & Tolley, 2005). Next, a column to the right in each of the pages of the
transcript was made to note significant and interesting details, to document emerging
titles in the form of concise phrases through the interpretive process (Snelgrove, 2014),
and to ensure sufficient data were obtained to address the research questions.
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The coding process began with identification of meaning units documented in my
interview journal. A total of 77 meaning units or themes were found which were
condensed into 36 categories/codes related to the research questions and documented in a
matrix chart for easy visualization which allowed me later with the study interviews to go
through each topic to pick out concepts and themes (see Denzin & Lincoln, 2008). The
transcript was also imported to the qualitative research software NVivo 11 for Windows
by QSR International and nodes were created based on the data entry on the manually
created chart to methodically find meaning units in the transcript. Data from the interview
was exported to the created nodes as the transcript was read to answer the research
questions. A detail description of the data analysis process carried for the study is
provided in the Data Analysis section of this chapter.
Lessons learned from the pilot study which affected the main study and were
implemented during the interviews’ process were:
1. To make sure the location for the interview was secured such as confirmation
in person at the library at least an hour earlier of the scheduled time. Even
though phone pre-arrangements are made, just the reservation without prior
confirmation does not guarantee the room.
2. To verify ahead of time that the place where the interview is scheduled is
indeed quiet and private.
3. To become familiarized with the recorder and its functions such as making
sure a pause during the interview does not start a new file, as well as having
extra batteries, and testing the recorder before each interview.

108

4. To prepare with a list of additional questions to ensure the core questions are
answered completely.
5. To develop a strategy to bring the participant back to the core question when
digression takes place.
6. To remember that the program that enables transferring data from the recorder
to the computer must be downloaded to all the computers used for that
function.
7. To keep in mind that the NVivo license allows data import to be performed
only in my personal laptop computer.
8. To consider that the transcriber make take from 72 hours to 5 days to get the
interview transcripts back to my email so checking daily is a must.
9. To reassure that the data analysis process (reading of the transcript, coding,
synthesis, compression of the data into the data matrix, and importing the data
to NVivo) must take place immediately after receiving each interview
transcript to ensure observations are well documented.
Setting
There were no personal or organizational conditions that influenced participants
or their experience at the time this study was conducted and the interpretation of the
study results. All the participants I recruited in this study, including the pilot study,
participants were recruited using the methods approved by the Walden University
Internal Review Board (IRB). All the participants were enrolled in the study from the
pre-approved IRB research sites: Los Angeles County Lyme disease group, L.A. Lyme
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social media website and word of mouth referrals. All the participants met the inclusion
criteria and voluntarily participated in the interview.
Demographics
The sampling method I chose, stratified purposeful sampling, was the method that
best enabled insights into the research questions of this study (see Ali, Vitulano, Lee,
Weiss, & Colson, 2014; Drew & Hewitt, 2006; Suri, 2011). The purposive sample
consisted of voluntary participants recruited from Los Angeles Lyme group (Facebook);
a chronic Lyme disease (CLD) support and discussion website, CLD patients who I met
at the L.A. Lyme group social gatherings, and participants that were referred for the study
in the age range from 18 to 40 years old. Additional eligible criteria included both men
and women who reside in the Los Angeles County, had been diagnosed with chronic
Lyme disease by either clinical disease diagnosis (medical case definition criteria) or by
confirmatory laboratory diagnostic tests, and had received or were currently receiving
treatment for the disease.
The sample was 67% females (n = 6) and 33 percent males (n = 3). Males were
mainly white, while the female population consisted of a mixed race/ethnical
background. Participants’ age average was 33 years old. Education level ranged from
high school to graduate school. The interviews took place at the location chosen by the
participants. Locations included the local library as planned to ensure privacy located
near the participants place of residence, their home, and one interview was carried at my
place of residence as requested by the participant. Duration of the interviews varied from
as short as 32 minutes to as long as to 84 minutes (one hour and 24 minutes). The average
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length of interviews was 55 minutes. A summary of the participant demographics
relevant to the study is illustrated in Table 3.
Table 3
Participants Demographics
Participant

PRN

Gender

Age

1

022701

F

27

2

022702

F

34

Race/ethnicity

Mixed (White
Hispanic/Pacific
Islander/Asian)
Asian

Education

Interview
location

Interview
duration
(minutes)
32

AS degree in
Nutrition

Library

BS in

Participant’s
home

84

Participant’s
home
Library

75

Business
3

031903

F

27

White Hispanic

Some college

4

030704

M

27

White

BS

48

Accounting
5

031605

M

32

White Hispanic

High School

Library

60

6

031906

M

35

White

Some college

40

7

050207

F

36

MS Speech
Pathology

8

050708

F

40

Mixed (American
Black, White,
American Indian)
Mixed (White, Asian)

Researcher’s
home
Participant’s
home
Library

60

9

060409

F

39

Library

54

Mixed (White,
American Indian)

Registered
Nurse
Mental
Health
Counselor

42

Data Collection
The data collection phase of the study started with the pilot interview on March 6,
2017 and ended on June 5, 2017, a total of 14 weeks. Final IRB approval was received on
February 17, 2017, and soon after, the IRB approved recruiting flyers were posted on the
L.A. Lyme website on Facebook and the LinkedIn social media website (see Appendices
D & F). Exactly 10 days after the IRB approval, the first participant was recruited
(February 27, 2017). Participants were continuously recruited and immediately scheduled
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for interview after eligibility was confirmed. Sampling and analyzing continued until no
new data appeared; theoretical saturation had apparently been reached. Overall
recruitment proceeded as expected. Initially response was fast. Five out of nine
participants were recruited and interviewed in the month of March. Recruiting then
slowed down. The recruitment flyer (see Appendix F) was then re-posted in the L.A.
Lyme website. This resulted in additional participants to enroll. In April one participant
was interviewed, followed by two in May and the last interview took place in June when
saturation was confirmed. No response was received from recruiting flyer posted in
LinkedIn social media website (see Appendix D).
Prospective participants contacted me by email whom I contacted back by phone
and completed the Respondent Screening Form (see Appendix G) to determine eligibility
to participate in the study. All the eligible individuals (n = 9) were sent via email the
Inform Consent form (see Appendix C). Once I received the words I Consent from the
participant by email the participant was assigned a Permanent Record Number (PRN)
consisting of six digits indicating date of acceptance and sequential order of recruitment.
For example, the pilot interview individual was qualified eligible to participate in the
study on February 27, 2017; therefore, the PRN created was 022701. The PRN followed
the participant in all the phases of the study: interview, transcription, data analysis, results
reporting, and will follow publishing, thus providing confidentiality of personal
identifiers in all the records. Only I have access to the participant’s identification data
matched with the PRN currently stored in a locked drawer at my desk. Two of the
respondents to the recruitment flyer did not meet the eligibility geographical location
requirement.
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All interviews were face-to-face, in depth, open ended questions (see Appendix
H). I made a conscious effort to follow rather than lead for every interview. Out of a total
sampling group of nine interviews, five were conducted at the local library, three
interviews took place inside the participants’ home as requested by the participants who
for reasons of the disease stage where unable to meet at the local library, and one
participant was interviewed at my home due to the participant’s available time to conduct
the interview (only after 7:00 p.m.) and absence of a permanent place of residence (see
Table 3). The proposed sample size was from 8 to 10 participants to achieve saturation
(Suri, 2011). Saturation in the study was achieved with participant number eight and one
more participant was interviewed to confirm saturation; where no new information was
obtained. Each interview was audio recorded using the Olympus WS-321M digital voice
recorder. Duration of the interviews varied as illustrated in Table 3 above from as short as
32 minutes participant 1 (PRN 022701); a young lady who was on the road to recovery
from the disease to as long as to 84 minutes from participant 2 (PRN 022702) who was a
very sick patient; bedridden for almost two years and wanted to share her experiences
dealing with the disease. The average length of interviews was 55 minutes. Participants
were excited and happy to have someone hear their CLD stories and look forward for the
information provided to be shared with numerous readers through this study. The
qualitative design interview of open ended questions (Crosby, DiClemente & Salazar,
2006; Patton, 2002; Turner, 2010) provided the means to express the participant’s
experiences with CLD without interruption, in a transparent and introspective manner
addressing each of the research questions. Immediately after each individual interview,
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field notes were taken documenting the participant’s nonverbal reactions, my personal
feelings, insights, biases, and overall perceptions.
Recordings were reviewed for clarity and completeness before they were sent to
the transcriber. All nine transcriptions were performed by Weloty Academic
Transcription Services. The company provided a Non-Disclosure Agreement for
Transcription Services (see Appendix R) reassuring confidentiality of the recordings and
deletion of the interview contents upon completion on the study transcription services.
The cost of the transcription services was $0.75 per minute. The total interview time was
495 minutes for the grand total of $372.00.
Neither variations nor deviations of the data collection plan or the study protocol
occurred with any of the nine interviews conducted. Early discontinuation of participation
did not take place. Two of the participants requested the interview to be paused;
participant 2 (PRN 022702) to take scheduled medicines and participant 3 (PRN 031903)
to use the restroom.
Data Analysis
Data analysis was a continuous and evolving process beginning from personal
notes taken at the interview and continuing immediately after receiving the transcripts of
the recordings. The first step in analyzing the data was by reading and rereading the
transcripts. I read each transcript at least three times, put aside preconceptions,
preexisting personal experiences, attitudes, and beliefs to view and understand the
phenomenon in a pure and clear form (see Drew & Hewitt, 2006) and became familiar
with the responses (see Creswell, 2012).
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Reading the transcripts many times ensured sufficient data was obtained
addressing the research questions. I requested the transcripts of the interview to be
written in such a way as to provide sufficient space to contain two columns. The page
was laid out in portrait orientation to insert the columns. The first column of the
transcript was used for commentary and to note significant and/or interesting details of
what the participant said. The second margin column was used to begin the coding.
The coding was performed by documenting patterns within the data searching for
similarities and differences in the responses and formulating meaning unit’s titles in the
form of concise phrases through the interpretative process (Snelgrove, 2014) using words
related to the research questions. This process was continued for the entirety of each of
the transcripts. A code matrix was then created using Windows Excel spreadsheet with 36
codes corresponding to the answers given to the interview core questions in relation to
the six research questions. Simultaneously, each transcript was also imported to the
qualitative research software NVivo 11 for Windows by QSR International the data
obtained from each interview was exported to the individual nodes designed to match the
manually created code matrix to methodically find meaning units. The qualitative data
analysis software package NVivo from QSR International set of tools assisted the
researcher in coding, analyzing, managing, and shaping the data (Bazeley & Jackson,
2014; Creswell, 2012).
NVivo software also provided security by sorting the database in a single file and
enhanced rigor to the research by providing a comprehensive trail of decisions made
during data collection and analysis (Creswell, 2012; Houghton, Casey, Shaw, & Murphy,
2013). Upon completion of all the data collection and the coding process completed, the
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data reduction took place followed by data synthesis, and finally, interpretation of the
data (Ulin, Robinson, & Tolley, 2005).
Manual analysis of the transcripts and use of the NVivo tools facilitated the
creation of five categories: a) Vulnerability/Prevention, b) Diagnosis/Personal Story; c)
Impact of the Disease; d) Management/Treatment; and e) Influences on Care; which
evolved from primary and secondary themes discussed in the results section of this
chapter. Codes and nodes were developed using words related to the research questions to
name a few; route of transmission, health before CLD, prevention of CLD, symptoms,
diagnosis, treatment, support, and recovery. For example, Participant 6 (P 031906)
described his experience with CLD as follow:
So, when I was in college, I actually I had got some weird strange symptoms one
day, kind of out of the blue. And I do not remember a tick bite, I never had bullseye rash either, nothing like that that I remember. And it just kind of appeared.
And then it went away. I never knew what it was, all the symptoms went away. I
was fine. Actually, I was fine for about 8 years and everything kind of dissipated.
And then about over 4 years ago, all of my symptoms came back, kind of had a
lot going on in my life and it brought everything to ahead. I was diagnosed by
luck, I mean I actually went to a doctor who knew how to diagnose for Lyme, she
had dealt with Lyme herself, so she knew what test to order and the test came
back positive.
The first part of his response was coded as route of transmission under the
category Vulnerability/ Prevention and the theme Acquiring CLD. The route of
transmission code captured the essence of experience acquiring the disease (Radolf,
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Caimano, Stevenson, & Hu, 2012). Another coding resulting from his response was his
experience being diagnosed coded under the category Diagnosis/Personal History under
the theme Diagnosis illustrated in Table 4 in the Results section of this chapter. There
were no discrepant cases to be factored into the analysis of this study. Participants shared
their CLD stories in a transparent and straight forward manner.
Evidence of Trustworthiness
Credibility
To demonstrate the congruency of my findings with reality, the following
provisions were made to promote confidence that health promoting behaviors of different
ethnic groups with average levels of socioeconomic status, education and third-party
coverage dealing with Chronic Lyme disease had been recorded under scrutiny:
1. Establishment of a relationship of trust was ensured during the recruitment and
the interview process by spending sufficient time with the participants to gain a
full understanding of the phenomena (Shenton, 2004).
2. Continuous recruitment and engagement in the field was maintained until no new
themes emerged or categories evolved as evidence that saturation has been
achieved (Creswell & Miller, 2000; Houghton, Casey, Shaw, & Murphy, 2013;
Simon, 2011).
3. Triangulation was maintained by examining the data multiple times to verify
interpretations, documenting in a journal detailed observation, and confirming
completeness of the data making sure overlapping areas did not exist when
formulating categories and themes (Creswell & Miller, 2000).
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4. The verification panel composed of three members was established. Each
member was given the interview transcripts and a spreadsheet matrix with my
interpretation of the responses to the interview questions. Each of the panel
members reviewed the data and put it under scrutiny for accuracy and
completeness of its contents. No discrepancies were found. One of the members
added a few words to the pilot interview I had omitted on my interpretation to
clarify the responses to three of the core questions. The other member agreed
100% with the matrix contents.
5. Finally, as described by Lincoln and Guba (1985) “the most critical technique for
establishing credibility” is member checking. Each of the members was emailed
his/her corresponding matrix of synthesized responses to each interview question
given an opportunity to review the data. None of the participants had a negative
reaction to the data synthesis and its interpretations.
Transferability
As indicated previously, according to Malterud (2000) no study can provide
information in its findings that are universally transferable regardless of the methods
used. The aim of the study was to produce enough information that can be shared and
applied beyond the study settings (Sharma, 2016). Transferability determination to
similar contexts or settings by the readers is facilitated by thick rich descriptions and
details of the setting, the participants’ accounts, perceptions, ideas, events, situations, and
the themes.
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Dependability
To establish dependability in these research findings I adhered to the proposed
methods with no deviations from the protocol and interview guide. I reported in detail the
processes within the study enabling future researchers to repeat the work and the readers
to gain a thorough understanding of the methods and their effectiveness (Shenton, 2004).
The following measures were taken to establish trust in this study findings: an audit trail
was established by keeping a research log of clear documentation of activities such as
participant eligibility based on meeting inclusion criteria, screening date, consent
agreement, interview date, duration of the recorded interview, date of transcript, and
interpretation of interview responses. NVivo query tools in conjunction with the
researcher’s reflective diary was used to keep a comprehensive trail of decisions made
during data collection and data analysis. I used NVivo tools to search for specific words
in all the participants’ interview transcripts for important terms, codes, and themes for
analysis ensuring that the findings were not the perception of one person, but of all the
participants sharing the same perception or experience as illustrated in the results section
of this chapter (Bazeley & Jackson, 2014; Houghton, Casey, Shaw, & Murphy, 2013).
In addition, I elicited the support of one qualitative researcher to examine the raw
data and interpret its findings to establish inter rater reliability. The qualitative
independent researcher used the protocols previously established outlining the data
collection process, data analysis process, and the process used to interpret the findings
(Appendix P). The independent qualitative researcher used the established protocols to
code the data. The percentage of agreement reliability was calculated after several
periods of debriefing and two meetings to compare our individual findings. In our first
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meeting, we discussed the method used to code the pilot interview. After review of the
pilot interview I had 77 manual codes and the inter rater had 70 codes obtaining a 91%
agreement. For our second meeting, we discussed the task being too cumbersome since
many codes overlapped. The codes were then reduced based on the interview questions as
they relate to the research questions and NVivo coding. After coding 2 more interview
transcripts, the inter-rater coded 36 codes and I had 35 codes giving an agreement
percentage of 97%. All the transcripts were then coded using 36 codes and a matrix
consisting of 36 codes belonging to all the nine participants’ interview responses was
created to help visualize the responses and document emerging themes, subthemes, and
eventually categories related to the research questions. The same 36 codes were used to
perform the creation of nodes using the NVivo from QSR International set of tools which
helped to manage and shape the data as illustrated in figure 8 below comparing two
transcripts depicting the 36 codes agreed with the inter rater to be used in this study
coding.
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Figure 8. NVivo 36 codes used for transcripts coding.
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Confirmability
To ensure confirmability of the study I used the following steps so that the study
findings are the results of the participants’ ideas and experiences rather than the
researcher’s preferences and characteristics. After each individual interview my personal
feelings, insights, and biases were documented; during the interview, I made a conscious
effort to follow rather than lead; and an audit trail was documented in my research
journal as well as in NVivo.
The in-depth methodological measures taken in the processes of credibility,
transferability, dependability, and confirmability described above allows the integrity of
the results to be scrutinized (Thomas & Magilvy, 2011).
Results
Table 4 summarizes the categories, primary themes, and secondary that emerged
from the data analysis.
Table 4
Emerging Categories and Themes
Categories

Primary Themes

Secondary Themes

Vulnerability/Prevention

Health Status Change

Acquiring CLD
Preventing CLD
Advise on prevention

Diagnosis/Personal Story

Diagnosis

Impact of CLD

Challenges of having CLD

Issues getting diagnosed
Reaction to disease diagnosis
Symptoms
Physical Health
Family/close relationships
Social Issues
Emotional Issues
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Management/Treatment

Recovery from CLD

Influences on Care

Support

Treatments received
Effectiveness of treatment
Acquiring CLD treatment information
Challenges obtaining treatment
Beneficial activities combating CLD
Motivation
Family and friends
Community
Health care providers
Public Health

The emergent themes were listed first chronologically in a separate data sheet
where I looked for connections between the emerging themes or primary themes and
subthemes or secondary themes to arrange them in a more analytical and theoretical order
making connections between the emerging themes (Denzin & Lincoln, 2008). Some of
the themes clustered together, while others emerged as subordinate concepts (Smith &
Osborn, 2007). A table of primary themes was then created and arranged in a coherent
order as well as the secondary themes (Smith & Osborn, 2007; Denzin & Lincoln, 2008).
After analysis of all the transcripts in the described fashion and revision of the emergent
themes in a table format multiple times; Table 4 above was developed discussed herein as
they relate to the six research questions.
I discussed with each study participant guided by 35 core interview questions
their perceptions of susceptibility to chronic Lyme disease (CLD), severity of symptoms
affecting physical, family, social, and emotional life, treatments and benefits of
treatments, barriers in obtaining treatment, and recovery of the disease using the Health
Belief Model. I also queried the participants on cues to action and self-efficacy in terms
of internal and external triggers such as motivation, support from family, friends, the
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community, and health care practitioners in the health care system including public health
agencies.
Research Question 1
RQ1 stated, to what degree do different ethnic groups with average levels of
socioeconomic status, education, and third-party coverage, perceive the likelihood of
acquiring comorbidities related to CLD?
Data collected from open-ended questions 1-7 of the interview guide (Appendix
H) answered this research question. Study participants indicated that the likelihood of
acquiring comorbidities related to CLD does not depend on any degree on being healthy
or identifying how they got the disease, but on awareness of the existence of the disease
in the Los Angeles County and timely diagnosis.
Vulnerability/Prevention: Health Status Change. Seven of the nine participants
noted that they were productive and involved in an active daily life style before CLD and
described themselves as “excellent health, not tired, normal”, “extremely active, weight
lifting, martial arts, very active”, “exercised a lot, yoga, ate healthy, lived an active and
healthy life”, “amazing health, active, and a hiker”. The other two participants
(Participants 3 & 9) had been sickly since childhood; participant 3 expressed her
declining health:
I had health issues throughout my childhood I was always sick. I think the biggest
time where I noticed something I was in college. On my sophomore year at
college, it was just like every system was kind of failing. Then, I would get better
for a little while, and then they would just be bouts throughout my life. It wasn’t
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until I was in my early thirties, at post-partum after my second daughter was born,
that I was just completely knocked out.
And participant 9 expressed her sickly teenage years as:
I had no problems before the age of 13, then I kind of got recurrent ear and nasal
infections, I had all kinds of chronic tonsil infections all the time and I was put on
all kinds of varying antibiotics, a million times over. Then when I was developing
as a teenager I had pneumonia, and I almost died I remember it was horrible when
I was 16. By 19 I couldn’t get up early in the morning anymore, I was tired, since
age 13 I had horrific joint pain, where I had trouble walking.
Acquiring CLD. Six out of the nine participants did not know how they acquired
the disease:
Participant 1: “Not exactly known.”
Participant 2: “I’ve no idea how I was infected, but I started to see the symptoms
that we now know that are associated with Lyme disease when I was 7 or 8 at
least so that was at least 25 years ago really don’t know how I got Lyme. I’d
never seen a tick, we never lived in the woods.”
Participant 6: “It’s unknown, it’s speculated it may be in the family because of
symptoms my family has and my sister has, but it’s unknown.”
One of the three participants who knew the route of transmission explained:
I found the tick, but I did not get it properly diagnosed or treated. Then for about
maybe a week or later I got sick for just kind of felt like a cold running, run down,
like feverish a little bit. I figured I just had a flu or cold. Then about 6 to 8 months
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later I started dealing with more very severely ongoing fatigue, and other
cognitive issues with my brain and short-term memory. Nothing too significant to
make myself not have like a daily living struggle. But it made things more
difficult and I felt like I was really exhausted, and kind of a in a mental fog and
didn’t really know why. To a certain point where I kind of had a crash of my
health, and I actually had I went to several hospitals to get you looked at. Because
they knew that there was something going on, and my body becoming weaker and
I couldn’t walk long distances. Eventually my legs would get really tired and this
kind of like nerve, feeling in my nervous system that is hard to describe. But
going through proper testing, through different labs and hospitals. Nobody really
knew what it was and they just prescribed me stuff for anxiety. They said usually
it was in my head, or I was just anxious and stuff like exaggerating symptoms of
being hypochondriac.
Preventing CLD. All nine participants when asked how they would have
prevented CLD declared that awareness of the disease existence in Los Angeles County
and the disease symptoms are key to prevent the disease. The participants expressed the
need of awareness, more awareness which must exist not only by the public, but
primarily by physicians. One of the participants stated:
Knowledge of the disease and awareness. Just knowing that it exists, that it’s in
Southern California and having doctors that would be aware of the disease and
take it seriously it would have made an enormous difference.
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Advice on prevention. Each of the participants expressed her/his ideas depending
on their experience of the disease in a slightly different way, but all the participants had
in common tick checking, immediate seeking medical attention, and education on the
disease. A few examples of advice on prevention included:
Participant 1; “Be cautious of where you hike, be cautious about being outdoors.
As well as always check yourself after being outdoors for any ticks or unusual
bites. If I had the knowledge I would have been able to better find my diagnosis,
and treat more effectively and sooner”.
Participant 2: “So, it’s just important to do tick checks, I would have loved if I
had known to do tick checks. I would have avoided certain areas where they
would be kind of hanging out. Wearing protective clothing, so that I would be
able to catch it earlier. Really it was just a huge bummer that had I known been a
little bit more aware, I never would have gone through it”
Participant 3: “Use essential oils as tick repellent when outdoors, hiking, on in the
wilderness such as lemon eucalyptus, lavender, black seed oil. Take care of the
immune system and do not mask symptoms and emotions”
Participant 6: “That is a big question. I mean there are a lot of answers, from a
like simple standpoint, it’s really be aware of ticks no matter where you live,
because unfortunately they may be anywhere even in your backyard. No matter
where you live you should be always aware of ticks. If something does happen
you need to make sure that you go to a Lyme literate doctor right away.
Immediately, if you have strange symptoms go to a doctor right away, like a
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doctor who knows what they’re doing and knows how to prescribe antibiotics
right away. It will go away, it will not turn into chronic Lyme”
One of the participants; however, had a very different answer when it came to advice to
others on prevention:
There is one theory that if you take antibiotics early, then you could prevent from
having chronic Lyme. I don’t know if I believe that is true, what I see is a lot of
people taking antibiotics early based on the advice. And then six months, a year
later or maybe they go through a traumatic experience such as a car accident or
maybe they get a divorce or whatever, and then they get sick all over again, but
they are not really thinking about the Lyme that they had before. Because they
thought they treated it with the four weeks of antibiotics, or the two weeks of
antibiotics recommended. So, I’m not sure that I believe that there is anything that
you can do to cure or treat to keep from having chronic Lyme, other than build
your overall health. Other than deal with your past traumas and your stressors and
all your emotional stuff, and try to have better strategies for moving forward.
Diagnosis/Personal Story: Issues getting diagnosed. Eight of the nine
participants were diagnosed by IGeneX Laboratories and one by the CDC Lyme testing
algorithm. Time to diagnosis ranged from months to years from the onset of symptoms.
All the participants expressed problems getting diagnosed as illustrated by the following
reactions to the question on difficulties encountered being diagnosed:
(a) Many, first within myself as I didn’t know what was going on inside my body.
Second with the doctors because they were unable to diagnose me, and kept
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telling me that it was all in my head, and that what I was feeling wasn’t
necessarily an illness but instead something that could be fixed with antidepressants and such. Third, within my family because they didn’t know what I
was going through either. So, it was hard for them to understand exactly what I
was feeling because of the lack of knowledge of Lyme disease among everyone
really.
(b) Was accused by doctors that it was all in my head. I was seen at hospitals for
anxiety attacks, tested for many autoimmune diseases and viral infectious
diseases; lupus, West Nile, Hepatitis B and others.
(c) Have symptoms since very young, and went undiagnosed for years. After
visiting various doctor finally, a doctor had Lyme testing on his radar and ordered
the test which came back positive. It took a year since I had to pay out of pocket
$360.
(d) In High school was never diagnosed and the symptoms subsided, until 8 years
later when the symptoms returned more aggressively and I was diagnosed within
a couple of months.
(e) Took 15 years to get diagnosed and many “oologists”; dermatologist,
cardiologists, rheumatologist, endocrinologists, gastroenterologist, and
chiropractors and nutritionists.
(f) Took two years to get diagnosed after being treated for mental illness; treated
with electroshock, bipolarity and Fibromyalgia.
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Research Question 2
RQ2 explored the perceived severity of CLD impact on the lives and decisionmaking processes of the qualifying participants chosen for the study. Two subthemes
belonging to the “Diagnosis” theme (issues getting diagnosed and reaction to diagnosis)
and a new category “Impact of CLD” with a main theme “Challenges of Having CLD”
and three subthemes emerged pertaining to this question from the interview questions 8
to 14. I found that the severity and duration of the symptoms affected participants’
physical, family, social, and emotional life to a high degree of impact on their everyday
life and their decision-making process.
Diagnosis: Reaction to disease diagnosis. The following phrases described the
reactions of the participants once CLD was diagnosed: “Relief, scared, not know what to
do next”, “angry at first then relieved knowing I could treat something and could get even
better and eventually cured”, “relief to know my condition had a name, but struggled
believing it was the right diagnosis”, “not really feeling nothing, accepted what it was”,
“it was hard to comprehend I had CLD, tested a few times to finally accept it”, “at first I
thought it was ridiculous until saw a program on a girl bed ridden with CLD and many of
the symptoms I had”, and “doctor kept it confidential for a while because they were
afraid of my emotional response, but it was great news and I knew it was at least curable,
it was scary but it wasn’t as demeaning as all the labels given to my condition”
Symptoms. The plethora of symptoms described by the participants started with
flu like symptoms, fatigue and tiredness, dizzy, feeling unbalanced, anxiety, and muscle
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weakness which progressed to central nervous system involvement described by four
participants as follow:
Participant 3: “Joint pain, noise bleeds all the time, dizzy, light headed, migraines,
chronic fatigue, burning sensations coming down the spine, digestive issues,
anger, rage, stress anxiety, hyperthermia, and gastroparesis. Hand, legs, shin, feet
pain, neuropathy, tendinitis, anxiety, anger, depersonalization, derealization,
electrical sensation on left side of brain, seizures like reactions; body lock up,
tremors, sense of impending doom, paralyzing fear.”
Participant 4: “Body aches, congestion, brain fog, disorientation, memory loss,
slurred speech, cognitive impairment, light headed, sensitivity to light and sound
at the same time, tachycardia, arrhythmia, low blood pressure, PoTS syndrome,
constant fevers, chills, dehydration, head rush, hyperthermia, vision distortion,
mild hallucinations, sadness, anxiety, terror of dying.”
Participant 7: “Symptoms will vary from vaginal issues: yeast infections,
vaginitis, pain in the vaginal walls, to gingivitis, had numbness on the center of
nose, lips, tongue, and throat that will come and go. Had heart problems;
palpitations, cognitive issues. Memory lapses, speech problems, vision
disturbances, temporary loss of vision, sensory experiences, and chemical
sensitivities, unable to drive or work.”
Participant 6: “Chronic fatigue, air hunger, chronic inflammatory response; pain
in muscles, tendons, and joints. SIBO, chest pains, double vision, bed ridden,
acute stress response, phono phobia, headaches, nausea, pain behind the eyes,
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dizziness, severe muscle weakness, difficulty swallowing, weak neck muscles,
and feeling faint.”
Impact of CLD: Challenges of having CLD. The participants’ challenges of
living daily for days, months, and even years experiencing various symptoms, many of
the symptoms at the same time; day and night affected their physical, family, social, and
emotional life to a high degree.
Physical Health. Chronic Lyme disease is a debilitating disease where the
progression of symptoms as expressed by the participants caused them weight loss, made
them undernourished and weak, and challenged them to move around and be involved in
the activities previously involved, unable to walk, drive or carry a normal life. Three
participants described their physical condition as follow:
Participant 1: “There was a point where I did drop down to about 87 pounds, and
that was deathly scary as I looked skeletal and unnourished, which I probably
was. Now I’ve gained some weight and I look better, but I still feel unnourished
within myself.
I can’t go out any place. I stay in the house most of the time, because of my
difficulty swallowing; I can’t eat out or go out to a restaurant. I can’t go out to see
people. I also get seizure-like attacks if I get in the car, where I would say shake
like a seizure. I’m really to the point where I have no kind of life. My life is in
bed, and that basically it. My daughter she is staying with my parents right now,
because of the fact that I really can’t physically take care of her fully. I mean she
is 17 years old, but it is hard to do anything with and for her.”
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Participant 6: “Bedridden, unable to do for myself. Developed comorbidities such
as sclerosis, autoimmune predisposition and coinfections of Babesia,
Mycoplasma, Bartonella, Candida and parasites. Neurological symptoms:
concentration problems, memory lapses, trouble forming words, trouble following
conversations. Suicidal thoughts and actions.”
Family/Close relationships. All the participants expressed how CLD affected
greatly their family life and close relationships with friends, siblings, parents and
spouses. These statements represent their experiences:
(a) Affected greatly with family and friends unable to participate in activities as
before and with my children unable to spend time together very low energy to
take care of them as wanted to. My husband left.
(b) Brother and relatives very supportive. Parents not understanding, they both
told me to suck it up! Told I was fine, just anxious.
(c) Had to take care of myself, as a child I was told I was lying or faking it. Illness
have made me develop a self-filtering devise for whom my real friends are and
have healed after a long time to be able to get close to my parents.
(d) Friends and family including my husband did not know what to do. Friends
did not really help or knew how to help, they didn’t offer to cook, baby sit, and
walk kids to the park. I would say think it like I have cancer, what would you do?
Bring us food, help take care of our kids, like all these thing, people didn’t get
that.
(e) Friends were scared. Friendships have changed now, I have different friends.
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Social Issues. Social life for all the respondents was also greatly affected and for
some it ceased to exist as they did not have the energy to go out and socialize. Three
participants expressed:
Participant number 2: “Life basically went down the drain, unable to hang out
with friend’s low energy to socialize, no control, extreme frustration, sadness,
symptoms lasted, and lasted, and lasted.”
Participant 6: “Social life disappeared was not able to engage.”
Participant 7: “I had no social life for years, recently able to socialize for short
time. This is not my fault. I got a bite by a tick or something and it took
everything that I could do. Took away my ability to work, cook, clean, have fun,
took away my ability to be a lover…took my life.”
Emotional Issues. Emotional issues were one of the subthemes that emerged in
which lots of sadness and anger was expressed from all the participants who also referred
to psychological and neurological involvement as the root of their emotional instability.
Words such as fear, easily depresses, detached; not feeling for others, traumatic, feeling
alive, but not really living, no empathy or sense of compassion, and apathetic were
spoken. Some of the participants expressed:
(a) Sadness, lot of suffering, but not angry just suppressed lots of feelings and it
was just dark, very dark and cried a lot, became apathetic, dazed out.
(b) Anger, feeling of dying. Emotions change, unable to handle life or being
normal; crying fits, laughing fits, psycho thoughts of hurting yourself or others.
(c) Had to have a lot of emotional trauma healing. Did not have much empathy or
sense of compassion until recently. Emotionally and psychologically affected.
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(d) Every level of torture because there is physically and emotionally pain. Being
in bed where you cannot do anything. There is family and friend’s rejection,
inability to do for yourself, there is brain malfunction; so, you lose your brain and
you are just stupid.
Research Question 3
RQ3 explored the perceived benefits of treatment that impacts the lives and the
decision-making process of the study group.
Interview questions 15 to 22 queried the participants on the effectiveness of
treatment to reduce or cure the illness and the impact on their decision-making processes.
The category “Management/Treatment” with the primary theme “Recovery from CLD”
and 3 secondary subthemes emerged. Five of the participants (56%) have tried multiple
treatments at the same time including a combination of conventional antibiotic treatment
and complementary and alternative medicine (CAM), three participants (33%) decided to
try one treatment modality at a time and see what the results were before changing
treatment, and one of the participants (11%) decided to take herbal remedies and
nutritional supplements only. There were different degrees of perceived benefits of
treatment received and not one specific treatment or a combination of given treatments
that have benefited the participants towards recovering from CLD, the benefits of the
treatments were rather dependent on everyone’s response to treatment at time of
intervention.
Management/Treatment: Recovery from CLD: Only one participant claimed to
have achieved 100% recovery. Four participants rated their recovery to be between 8090% and are currently in maintenance treatment modalities of herbals, supplements, and
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healthy diets; two participants have partially recovered to 60-70% where they have
relapses on and off when not taking medication on the regular basis; and the other two
participants of the study group were in the acute stage of the disease.
Treatments received. The list of treatments the participants have tried are
compiled in the following table:
Table 5
List of treatments
Antibiotics

Herbals

Supplements

Miscellaneous

Specific
Protocol

Rifampin
Cefuroxime
Amoxicillin Nyastatin
Nizac
Doxycycline
Augmentin
Flagyl Azithromycin
Amoxicillin
low dose antibiotics

Lomatium
dissectum
herbal
mixtures
lemon grass
olive leaf
extract
walnut
plantain
Piniella,
Samento,
Banderol
Japanese
knot-weed
Oregano oil
turmeric

Glutathione
Nutrametrix
Vitamin C IVs
hlorine dioxide
Miracle Mineral Solution
(MMS).
Low dose amino therapy
deliberate dieting high
protein and fats such as
Vitamin D
grass fed butter
essential oils
silver
IV immunoglobulins

acupuncture
energy frequencies
coffee enemas
metal chelation
castor oil packs
infrared lamps
sauna detox
salt baths
ozone treatment
nasal activation
histamine
UV light
IV Chemotherapy
Stem cell transplant

Chinese formulas
Dr. Stephen
Buhner protocol
Cowden protocol
Bee venom
therapy
parasite treatments
Guaifenesin
protocol
Natural holistic
and Homeopathic
GAPS health
work remedies
Indigo
biofeedback
Bartonella and
Lyme Treatment
Stool transplants
Rife machine ONDAMED
Infusions

Effective treatments. When asked about the treatment that have worked the best
the participants have different responses, but it seems herbals, antibiotics, and bee venom
are the most mentioned effective treatments from the study group: Participant 1:
“Combination of treatments especially acupuncture and herbal treatments, lowering stress
level”; participant 2: “Long antibiotics treatment (one and half year) felt better after 8
months and the Stephen Buhner herbal treatment are the best”; participant 3:
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“Antibiotics”; participant 4: “Bee venom therapy healed me from the cellular level,
normal blood pressure, normal heart rate, normal oxygenation”; participant 5: “I believe
all help in some way, but Bee venom is working for me”; participant 6: “Rife machine
and traditional Chinese medicine using visceral manipulations and little acupuncture”;
participant 7: “Did not rush into treatment. Being flexible and in tune with my own body.
Partnering with the right practitioner”; participant 8: “On ONDAMED for three years. I
can eat a little bit more”; and participant number 9: “Herbals, gut protocol, and a full
detoxing program. Silver has also worked well for me”.
Acquiring treatment information. All the participants agreed on how they
obtain CLD treatment information; the Internet, Facebook, and the L.A. Lyme group
website.
Research Question 4
RQ4 states, to what degree do perceived barriers impact the lives and decision-making
processes of different ethnic groups with average levels of socio-economic status,
education, and third-party coverage?
Data collected from open-ended core questions 23 to 27 on perceived barriers
impacting the lives and decision-making processes of participants covered challenges
encountered when in obtaining treatment; insurance coverage, treatment inadequacy, and
transportation issues. Respondents indicated a high degree of influence on perceived
barriers on their live and decision-making process.
Challenges of having CLD: Challenges obtaining treatment. The number one
challenge for all the study participants when asked about challenges encountered
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obtaining treatment was financial issues. Insurances cover laboratory tests and antibiotic
treatment, but do not cover many of the treatments especially herbals and naturopath
doctors’ expenses was communicated by all the participants. Participant number 6
expressed the magnitude on the cost of treatment:
“Have spent almost $20,000 in miscellaneous treatments, $10,000 in Rife doctor,
and $3,000 in Lyme literate doctor, co-pays and occasional IV, and lots of out of
pocket in Chinese medicine and doctors too”.
Participant number 9 who has been critically ill for extended amount of time expressed:
“My challenge is money, I am in debt for over $45,000 and bankrupt. Also,
distance for care and treatment by good providers who are familiar with Lyme
disease. Many times, will drive somewhere for care and slept in the van
overnight”
Relating to treatment inadequacy as another challenge experienced, one participant
replied:
I was misdiagnosis since childhood until 22 years old.
Another participant expressed:
I was misdiagnosed as bipolar. I was also a victim of mistreatment with too strong
dose of antibiotics orally that destroyed the digestive system. No one told me
about a PICC line for IV long term use of antibiotics.
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Transportation issues to receive treatment were common to seven participants who were
too sick to drive themselves to their health care practitioner’s appointments and the
following responses by two of the participants illustrate the issue:
Participant 1: Yes, I encountered transportation issues accessing treatment; many
LLD are outside the Los Angeles area too far to drive or get transportation to
appointments.
Participant 6: Transportation issues is a big one since my parents are in their 70’s,
I sometimes get rides from friends, use Uber for appointments which are very
expensive, or just miss my appointments.
Research Question 5
RQ5 explored the degree “cues to action” impacting the life and decision-making
process of the study’s participants.
Actions that trigger a decision to change behavior include the individual
motivation to internal and external cues that trigger action to take place regarding
recovering from CLD (Burke, 2013). Internal and external triggers were found to affect
cues to action in everyone in various degrees. Internal triggers degree of impact on the
live and decision- making process varied depending on the individual’s physical and
emotional health status, and stage on the road to recovery from the disease. However,
external triggers expressed by all the participants in the form of support from family,
friends, and the community either the lack of it or its availability influenced in high
degree daily life and decision-making process the management of CLD.
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Under the primary theme “Recovery from CLD” internal cues to action included
activities the participant got involved that trigger a change of behavior and motivational
goals and plans on the road to recovery.
Beneficial activities combating CLD. Some of the internal cues to action
triggers the participants mentioned benefiting combating CLD were: “stress management,
meditation”, “spirituality, meditation, energy healing, slowly back to exercise”,
“exercising few minutes daily, stay balanced, eat properly, and rest properly”, “energy
work, spiritual healer, practicing yoga and strength training to build the muscles and
physical strength”, “sweating to release toxins, accepting being vulnerable, and
surrender”.
Participant 5 expressed his way of finding healing:
Learning to let go, it’s about how the mind interprets the situation, the situation is
going on but you cannot control it, 60must change the way you and your mind
reflect it. Look at the positive and empowering yourself like in trauma and not
allowing it to affect me and my relationship…changing my mind and my
relationship to it.
Inspiration to recover. When the participants were asked on what inspire and
motivate them to recover from CLD each of them had a personal goal (internal trigger)
which motivated them to recover from the disease as a vision for the future for
themselves or for others. The only participant who claims to be completely healed shared
her vision:
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Seeing other women heal. What motivates me is when I can see where people
with CLD aren’t free, where their hang-ups’ are, and I want to get in there and
help them be free of them to benefit from treatment.
One of the participants 80-90% on the recovering road is motivated to go on healing and
treatment by not forgetting her life goals before CLD:
My goals and aspirations in life before becoming ill and now that I am almost
recovered from the illness are basically the same even though I’m no longer the
person who I used to be before becoming ill. I still hold on to the goals that I have
for myself such as finishing school and having a career for my children and for
my family.
A participant in the 60-70% way to recovery expressed:
Do not want to live for me only, want to help others to recover and change the
world in awareness on CLD, health in general and wellness.
And one of the participants in the acute phase of the disease is inspired by remembering
who she has been all along:
I think part of me is a fighter, I have always been a fighter, and when somebody
tells me I couldn’t do something I always want to prove them wrong. I always
have a little bit of hope that I will do something one day to stop this thing and
help others.
External cues to action fall under the category “Influences on Care”, primary theme
“Support” and the secondary themes “Family and friends” and “Community”.
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Influences on Care: Support. An external trigger expressed by all the
participants was support. Support either the lack of it or its availability from either
family, friends, or the community influences in high degree daily life and decisionmaking process on the management of CLD.
Family and friends. One of the participants who is on the way to recovery
believes support from family and friends is key in recovery as she expressed:
Support from family and friends is very helpful in overcoming CLD and really
any type of illness” she also expressed “in my circumstance feeling almost
recovered I’ve had a great deal of support all throughout my illness by my family
and friends.
On the other hand, participant 6 who has been sick for many years expressed her
frustration with her family’s lack support:
Many times, not there, it has been very challenging to get the family and my
friends’ support needed, it makes me feel sad and depressed they just do not try to
understand what I am going through, or even get informed on Lyme and ways to
help me, sometimes they have been very abusive which does not help me at all.
Community: all the participants find support from social media and from the
Los Angeles Lyme group.
Participant 1: “The social groups are definitely supportive and their help
meaningful overcoming the challenges of Lyme disease. Because you get to relate
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what others who are going through the same things that you are, and having those
relationships help.”
Participant 5: “Sure, the community like the Los Angeles Lyme community itself
has been a lot of support for me, and I’ve have made new friends from the group
who have been very supportive. We try to help each other as much as possible
with information on treatments, and get together for social activities, forums, and
meetings motivating each other, and changing success stories.”
There were only two participants who found support by their church members as
expressed:
Participant 1: “Churches yes, people from the church have helped me cope, I
would say. In terms of having a greater outlook as to why we suffer. As well as to
just coming over my home and just by holding my hand, praying with me, and be
there for me with whatever I’m going through.”
Participant 9: “I had always had a church system I tried to work in and I’ve had a
great church support system. My church has branches wherever I go and I can go
and I can beg for help wherever I am and for whatever I may need and find some
kind of assistance. So, they’ve been very supportive overall. I made a whole new
list of church friends from my church family.”
One of the participants was very upset of the kind of treatment received by her church:
I was part of a church group, and I felt like they were not very supportive through
my illness. I remember yelling at one woman, she kept asking me to take care of
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things even though I was sick, I was a church leader actually, and I had to drop
out of all my activities because I was too sick in bed and she kept calling me and
asking me to do for them instead of offering help or assistance; why didn’t she
offer to make a meal, or baby sit, help me clean or offer help for my family?
Research Question 6
RQ6 stated: To what degree does self-efficacy impact the lives and decision-making
processes of different ethnic groups with average levels of socio-economic status,
education, and third-party coverage?
Data collected from open-ended questions 32-35 answered this research question.
As mentioned earlier, self-efficacy is directed affected by the level of the individual’s
confidence in their ability to perform a behavior successfully (Behavioral change Models,
2012). The participants communicated low degrees of confidence in the health care
system and public health agencies and expressed ways in which public health, health care
providers, family, friends, and the community can help those living with CLD in their
decision-making process.
Support: Public Health. All the nine participants expressed the lack of
involvement of public health agencies including the CDC in recognizing the
existence of CLD, testing for the disease, and spreading awareness. When asked
about what public health can do more efficiently for CLS patients, the following
responses were obtained:
(a) Recognize the disease as Chronic, spreading awareness.
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(b) Take the disease and situation more seriously. Find ways to fix the problem
and not call CLD a syndrome.
(c)Education and awareness, develop and offer testing for CLD, offer low dose
immunotherapy and new treatments available for affordable prices.
(d) Awareness of how big CLD is affecting everyone and ticks are everywhere
and how LD is so transmissible so something must be done to mitigate this crisis
right away. Second diagnosis are wrong completely wrong, the CDC algorithm is
a joke. There is a lot of misinformation and misdiagnosis of CLD.
(e) Becoming allies in movements, lobby as representatives for awareness in
CLD since those affected are too sick to have marches, to demonstrate.
(f) Government agencies are antiquated and evidence based practices are stuck on
Western medicine. PH needs to apply new practices such as reaching people
where they are and new methods giving hope and help in progressive ways.
Accepting the severity of CLD, based counseling in cases of healed patients and
practicing a holistic approach.
(g) Must have CLD therapists to be able to talk. Must have more of that because
we go through hell with this disease. I have no one to talk to me. We need
somebody to talk to and to boast on our disease.
(h) Get the word out that LD is a pandemic, inform of the toxic environment that
affects CLD, and that not everyone bitten by a tick or other LD infected insect
does not have to get so sick if treated properly. Awareness and protection when in
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the woods of essential oils and natural Lyme tick repellants. Information about
detoxing of all the garbage on GMO and toxins in the environment.
Health care: All nine study participants expressed their frustration and
disappointment with the conventional health care system expressed as follow:
1. The health care system does not do much for me except blood test panels, our
health care is based on insurance pay not really care for people’s well-being and
besides they do not have enough knowledge on disease treatment.
(d) Need more awareness of the disease at all levels to create empathy by
emergency room doctors and the health care system knowledge of alternate
treatment not just antibiotics.
(c) It is an absolute joke.
(d) Medical doctors are denying the sickness. No healthcare available to the poor
experiencing CLD. It all must come from the top; the CDC and the Infection
Disease Society of America must recognize CLD first.
(e) Not much help there except for a few of those physicians who are Lyme
literate and there is much more to learn and research to do and be available to all
CLD affected.
All the participants also expressed what family, friends, and the community can do better
to support those living with CLD and impact their lives and decision-making process:
Family and friends: Phrases such as these were expressed by the participants:
“they need to be more involved and conduct their own research of the disease and
treatment options, and provide me with support in my lifestyle changes”, “be
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sympathetic and have a good listening ear”, “educate themselves and be
supportive and understanding of the disease; show compassion”, “Family and
friends can do what was done for HIV/AIDS movement who made sure their ill
loved one was seen as a patient; a human, not as detestable human being. CLD
patients not seen as detested, but are being abandoned because people don’t
believe we even have a disease.”
Participant number 5 summarized his expectations from his family as follow:
“Some things that my family and friends can do to be supportive of my dealing
with Lyme are: don’t tell me, things like, you don’t look sick. Don’t question why
I do certain things that might seem odd to you. Take the time to call me and see
me, and show you care. If you’re living with me, please help me create a peaceful
environment. Talk to me in a loving caring way. Don’t tell me I’m selfish, and I
don’t think of you, listen to my needs, work with me to get better, not against me.
Respect my boundaries, don’t ask me what I did today. And ultimately be there
for me.”
Community: Participants expressed their need for involvement of the
community; neighbors, relatives, coworkers, church, agencies, and the general public
with the following statements: “awareness and education”, “awareness, education and
advocacy for better decisions in treatment, insurance coverage and financial support for
the chronically ill”, “awareness, understanding the seriousness of the disease and the need
for help in transportation and better management options”, “be more aware of what CLD
is and try to understand that CLD is a devastating disease like cancer or ALS even though
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it has not risen to the same awareness”, “provide rides to doctors’ appointments, grocery
delivery, money help for treatment”, “offer support to go visit with people with CLD,
cook for them, love them, take kids for an hour or so they can have a break; but the
process cannot be dictated to them. Be available to them no matter what it is”, and “need
a lot of support in every level. Any help is good; like rides, watching TV or movies with
me, just having their company. Friends can bring a cooked meal once in a while”.
Summary
In conclusion, based on the data analysis this study provided insights into the
health beliefs, lived experiences, and the impact on the decision process of young adults
of different ethnic groups with average levels of socioeconomic status, education, and
third-party coverage in the Los Angeles County living with CLD. All the participants in
the study based on research question 1 agreed that neither their health status previous to
CLD plethora of symptoms experienced nor knowledge of how they acquired the disease
affect in any degree the likelihood of acquiring comorbidities. The likelihood of
acquiring comorbidities that accompanies CLD depends on awareness of the individual
and the health care providers of the existence of the disease in the Los Angeles County
and timely diagnosis.
Research question 2 explored the perceived severity of CLD impact on the lives
and decision-making processes of young adults in L.A. County living with CLD. It was
found that the severity and duration of the symptoms affected their physical, family,
social, and emotional life to a high degree on their everyday life and their decisionmaking process.
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The third research question explored the perceived benefits of treatment that
impacts the lives and the decision-making process of the study group. I concluded based
on the extensive amount of data obtained from the participants on the subject that there is
not one specific treatment or a combination of given treatments that benefits CLD
patients to a high degree towards recovering from the CLD, but that rather the benefits of
the treatments are dependent on a combination of several factors such as the individual’s
stage of the disease at time of intervention, insurance coverage, and socioeconomic status
to pay for alternate treatments. Perceived barriers or challenges encountered when
receiving treatment impacting the lives and decision-making process of the study group
were found to be insurance coverage, treatment inadequacy, and transportation issues
explored in research question 4. Respondents indicated a high degree of influence on the
perceived barriers in their lives and the decision-making process.
Research question 5 explored the degree “cues to action” impacting the life and
decision-making process of the study group. Internal and external triggers were found to
affect cues to action in everyone in various degrees. Internal triggers degree of impact on
the live and decision- making process varied depending on the individual’s physical and
emotional health status, and stage on the road to recovery from the disease. However,
external triggers expressed by all the participants in the form of support from family,
friends, and the community either the lack of it or its availability impact in high degree
management of CLD on the lives and decision-making process of the study group.
Lastly, research question 6 explored the degree self-efficacy that impact the lives
and decision-making processes of different ethnic groups with average levels of socioeconomic status, education, and third-party coverage in Los Angeles County. It was
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found that all the participants have a low degree of confidence in the health care system
and public health agencies. In addition, the participants expressed ways in which public
health, health care providers, family, friends, and the community can help those living
with CLD manage the disease on their daily life and their decision-making process.
The following and final chapter of this study is chapter 5. This chapter offers key
findings concisely summarized including how the interpretations of the findings compare
to the literature and how the study extends to current CLD knowledge. I also discuss the
limitations of the study and make recommendations for further research that are grounded
in the strengths and limitations of the study as well as the literature reviewed in chapter 2.
Finally, I present potential positive social change implications of the study.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
I conducted this study to obtain insights into the health beliefs and lived
experiences of Los Angeles County chronic Lyme disease (CLD) young adult patients
and to examine the impact the disease has on their daily lives and the decision-making
process. In Los Angeles County; an ethnic, educational, and socioeconomic diverse
population area (CDPH, 2013; California LD Association, 2015) both patients and
practitioners fail to recognize the disease, resulting in misdiagnosis and delayed treatment
(Ostfeld, Lane, & Briggs, 2011). Long term CLD consists of many nonspecific symptoms
affecting various body systems and consequently the individual’s quality of life (Drew &
Hewitt, 2006; Stricker, 2007; Borgermans et al., 2014).
There is a lack of knowledge in previous studies about CLD patient’s experiences
and the impact on young adults’ health behaviors in the Los Angeles County (California
LD Association, 2015). The purpose of this study was to address the gap in the literature
by examining the impact that chronic Lyme disease (CLD) has on the health promoting
behaviors of ethnically diverse, insured, young adults from similar educational and socioeconomic backgrounds in Los Angeles County based on their lived experiences. The
qualitative hermeneutical phenomenological inquiry approach, allowed me to draw upon
lived experiences of the participants to gain a deeper understanding and appreciation of
the impact of CLD on their lives and their decision-making process (Rudestam &
Newton, 2015). The use of semistructured interview questions format provided lived
experiences insights of CLD patient’s life and the impact on their personal, social,
professional, and decision-making processes (Smith & Osborn, 2013).
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The key findings of this study based on Chapter 4 analysis of the in-depth, faceto-face interview responses of nine young adult participants living with CLD in Los
Angeles County revealed that patients with CLD daily lives are marked with substantial
limitations physically, socially, and emotionally due to their decline in health status.
Perceptions on susceptibility, severity, barriers, and benefits of treatment for CLD are
similar. Most of the participants reported wellness and good to excellent health prior to
CLD. Lack of awareness of the existence of the disease and mode of transmission by both
the general population and health care practitioners in Los Angeles County leads to poor
prevention measures, misdiagnosis, and mistreatment. Some of the participants have
lived years improperly diagnosed with CLD.
Once diagnosis was established most study participants expressed their relief to
have a name associated with their symptoms and a hope for effectiveness of the
prolonged use of antibiotics and/or complementary alternative medicine (CAM) therapies
directed towards killing the bacteria, controlling the symptoms, and eventually curing the
condition. Anger, fear of dying, and sadness was a common reaction to CLD diagnosis.
Difficulties in obtaining treatment for CLD included mainly financial issues; since most
insurances do not cover long-term antibiotics and CAM therapies. Other issues in
obtaining proper treatment are lack of Lyme literate medical doctors (LLMD) accessible
in metropolitan areas and transportation to the long-distance location of the LLMD
practice. Some CLD patients are willing to try almost anything as a possible cure to the
condition. Some of the participants experienced multiple bee bites on a regular schedule
from months to years in the treatment, or trying the latest protocol or treatment shared by
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CLD recovered patients in the Lyme disease social groups or the Internet. Family,
friends, and community support are key in the recovery from CLD. The health care
system and public health involvement in awareness, prevention, and research for new
diagnostic tests, as well as affordable treatments, and advocacy to care for CLD patients
is warranted.
Interpretation of the Findings
The limited number of studies found in the literature on the lived experiences of
those diagnosed with chronic Lyme disease (CLD) not only in Los Angeles, California,
but nationwide indicate that the researchers in the field of epidemiology have just barely
began its involvement performing qualitative studies on this disease. CLD develops
because of delayed diagnosis and treatment of Lyme disease; the most prevalent and
reported tick-borne infection in the United States (Stanek et al., 2011; Levi, Kilpatrick,
Mangel, & Wilner, 2012) rendering CLD a condition of increasing public health
importance (Aronowitz, 2011; Horowitz, 2013). The following subsections will address
some of the gaps in the literature and explain how this study findings not only compares,
but also enriches the current literature.
Demographic Gap in the Literature
Previous phenomenological qualitative studies on CLD were conducted
exclusively on Caucasians participants in a wide age range from 20-69-year-old in Lyme
disease endemic geographical areas (Drew & Hewitt, 2006; Ali, Vitulano, Lee, Weiss &
Colson, 2014) which does not relate to the racial/ethnic diversity background, age group,
or endemic area classification of those affected in Los Angeles County, California. This
gap in the literature was explored in this study by selecting a group of participants with
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diverse racial/ethnical background, education, and socioeconomic status with an age
range from 18-40 years old. Insights into health beliefs and lived experiences in this
study provided similar results as those obtained on previous qualitative studies on CLD.
The similar findings included decline in health status, considerable limitation of
daily activities, frustration being diagnosed, financial stress, contrasting patient-doctor
relationships, and variety of therapies to treat CLD. The findings of this study not only
confirm what has been found in the current peer-reviewed literature, but extends
knowledge on the challenges of being diagnosed and provide rich data about the
experiences of becoming diagnosed with CLD including how the family, friends, social,
and emotional life is affected by the disease.
Changes in Health Status
All the participants reported good well-being to excellent health prior to onset of
sudden symptoms. The participants expressed a progression of the symptoms starting
with flu-like symptoms followed by myalgia, fatigue, anxiety, fever, chills, headache, and
muscle weakness characteristic of the primary stage or stage I of CLD presentation
(Horowitz, 2013). Only one patient recalls a rash or presentation of erythema migrans
(EM) which according to the literature occurs in only 60-80 percent of patients following
the bite of an Borrelia burgdorferi (Bb) bacteria infected tick bite (Biesiada, Czepiel,
Lesniak, Garlicki, & Mach, 2012; Ljostad & Mygland, 2013). The symptoms progressed
to secondary stage or early disseminated stage manifested by neurological involvement
(neuroborreliosis); mental fogginess, inability to concentrate, memory lapses, confusion,
intense headaches, migraines, photophobia, pain behind the eyes, vision distortion, mild
hallucinations, irritability, depersonalization, derealization, tremors and involvement of
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other organs (Miklossy; 2012; McKechnie, 2016). Two study participants had progresses
to late chronic disease or tertiary stage after years of initial onset manifested with
difficulty moving around, joint pain, profound fatigue, problems concentrating, reading,
temporary loss of vision, and psychiatric symptoms (Logigian & Steere, 2012; Holtore,
2015).
Five participants reported the onset of the myriad of symptoms associated with
CLD after the occurrence a stressful life-changing event. Two women reported symptoms
starting after the birth of a second child combined with the stresses of a new home, job,
and school demands. Two male participants reported onset of CLD after moving away
from home and starting college, and one participant reported symptoms that progressed in
severity after a traumatic car accident. The data provided by this study may be associated
with the characteristic stealth pathology of Bb. As studied by Stricker (2007) stealth
pathology refers to mechanisms used by Bb to evade immune response which include
immunosuppression; genetic, phase and antigenic variation; physical seclusion; and
secretion of factor to engage in autoresurrection a dormant organism. This study finding
suggest that stressors in the life of a previous infected individual in which the bacteria are
dormant may trigger the onset of CLD symptoms and disease presentation.
Difficulties Being Diagnosed
Lack of knowledge on the proper evaluation of Lyme disease key symptoms by
health care practitioners as well as timely and appropriate treatment leads to patients
being diagnosed with an array of conditions including Epstein-Bar virus, multiple
sclerosis, fibromyalgia, chronic fatigue syndrome, and psychiatric conditions has been
reported in various studies (Bransfield, 2012; Horowitz, 2013; Holtore, 2015). In this
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study, participants reported not only problems getting diagnosed, but misdiagnosed with
lupus, West Nile virus, hepatitis B, Myasthenia Gravis, in addition to the aforementioned
conditions. Some of the participants were accused of being hypochondriac, crazy, and the
disease to be all in their heads; as also indicated in previous studies on CLD patients
(Bransfield, 2012; Ljostad & Mygland, 2013).
Horowitz (2013) and Hersh et al. (2014) stated that coinfections such as
Anaplasma, Babesia, Bartonella, and Ehrlichia to name a few transmitted by an infected
tick bite also might be present in CLD patients making diagnosis and treatment more
challenging. Participants in this study reported laboratory confirmed coinfections mainly
Babesia and Bartonella exacerbating their CLD symptoms with increase fatigue,
headache, joint pain, ophthalmic problems, seizures, and cognitive dysfunction as also
indicated by the CDC (2014) and other authors (Berghoff, 2012; Horowitz, 2013; CLDA,
2015).
This study also confirms the findings that highly specialized laboratories such
IGeneX in California (Horowitz, 2013) is reliable and accurate diagnosing CLD with
their IgG Western blot protocol in which two of six band detected are diagnostic criteria
of Lyme disease (See Figure 6). (Haley, 2011; Schutzer, et al., 2013; IGeneX, 2015). As
discussed in chapter 4 eight out of nine study participants reported diagnosis of CLD by
IGeneX tests. Most of these participants in this study had tested negative by the CDC
algorithm multiple times before being tested positive by IGeneX laboratories. Only one
participant reported confirmed diagnosis of Lyme disease by the CDC testing algorithm.
The CDC’s two-tiered serology testing algorithm for IgG is diagnostic of Lyme disease if
five out of 10 bands present (Johnson, 2011; Lee, Vigliotti, Jones & Shearer, 2014).
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According to the literature, the CDC testing algorithm is 87% reasonably sensitive in
disseminated neurologic disease caused by B. burgdorferi (Hinckley et al., 2014; Lee,
Shapiro, 2014; Lee, Vigliotti, Jones & Shearer, 2014) which differs from the findings in
this study. However; this study findings confirm that diagnostic challenges of CLD may
be due to the various existing genospecies of Bb in California causing a somewhat
different syndrome with somewhat different clinical presentation, which in turn makes
clinical and laboratory diagnosis a challenge (Buhner, 2005; Center for Food Security
and Public Health, 2011).
Aspects Affected
The significant and measurable decline in physical health status and intellectual
acuity experienced by CLD patients interfere with all aspects of normal living and
functioning (Bransfield, 2012; Ljostad & Mygland, 2013). Aspects affected identified in
the literature include home life, marriage, employment, social interactions, and emotional
well-being (Bransfield, 2012; Medalia & Revhein, 2012). The physical burden of the
disease expressed by all the participants in this study as extreme fatigue, musculoskeletal
pain, and cognitive dysfunction persisting for long periods of time even years affected
their quality of life not only physically, but socially, and emotionally. The findings in this
study support the literature citing the challenges of living with CLD affecting close
relationship with parents, siblings, spouses, and friends; impairment in their ability to
work and study; lowered health quality status posing greater activity limitations; and
more mental health days.
The study’s qualitative design allowed interviewees to provide detail account of
their daily lives coping with the disease and provided additional insights that extends the
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current knowledge. In addition to the impact of CLD on the physical, social, and
emotional life; the interviewees provided account of the financial burden of the disease
and increased utilization of health services many of which are not covered by health care
insurances. The financial burden of CLD management found in this study support the
findings of Johnson, Wilcox, Mankoff & Stricker (2014) in the literature where the
authors used the CDC health related quality of life (HRQoL) indicators to compare CLD
to other chronic conditions in the quality of life survey. The authors concluded that the
significant burden of CLD symptoms demands more out of pocket medical expenses
compared to the general population.
Treatment Modalities Effectiveness
The minor clinical improvement of CLD symptoms after the use of antibiotic
treatment with either a monotherapy or a combination of antibiotics and repeated or longterm antibiotic therapy was evidenced in CLD trials conducted by Fallon, Petkova, Keilp,
& Britton (2012). This study supports the findings of the trial; 78 percent (n = 7) of the
interviewees had been in some form of antibiotic combination for short or long amount of
time after CLD diagnosis experiencing only minor improvement after treatment. The
frequent occurrence of the Jarish-Herxheimer (JH) reaction or exacerbation of symptoms
after beginning antibiotic therapy or its prolonged use experienced by the study
participants also supports the literature. JH is a temporary worsening of symptoms due to
the combination of the bacteria dying and the body’s immune inflammatory response
(CDC, 2013; CDPH, 2013; Horowitz, 2013; Perrone, 2015).
Natural CLD treatment as the herbals and nutritional supplements used in
complementary and alternative medicine (CAM) protocols inhibit the inflammatory
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process, reduce bacterial circulating load, and results in elimination of Bb from the
tissues leading to the repair of the damage caused by the bacteria (Buhner, 2016). This
study not only supports the findings of Buner (2016), but also enriches the knowledge on
the effectiveness of CAM and new CLD effective treatments such as Bee venom therapy.
Evidence on the effectiveness of additional natural treatments such as
acupuncture, homeopathy, probiotics, massage therapy, and exercise on helping the body
to get rid of the infection; reducing inflammation, and restoring the immune system
found in the literature (Whitmont, 2012; Gardner, 2015; Zerbe, 2015) is also supported
by the participants in this study. The participants in this study found relief of symptoms
when they used additional natural treatments either by themselves or as part of their
hybrid protocol with CAM treatments. A participant reported that after her herbal
treatment was complete and followed additional maintenance natural treatments she has
not experienced a relapse of the disease even though the participants discontinued CAM
protocol at some point.
Prevention
The literature stated “education” as the best prevention measure against Lyme
disease and the development of CLD (CDC, 2010; CDPH, 2014). Education referred by
the authors to prevent CLD in various ways; tick avoidance, proper tick removal,
appropriate dress when outdoors, application of repellants, and maintenance of the
environment (CDC, 2013; Britain, 2013). This study supports the literature prevention
measures and further extends prevention as being aware of the existence of the disease in
Southern California and Los Angeles County. The participants in this study alluded as
prevention measures acquisition of knowledge of CLD existence not only by the general
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population, but also by health care practitioners. In addition, the participants expressed
that medical doctors must get education and awareness of diagnostic tools and effective
treatment modalities for the different stages of the disease. The media must be involved
in bringing awareness and promoting campaigns to prevent CLD by radio, television, and
movies; and advocacy groups must lobby to bring awareness for the development of new
testing procedures and new drugs and therapies to combat CLD.
Theoretical Framework
The dimensions of the Health Belief Model (HBM) constructs provided the
framework that guided this study for the development of the research questions and the
basis for data analysis and discussion of the findings. The HBM theory created by Kurt
Lewin in 1947 served as basis for the further application of health behavior prediction in
public health programs by Hochman, Rosenstock, and Kegels in the 1950s. The HBM
constructs are perceived susceptibility, perceived severity, perceived benefits, perceived
barriers, cues to action, and self-efficacy. I considered the dimensions of the HBM
constructs in this study to focus on the lived experiences and perceptions of the study
participants to understand CLD presentation, challenges, health care options, diagnostic
methods, treatment options, health benefits, and the beliefs and expectations of CLD
affected young adults.
Good to excellent health status before CLD and knowledge of how the
participants acquired CLD bears no weight on the disease course or diagnosis if the
general population and health care practitioners are not aware of its existence in Los
Angeles County. Duration and severity of the constellation of debilitating symptoms
experienced by CLD patients affect them physically, socially, and emotionally on their

160

daily lives and their decision processes. The treatment chosen whether conventional
antibiotic therapy, or hybrid treatment of CAM and antibiotic therapy benefit individuals
differently depending on the stage of the disease where it may decrease the symptoms,
but not cure the disease permanently. There is not one available protocol or combination
of therapies effective for every single person, a fact that adds to the frustration and many
times hopelessness feelings when dealing with the disease diagnosis. In addition to the
challenge of finding the right treatment fitting individual anatomical and immunological
needs, there are other barriers when obtaining treatment such as insurance coverage and
transportation issues to obtain what may be an effective treatment and proper health care.
Therefore, family, friends, and community support are essential to trigger motivation and
encourage management of the disease. Likewise, support from public health agencies and
the medical health care system in bringing awareness of the existence of CLD in Los
Angeles County and the severity of the disease are essential for the establishment of
policies based on patient-centered approaches on research of new diagnostic tools and
effective treatment of the disease.
Limitations of the Study
I considered potential limitations to the trustworthiness of this study results when
I chose the phenomenology nature of this qualitative study design. There were several
limitations to the study that were addressed; first, the small sample size. Recruitment of
participants and analysis of the data took place on the continuous basis to ensure no new
data appeared and all concepts in the theory were well developed (Morse, 2015). Second,
generalizability; phenomenology does not generate generalizable data (Patton, 2002).
Since the findings of the study are specific to Los Angeles County, I leave the
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interpretations of the findings up to the reader to apply to a wider population. I have
provided in this study sufficient contextual description and information of promoting
behaviors of young adults with chronic Lyme disease (CLD) captured in the candid,
transparent, and rich responses to the interview questions to enable the reader to make
such a transfer (Shenton, 2004). Third, subjective interpretation of the data. I used
acknowledgement of my own bias as a method of dealing with them (Rajendran, 2001).
As the data went through my mind, I confronted my opinions and prejudices by talking to
myself of my own presuppositions, experiences, and actions during the research process.
To further address for bias in the interpretation of the data, a verification panel was
engaged to examine the data interpretations against the transcripts as well as an
independent qualitative researcher to examine the raw data and interpret its findings using
the same coding system and NVivo tools I used to establish inter rater reliability.
In addition, I took several measures to encourage transparency, promote trust,
confidence, and openness of the participants. I spent sufficient time with the respondents
sharing my experiences of knowing someone close to me with CLD and remained in the
field until achieved data saturation, thereby establishing a rapport. Additionally, to ensure
that the participants could articulate in less than one hour their experiences in managing
the disease, a validity panel reviewed the semi-structured interview questions to facilitate
an understanding of the health promoting behaviors of young adults with CLD. A form of
triangulation was used which involved the use of a wide range of participants
racial/ethnically, culturally, and financially diverse viewpoints and experiences verified
against each other (Rajendran, 2001; Patton; 2002, Shenton, 2004). Participants were
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giving the opportunity to read the interpretation of the information captured in the
interview to ensure that those were their intended words (Guba 1981; Patton, 2002).
Recommendations
Qualitative research studies on chronic Lyme disease (CLD) are in the
introductory phase of the condition severity and the experience of diagnosis with the
disease. This study examined the gap in qualitative research studies on CLD restricted to
a geographical area where the disease is endemic (Connecticut, USA) and the knowledge
of CLD is prevalent. In addition, the participants in previous studies were a racial/ethnic
homogenous (Caucasian) group. This study constitutes the first one of its kind in Los
Angeles County, a non-endemic geographical area where there is lack of knowledge of
the existence of the disease, prevention, diagnosis, and treatment. The participants in this
study was composed of a racial/ethnic, education, socio-economic and third party
coverage diverse group. I recommend further studies where the African-American
population of Los Angeles County are better represented. The findings in this study
contribute to the knowledge base of CLD experiences of a group of participant’s
representatives of the diverse racial/ethnic, educational, and socioeconomic population of
Los Angeles County.
The assessment of health promoting behaviors of young adults diagnosed with
CLD and the impact of the disease on their daily lives and their decision-making process
revealed a need for education and awareness on the existence of CLD in Los Angeles
County. To reach not only the general population, but also health care practitioners and
providers further studies need designing and dissemination to spread knowledge on CLD
and the experiences of those affected by the condition. In addition, studies on the impact
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of CLD on the individual’s physical, family, social, emotional, and physiologic life
warrant its development. There is the need for further studies that acknowledge the urgent
need of existing social programs that assist CLD patients. Another recommendation is
continuous research with CLD affected individuals in different age group and at-risk
populations. Participant number 7 expressed the fact that the disease transmission can
take place from an infected mother to the unborn child, as expressed and confirmed by
diagnostic testing:
“So, it wasn’t until I saw a holistic pediatrician, and I was there with my second
baby daughter like barely alive, just like poof of my disease passed to the baby when her
test came back positive for Lyme that she was properly treated to prevent progression to
CLD.”
Moreover, the possibility of sexual transmission of CLD needs further exploration.
In addition, this study identified the importance of support in the management and
recovery from the disease. Programs that educate family, friends, and the community on
how to offer support to CLD affected individuals needs development and establishment
by health care and public agencies as expressed by participant number 8:
“Must have CLD therapists to be able to talk to. The health care and public health
agencies must have more of that because we go through hell with this disease. I have no
one to talk to me who knows about the disease. We need somebody to talk to and to boast
on our disease not psychologists or present therapist who have no idea of CLD
presentation and how to cope with it.”
The knowledge gained from this study in addition to the areas elucidated in need
of further exploration and assessment can be used to influence local, state, and federal
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policy to develop better insurance coverage of diagnostic laboratory testing, treatment,
and care of CLD affected individuals as well as development of more reliable laboratory
testing technology and effective treatment protocols.
Implications
Potential Impact for Social Change
The potential to create a positive social change from the findings in this study on
health behaviors of young adults with chronic Lyme disease include:
1. Contribution to the limited current information about the lived experiences of
young adults with CLD regarding health behavior; impact of CLD on the
physical, social, emotional, and psychological life; challenges in diagnosis
and treatment of the disease; and impact on the decision-making process in
CLD individuals’ private and professional life.
2. Influence the development of health care and public health practitioners’
programs to assist CLD affected individuals, their families, and the
community where they live to manage the disease, such as therapy and
counseling by CLD literate health care practitioners.
3. Enhance awareness of not only of the existence of Lyme disease in Los
Angeles County, but how the disease misdiagnosis and inadequate treatment
lead the development of CLD; an emerging epidemic.
4. Influence providers and the public to work collaboratively to retard the spread
of this disease and safeguard the health and safety of society.
5. Influence local, state, and federal policy on third-party coverage on the
diagnosis and treatment options of CLD. Currently, health insurance providers
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have limited coverage of Lyme literate health care practitioners, diagnostic
tests, and only short-term antibiotic therapy as an option to treat the disease.
6. Development of prevention measures and dissemination of such measures to
an audience where the disease have been and neighboring areas.
7. Generation of rich data that provides the opportunity for further research on
CLD, its proper diagnosis and effective treatment.
8. This study may also serve as a positive catalyst for societal change by altering
health promoting behaviors of the public based, in part, on the lived
experiences of the participants.
9. Finally, it is my sincerest desire to see this study lay the foundation for future
qualitative inquiry in the nature and scope of CLD in the U.S. and abroad.
In addition, to the areas where the findings of this study have potential for
positive social change, the results of this study will be disseminated to spread awareness
of CLD and knowledge on the experiences on being diagnosed with the disease via
multiple venues including presentations at local public health agencies, medical clinics,
professional conferences, and peer-reviewed journals. I will also intend to share these
study findings at the Los Angeles Lyme disease group meetings and the Southern
California American Society for Microbiology symposium.
Conclusion
This study provides insights into the health beliefs and lived experiences of young
adults with chronic Lyme disease in Los Angeles County where the general population
and health care practitioners are not aware of the disease existence. It is my hope that the
results of this study will raise public health awareness of the impact of CLD on the life of
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young adult affected by the disease. Most participants were in excellent health prior to
infection by a tick’s bite carrying the Lyme disease causing bacteria and coinfections.
Participants experienced a marked declined in health status because of the disease not
being recognized or properly treated. Participants also reported going any length not only
geographical to find a Lyme literate practitioner, but also in willing to try CAM providers
and miscellaneous therapies. Many participants experienced invasive therapies such as
long-term use of antibiotics affecting their intestinal normal flora and developing
secondary chronic conditions, multiple bee bites for extended period, and new treatment
protocols with no clinical history of effectiveness.
Further qualitative and quantitative research studies on CLD may elucidate the
urgent need of awareness of the disease existence not only in Los Angeles County, but
also on the West coast of USA. Studies such as this one highlights the need for
immediate action taken by health insurances to become more involved in offering
coverage on CLD for their clients. Lastly, these study findings may prompt scientist and
public health the need of new technology to recognize, diagnose and treat the disease.
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Appendix A: List of Bacteria Responsible for Lyme Disease

Bacteria responsible for Lyme or Lyme-like disease and other Borrelia sp.
belonging to the Borrelia burgdorferi sensu lato complex, and other tick-borne
micro-organisms isolated in humans
Bacteria responsible for Lyme Disease belonging to the Borrelia burgdorferi
sensu lato complex:
Borrelia burgdorferi sensu stricto
North America, Europe, North Africa
Borrelia afzelii
Europe, Asia
Borrelia garinii (several serotypes)
Europe, Asia, North Africa Borrelia
bavariensis (previously B. garinii OspA serotype4)
Bacteria responsible for Lyme-like disease:
Borrelia lonestari
North America
Borrelia miyamotoi (also cause of relapsing fever) Europe, Asia, North America
Non-identified spirochete
Brazil
Bacteria occasionally isolated in cases of Lyme-like disease
Borrelia spielmanii, Borrelia bissettii, Borrelia andersonii, Borrelia valaisiana,
Borrelia americana, Borrelia kurtenbachii,
Novel Borrelia sp. close to elapsing fever Borrelia
Other Borrelia sp., belonging to the Borrelia burgdorferi sensu lato complex with
unknown or poorly documented pathogenicity:
Borrelia japonica; Borrelia turdi, Borrelia sinica; Borrelia tanukii, Borrelia
lusitaniae, Borrelia californiensis, Borrelia carolinensis, Borrelia yangtze
Borrelia sp. responsible for relapsing fever Louse-borne relapsing fever: Borrelia
recurrentis Tick-borne relapsing fever:
At least15 Borrelia sp. including Borrelia crocidurae
Africa
Borrelia miyamotoi (cause of Lyme-like disease)
Other human tick-borne infections
PARASITES: Babesia microti, Babesia divergens
BACTERIA: Ehrlichia chaffeensis, Anaplasma phagocytophilum, Rickettsia sp.,
Coxiella burnetii,
Francisella tularensis, Candidatus Neoehrlichia mikurensis
VIRUSES: Several Flaviviridae (including Tick-borne encephalitis virus),
Bunyaviridae (Crimean-Congo hemorrhagic fever)
Source: Perrone, C. (2015). Critical review of studies trying to evaluate the treatment of
Chronic Lyme Disease. La Presse Medicale, 2015(44), 828-831.
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Appendix B: Complementary and Alternative Medicine Treatment of Lyme Disease
Complementary and Alternative Medicine Treatment of Lyme Disease
Antibiotics

Herbal Remedies

Doxycycline
Minocycline
Amoxicillin
Augmentin
Azithromycin
Biaxin
Erythromycin
Vancomycin
Clarithromycin
Cefuroxime
axetil
Penicillin
Ceftriaxone
Rifampin
Flagyl
Plaquenil
Imipenem
Colloidal sliver

Samento
Cumada
Burbur
Allicin
Dragon’s blood
Cat’s claw
Devil’s claw Echinacea Citriodiol
(lemon eucalyptus extract)
Astragallus
Nettle
Gingko biloba
Curcumin
Oregano tea
Boswellia
Parsley extract
Red chili pepper (capsaicin)
Quercetin

Nutritional Supplements
Omega-3 Fatty Acids
Coenzyme -Q10
S-Adenosylmethione
Grapeseed Extract
Magnesium
L-Carnitine αLipoic acid
Dimethylglycine
Vitamin B-complex
Methylcobalamin
Vitamin C and D
Hydrolytic enzymes
Mushroom Extract and Betaglucan
Thymic enzymes
Pycnogenol
N-Acetylcysteine and
Glutathione
Probiotics
Royal Jelly

Source: Vojdani, A., Hebroni, F., Raphael, Y., Erde, J., and Raxlen, B. (2009). Novel
Diagnosis of Lyme Disease: Potential for CAM Intervention. Evidence Based
Complementary Alternative Medicine 6(3), 283-295.
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Appendix C: Informed Consent
Title of Research:

Informed Consent Form
Health Promoting Behaviors of Young Adults with Chronic Lyme Disease

Researcher’s Name and Title:

Name of the Researcher
Doctoral Student at Walden University

Researcher’s Contact Information:

The Researcher’s Contact Information

You are being asked to participate in a research study because you are 18 to 40 years old, residents of the Los Angeles
County, clinically diagnosed with Chronic Lyme Disease, and have received or are receiving medical treatment or
intervention including antibiotic therapy and or complementary and alternative medicine treatment. Please ask the
researcher to explain any information in this form that you do not understand. If you would like to participate in this
study, please respond to this e-mail with the words “I Consent,” see the statement of consent below.
PURPOSE OF THE STUDY:
The purpose of this study is to explore the impact that Chronic Lyme Disease has on the health promoting behaviors of
ethnically diverse, young adults from similar educational and socio-economic backgrounds based on their lived
experiences. In addition, this research is being conducted to partially fulfill the requirements of a doctoral dissertation.
STUDY PROCEDURES:
If you respond to this e-mail with “I Consent,” you will be asked to participate in an interview. The interview will last
about 60 minutes and may or may not be followed by a shorter interview of 15 to 30 minutes duration to clarify
questions if needed. You will be asked some questions about how you acquired Lyme Disease, how you were
diagnosed, symptom you have experienced, how the Chronic Lyme Disease has affected your everyday life, treatments
you have being under, and your views on recovery from the disease.
The interview and any follow up interview will be recorded to capture all this valuable information on Chronic Lyme
Disease. The recordings will also be transcribed to allow the researcher to analyze the information.
The transcripts of the interview(s) and its interpretations will be available for your review which may take 15-20
minutes so that you can verify the validity of the interview transcripts and the credibility of the findings.

NUMBER OF PARTICIPANTS
It is expected that approximately 10 – 12 individuals will participate in this study.
RISKS AND DISCOMFORTS:
Since this research consists only of a face to face interview, no physical risks are expected as a result of participation.
While this is not expected, it is possible that the nature of some of the questions may be recalling situations during the
course of your Chronic Lyme Disease condition that may be upsetting or uncomfortable. If you become upset or
uncomfortable at any time, please tell the researcher. While every effort will be made to keep your personal
information confidential, a breach of confidentiality is also a risk of this study.
CONFIDENTIALITY:
All study records will be kept in a locked cabinet in the researcher’s place of residence. Documents containing
information obtained from you during the study will not have your name or any other personal identifying information.
A permanent record number (PRN) will be assigned to identify your records. Only the researcher will have access to
the study records and the link between the assigned PRN and your personal information. The link will be kept in a
locked cabinet in the researcher’s place of work, but separate from the other study records.
The recording(s) of your interview(s), and follow up conversation if necessary, will be transcribed by a company that
provides this professional service. Only the PRN will be connected to the recording. Once the written transcript is
received by the researcher, only the PRN will be used to link the document to your personal information.
There may be some instances where records which identify you, such as the email where you responded “I Consent,”
may be looked at by the Walden University Institutional Review Board (IRB). The IRB is responsible for ensuring that
all Walden University research is conducted in compliance with the University’s ethical standards and applicable U.S.
federal regulations. While these parties are aware of the need to keep your information confidential, total
confidentiality cannot be guaranteed. All study records will be kept by the researcher for five years. After that time, all
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of the study documents will be destroyed by shredding. The results of this research may be presented at meetings or in
professional journals; however, you will not be identified in these presentations and/or publications.

VOLUNTARY PARTICIPATION, ALTERNATIVES, AND WITHDRAWAL:
Your participation in this study is voluntary. You have the alternative to not participate. Even if you begin the study,
you may refuse to answer any questions. You may stop your participation at any time and you do not have to explain
your decision. This consent form is not a contract. Your participation may also be ended without your consent if the
researcher feels it is not in your best interest to continue (for example, if you become upset by the questions).
BENEFITS:
You may not receive any benefit from participating in this research; however, results from this study may positively
impact other individuals, the community, and society by shedding light on the nature and scope of Chronic Lyme
Disease from your perspective.
COSTS OF PARTICIPATION:
There will be no costs to you as a result of your participation.
REIMBURSEMENT FOR PARTICIPATION:
You will not be paid for your participation in this research.
CONTACTS FOR QUESTIONS, COMPLAINTS, CONCERNS:
If you have any questions about your rights as a participant or complaints regarding this research, please contact the
Walden University Institutional Review Board at 001-612-312-1210 or irb@waldenu.edu.
If you have any questions about the study itself please contact the researcher Patricia Bolivar at
patricia.bolivar@waldenu.edu.

STATEMENT OF CONSENT:
•
I have read this consent form in its entirety.
•
All of my questions have been answered to my satisfaction.
•
I may contact the researcher about the study at any time if I have further questions.
•
The researcher will answer any other questions I may have.
•
If I want a copy of my consent to keep for my records I will print the e-mail correspondence.
•
I agree to the recording of my interview and a follow up interview.

To give consent to the preceding, please respond to this e-mail with the words “I Consent.”
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Appendix D: Recruitment Flyer

Chronic Lyme Disease Research Study
• If you are 18-40 years old, live in Los Angeles County, and
have been diagnosed with Chronic Lyme Disease, you may be
eligible to participate in a research study investigating health
promoting behaviors of young adults living with Chronic
Lyme Disease
• This study is part of my PhD dissertation in Public Health at
Walden University
• Participation consists of a single one-hour interview
• The interview may be followed by a 15 to 30-minute phone
call to clarify any questions if needed
Please contact:
Researcher’s Name
Contact Cell Number
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Appendix E: Approval letter from the Los Angeles County Lyme Disease Association
Letter to the Los Angeles County Lyme Disease Association

My name is (Researcher’s Name) and I am a Public Health doctoral candidate at
Walden University. I am conducting a dissertation research to examine the impact that
Chronic Lyme Disease has on the health promoting behaviors of ethnically diverse young
adults from similar educational and socioeconomic backgrounds based on their lived
experiences. I am requesting your written permission to distribute the attached flyer at the
next monthly gathering and to post at the group’s private website.
As you are aware, there is a general lack of awareness of Lyme Disease and Chronic
Lyme Disease in the Los Angeles County. Perspectives from the participants will give
healthcare providers and the public a deeper insight into the impact Chronic Lyme Disease
has on the personal and professional lives of affected young adults.
This study will probe into the holistic needs of young adults living with by Chronic Lyme
Disease and the effectiveness of conventional and non-conventional treatment modalities.
This study is intended to increase awareness of the nature of Chronic Lyme Disease in Los
Angeles County where infection rates are growing so that health care providers and the
public can work collaboratively to retard the spread of the disease and safeguard the health
and safety of society.
I would welcome a telephone call from you to discuss any questions you may have
concerning the study. I can be reached at or by email at.sbcounty.gov or. Looking
forward to hear from you!
Sincerely,
Researcher’s Name
PhD candidate at Walden University
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Appendix F: Social Media Invitation to Study Participation
Social Media Invitation to Study Participation Facebook and LinkedIn Chronic
Lyme Disease Study Invitation
I am reaching out to you today because I am working on my dissertation for a doctorate
degree in Public Health/ Epidemiology at Walden University. If you have been diagnosed
with Chronic Lyme Disease (or know someone who has been diagnosed with Chronic
Lyme Disease), are 18 to 40 years old, live in Los Angeles County, are willing to give me
a one-hour recorded interview, and want to increase awareness of the nature and scope of
Chronic Lyme Disease in Los Angeles County where infection rates are growing; please
contact me to become my study participant.

Thank you in advance for your consideration!

Patricia Bolivar, CLS, PHM, MSc, CPH
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Appendix G: Respondent Screening Form
Respondent Screening Form
Demographic Information
Name: ______________________________ Date of Birth: __________________ Age:
_____
Address:
____________________________________________________________________
Phone Number: _______________________ Email:
__________________________________
Race/Ethnicity:
White

□

White Hispanic

□

American Indian/Alaskan Native

American Black

□

Age group 18-40:

African Black

Native Hawaiian/Pacific Islander

Inclusion Criteria:
Los Angeles County Resident:

□

□

Asian

□

Exclusion Criteria:

□Yes

□Yes

□No
□No

Chronic Lyme Disease diagnosed by:

□Clinical disease definition
□ Confirmatory laboratory diagnostic tests
Treatment Received: □Yes

□Self diagnosis
□No

Inclusion Criteria Eligibility met:
YES

□

NO

□

NO

□

Authorized to be recorded during the interview:
YES

□

Date________________
PRN _______________

□
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Appendix H: Interview Core Questions

Research Questions
Research Question 1
To what degree do different ethnic groups
with average levels of socio-economic
status, education, and third-party
coverage, perceive the likelihood of
acquiring comorbidities related to
Chronic Lyme
Disease (CLD)?

Interview Core Questions
Interview Questions
1. How did you acquire CLD?
2. How was your health before
CLD?
3. Was there anything you could
have done to prevent CLD?
4. What would be your advice to
others on how to protect
themselves against CLD?
5. Is there anything you could have
done to prevent progression of
acute Lyme Disease to CLD?
6. How were you diagnosed with
CLD?
7. What difficulties did you
encounter getting diagnosed
with CLD?

Research Question 2
To what degree does the perceived
severity of CLD impact the lives and
decision-making processes of different
ethnic groups with average levels of socioeconomic status, education, and thirdparty coverage?

8. How did you react when you
first learned that you had CLD?
9. How has CLD progressed since
diagnosis?
10. What symptoms have you
experienced since diagnosed
with CLD?
11. How has CLD affected your
physical being?
12. How has CLD affected your
close relationships?
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13. How has CLD affected your
social life?
14. How has CLD affected your
emotional life?

Research Question 3
To what degree do the perceived benefits
of treatment impact the lives and
decision-making processes of different
ethnic groups with average levels of socioeconomic status, education, and thirdparty coverage?

15. What CLD treatments have you
received?
16. How have the treatments
worked for you?
17. What treatment has been most
beneficial?
18. What treatment has been least
beneficial?
19. How do you get informed on
available CLD treatments?
20. What treatment would you
recommend to someone who has
been recently diagnosed with
CLD?
21. How effective has conventional
health care treatment for CLD
being for you?
22. How have literate (LLD: doctors
with experience and knowledge
in treating Lyme Disease) Lyme
Disease doctors helped you with
CLD?
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Research Question 4
To what degree do perceived barriers
impact the lives and decision-making
processes of different ethnic groups with
average levels of socio-economic status,
education, and third-party coverage?

23. What challenges have you
encountered in obtaining
treatment for CLD?
24. How has your insurance
coverage managed your CLD
treatment claims?
25. What kind of CLD treatment
inadequacy have you
experienced?
26. What kind of transportation
issues, if any have you
encountered accessing your
CLD treatment?
27. What tactics do you think will
be most beneficial to you to
overcome CLD?

Research Question 5
To what degree do the cues to action
impact the lives and decision-making
processes of different ethnic groups with
average levels of socio-economic status,
education, and third-party coverage?

28. What kinds of support (family,
friends, community, church,
support groups, health care
providers, etc.) have you had
since diagnosed with CLD?
29. How have these support groups
influenced you in dealing with
CLD?
30. What kind of activities are you
involved in that affect you
positively living with CLD?
31. What inspires and motivates you
to recover from CLD?
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Research Question 6
To what degree does self-efficacy impact
the lives and decision-making processes of
different ethnic groups with average
levels of socio-economic status, education,
and third-party coverage?

32. What can public health do more
effectively to care for patients
living with CLD?
33. How has the health care system
impacted your CLD recovery?
34. What can your family and
friends do to best support you
with CLD?
35. How can your community
(neighbors, church, businesses,
health care practitioners, etc.)
support you living with CLD?
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Appendix I: Informed Consent Participant Log
Informed Consent Participant Log
Name PRN

Screening Date “I Consent” email received date Status
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Appendix J: Content Validity Panel
Content Validity Panel
Name

Field of Expertise

Larry C. Shelton

Behavioral Sciences

Alexander Del Rosario Sociology
Yvonne Ortega

Education

Lynette Eusebio

Public Health
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Appendix K: Survey/Interview Validation Rubric for Expert Panel
Survey/Interview Validation Rubric for Expert Panel - VREP©
Name of Reviewer: __________________Review Date:___________________

Criteria

Operational Definitions

Score
1=Not Acceptable (major
modifications needed)
Questions NOT
2=Below Expectations
meeting standard
(some modifications
(List page and
needed)
question number) and
3=Meets Expectations
need to be revised.
(no modifications needed
Please use the
but could be improved
comments and
with minor changes)
suggestions section to
4=Exceeds Expectations recommend revisions.
(no modifications needed)

1

Clarity

Wordiness

Negative Wording

Overlapping
Responses

Balance

Use of Jargon

Appropriateness of
Responses Listed
Use of Technical
Language

The questions are direct and specific.
Only one question is asked at a time.
The participants can understand what
is being asked.
There are no double-barreled
questions (two questions in one).
Questions are concise.
There are no unnecessary words.
Questions are asked using the
affirmative (e.g., Instead of asking,
“Which methods are not used?” the
researcher asks, “Which methods are
used?”)
No response covers more than one
choice.
All possibilities are considered.
There are no ambiguous questions.
The questions are unbiased and do
not lead the participants to a
response. The questions are asked
using a neutral tone.
The terms used are understandable
by the participants.
There are no clichés or hyperbole in
the wording of the questions.
The choices listed allow participants
to respond appropriately.
The responses apply to all situations
or offer a way for those to respond
with unique situations.
The use of technical language is
minimal and appropriate.

2

3

4
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Application to
Praxis
Relationship to
Problem
Measure of
Research Question
1
Measure of
Research Question
2
Measure of
Research Question
3
Measure of
Research Question
4
Measure of
Research Question
5
Measure of
Research Question
6

All acronyms are defined.
The questions asked relate to the
daily practices or expertise of the
potential participants.
The questions are sufficient to
resolve the problem in the study
The questions are sufficient to
answer the research questions.
The questions adequately measure
this construct of the HBM: Perceived
susceptibility
The questions adequately measure
this construct of the HBM: Perceived
severity
The questions adequately measure
this construct of the HBM: Perceived
benefits
The questions adequately measure
this construct of the HBM: Perceived
barriers
The questions adequately measure
this construct of the HBM: Cues to
action
The questions adequately measure
this construct of the HBM:
Self-efficacy

Permission to use this survey, and include in the dissertation manuscript was granted by
the author, Marilyn K. Simon, and Jacquelyn White. All rights are reserved by the
authors. Any other use or reproduction of this material is prohibited.
Comments and suggestions:
________________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_____
Source: Simon, M. and White, J. (2016). Survey/Interview Validation by an Expert Panel.
Retrieved from http://dissertationrecipes.com/
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Appendix L: Completed VRP by Validation Panel
Completed VRP by Validation Panel
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Appendix M: Content Validity Panel and Results
Content Validity Panel and Results
Name

Profession

Possible
Score
64

Score
Obtained
N/A

Larry C.
Shelton

Behavioral
Scientist

Alexander
Del Rosario
Yvonne
Ortega
Lynette
Eusebio

Sociologist

64

60

Accepted, but did not
return rated
questionnaire
93.75

Educator

64

60

93.75

Public Health
Microbiologist

64

63

94.03

Total average congruency percentage obtained: 93.84

Items Percentage
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Appendix N: Original Core Interviews sent to Validation Panel for Review
Original Core Interview Questions Sent to Validation Panel for Review
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Appendix O: Participants Activity Log
Participants Activity Log

Name PRN

Screen
Date
Approval

Follow up
Consent Interview clarification Transcript Interpretation
Date
Date
if any
Review
Review Date
email
Date
Date
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Appendix P: Study Protocol

Study Protocol
Health Promoting Behaviors of Young Adults with CLD
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Schedule of Procedures
1. Check for eligibility by checking for inclusion and exclusion criteria during
screening evaluation of respondent. Upon determination of eligibility the
researcher will assign a unique Permanent Record Number (PRN) to the
participant’s record.
2. Send Consent Form and Core Questions to eligible respondent.
3. Upon receipt of signed informed consent, schedule date and time for the
interview.
4. Conduct interview
5. Send recorded interview to transcriber within 48-72 hours of finalizing the
interview process.
6. Receive transcribed interview and start data analysis.
7. Continue process of selecting eligible candidates until sufficient data is
obtained and saturation is achieved.
8. Interpret the findings.

Page 3
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Respondent Screening Form
Demographic Information
Name: ______________________________ Date of Birth: __________________ Age:
_____
Address:
____________________________________________________________________
Phone Number: _______________________ Email:
__________________________________
Race/Ethnicity:
White

□

White Hispanic

□

American Indian/Alaskan Native

American Black

□

Age group 18-40:

African Black

□

Native Hawaiian/Pacific Islander

Inclusion Criteria:
Los Angeles County Resident:

□

Asian

□

Exclusion Criteria:

□Yes

□No
□No

□Yes

Chronic Lyme Disease diagnosed by:

□Clinical disease definition
□ Confirmatory laboratory diagnostic tests
Treatment Received: □Yes

□Self diagnosis
□No

Inclusion Criteria Eligibility met:
YES

□

NO

□

NO

□

Authorized to be recorded during the interview:
YES

□

Date________________
PRN _______________

Page 4

□
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Consent Process
The researcher will review the following items with the eligible respondent:
1. The purpose and nature of the research.
2. The study procedure and the interview length will be explained.
3. The reason for the need to record the interview will be clarified.
4. The voluntary nature of the research will be discussed including withdrawal
from the study at any time.
5. Procedures to maintain confidentiality will be explained.
The researcher will make sure to:
1.

Provide opportunity to the participant to ask questions.

2.

Place an enrollment note in the participant’s record when the process of
consent is completed.

Page 5
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Title of Research:

Informed Consent Form
Health Promoting Behaviors of Young Adults with Chronic Lyme Disease

Researcher’s Name and Title:

Name of the Researcher
Doctoral Student at Walden University

Researcher’s Contact Information:

The Researcher’s Contact Information

You are being asked to participate in a research study because you are 18 to 40 years old, residents of the Los Angeles
County, clinically diagnosed with Chronic Lyme Disease, and have received or are receiving medical treatment or
intervention including antibiotic therapy and or complementary and alternative medicine treatment. Please ask the
researcher to explain any information in this form that you do not understand. If you would like to participate in this
study, you must respond to this e-mail with “I Consent,” see the statement of consent below.
PURPOSE OF THE STUDY:
The purpose of this study is to explore the impact that Chronic Lyme Disease has on the health promoting behaviors of
ethnically diverse, young adults from similar educational and socio-economic backgrounds based on their lived
experiences. In addition, this research is being conducted to partially fulfill the requirements of a doctoral dissertation.
STUDY PROCEDURES:
If you respond to this e-mail with “I Consent,” you will be asked to participate in an interview. The interview will last
about 60 minutes and may or may not be followed by a shorter interview of 15 to 30 minutes duration to clarify
questions if needed. You will be asked some questions about how you acquired Lyme Disease, how you were
diagnosed, symptom you have experienced, how the Chronic Lyme Disease has affected your everyday life, treatments
you have being under, and your views on recovery from the disease.
The interview and any follow up interview will be recorded to capture all this valuable information on Chronic Lyme
Disease. The recordings will also be transcribed to allow the researcher to analyze the information.
NUMBER OF PARTICIPANTS
It is expected that approximately 10 – 12 individuals will participate in this study.
RISKS AND DISCOMFORTS:
Since this research consists only of a face to face interview, no physical risks are expected as a result of participation.
While this is not expected, it is possible that the nature of some of the questions may be recalling situations during the
course of your Chronic Lyme Disease condition that may be upsetting or uncomfortable. If you become upset or
uncomfortable at any time, please tell the researcher. While every effort will be made to keep your personal
information confidential, a breach of confidentiality is also a risk of this study.
CONFIDENTIALITY:
All study records will be kept in a locked cabinet in the researcher’s place of residence. Documents containing
information obtained from you during the study will not have your name or any other personal identifying information.
A permanent record number (PRN) will be assigned to identify your records. Only the researcher will have access to
the study records and the link between the assigned PRN and your personal information. The link will be kept in a
locked cabinet in the researcher’s place of work, but separate from the other study records.
The recording(s) of your interview(s), and follow up conversation if necessary, will be transcribed by a company that
provides this professional service. Only the PRN will be connected to the recording. Once the written transcript is
received by the researcher, only the PRN will be used to link the document to your personal information.
There may be some instances where records which identify you, such as the email where you responded “I Consent,”
may be looked at by the Walden University Institutional Review Board (IRB). The IRB is responsible for ensuring that
all Walden University research is conducted in compliance with the University’s ethical standards and applicable U.S.
federal regulations. While these parties are aware of the need to keep your information confidential, total
confidentiality cannot be guaranteed. All study records will be kept by the researcher for five years. After that time, all
of the study documents will be destroyed by shredding. The results of this research may be presented at meetings or in
professional journals; however, you will not be identified in these presentations and/or publications.
VOLUNTARY PARTICIPATION, ALTERNATIVES, AND WITHDRAWAL:
Your participation in this study is voluntary. You have the alternative to not participate. Even if you begin the study,
you may refuse to answer any questions. You may stop your participation at any time and you do not have to explain
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your decision. This consent form is not a contract. Your participation may also be ended without your consent if the
researcher feels it is not in your best interest to continue (for example, if you become upset by the questions).
BENEFITS:
You may not receive any benefit from participating in this research; however, results from this study may positively
impact other individuals, the community, and society by shedding light on the nature and scope of Chronic Lyme
Disease from your perspective.
COSTS OF PARTICIPATION:
There will be no costs to you because of your participation.
REIMBURSEMENT FOR PARTICIPATION:
You will not be paid for your participation in this research.
CONTACTS FOR QUESTIONS, COMPLAINTS, CONCERNS:
If you have any questions about your rights as a participant or complaints regarding this research, please contact the
Walden University Institutional Review Board at 001-612-312-1210 or irb@waldenu.edu.
If you have any questions about the study itself please contact the researcher Patricia Bolivar at
patricia.bolivar@waldenu.edu.
MEMBER CHECKING STEP:
Once you send an e-mail stating “I Consent” you must contact the researcher via phone number at 626-259-9527. The
researcher will then ask you a few questions to confirm your eligibility to participate in this study. This member
checking step will take only ten to fifteen minutes. If found eligible, the phone call will be concluded with scheduling
your interview with the researcher for the study.
STATEMENT OF CONSENT:
•
I have read this consent form in its entirety.
•
All of my questions have been answered to my satisfaction.
•
I may contact the researcher about the study at any time if I have further questions.
•
The researcher will answer any other questions I may have.
•
If I want a copy of my consent to keep for my records I will print the e-mail correspondence.
•
I agree to the recording of my interview and a follow up interview.

To give consent to the preceding you MUST respond to this e-mail with the words “I Consent.” This
will ensure you are agreeing to participate in this study.
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Interview Guide
The research will establish trust with the participant by sharing information on
professional experience: clinical and public health scientist, investigator, reasons for
interest in CLD research, and reemphasize the importance of the study.
By the time the interview takes place the participant would have had the opportunity to
read the core questions that were mailed previously at the time the consent form was sent.
The researcher will ask the participant if the participant had read the questions and will
start the interview. The core questions serve as a guide for the interview as additional
questions will emerge as the interview process proceeds.
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Interview Core Questions
Research Questions
Interview Questions
Research Question 1
To what degree do different ethnic groups
with average levels of socio-economic
status, education, and third-party
coverage, perceive the likelihood of
acquiring comorbidities related to
Chronic Lyme
Disease (CLD)?

8. How did you acquire CLD?
9. How was your health before
CLD?
10. Was there anything you could
have done to prevent CLD?
11. What would be your advice to
others on how to protect
themselves against CLD?
12. Is there anything you could have
done to prevent progression of
acute Lyme Disease to CLD?
13. How were you diagnosed with
CLD?
14. What difficulties did you
encounter getting diagnosed
with CLD?

Research Question 2
To what degree does the perceived
severity of CLD impact the lives and
decision-making processes of different
ethnic groups with average levels of socioeconomic status, education, and thirdparty coverage?

15. How did you react when you
first learned that you had CLD?
16. How has CLD progressed since
diagnosis?
17. What symptoms have you
experienced since diagnosed
with CLD?
18. How has CLD affected your
physical being?
19. How has CLD affected your
close relationships?
20. How has CLD affected your
social life?
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21. How has CLD affected your
emotional life?

Research Question 3
To what degree do the perceived benefits
of treatment impact the lives and decision
making processes of different ethnic
groups with average levels of socioeconomic status, education, and third
party coverage?

23. What CLD treatments have you
received?
24. How have the treatments
worked for you?
25. What treatment has been most
beneficial?
26. What treatment has been least
beneficial?
27. How do you get informed on
available CLD treatments?
28. What treatment would you
recommend to someone who has
been recently diagnosed with
CLD?
29. How effective has conventional
care treatment for CLD
Page health
9
being for you?
30. How have literate (LLD: doctors
with experience and knowledge
in treating Lyme Disease) Lyme
Disease doctors helped you with
CLD?
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Research Question 4
To what degree do perceived barriers
impact the lives and decision-making
processes of different ethnic groups with
average levels of socio-economic status,
education, and third-party coverage?

36. What challenges have you
encountered in obtaining
treatment for CLD?
37. How has your insurance
coverage managed your CLD
treatment claims?
38. What kind of CLD treatment
inadequacy have you
experienced?
39. What kind of transportation
issues, if any have you
encountered accessing your
CLD treatment?

Research Question 5
To what degree do the cues to action
impact the lives and decision-making
processes of different ethnic groups with
average levels of socio-economic status,
education, and third-party coverage?

40. What tactics do you think will
be most beneficial to you to
overcome CLD?
41. What kinds of support (family,
friends, community, church,
support groups, health care
providers, etc.) have you had
since diagnosed with CLD?
Page 10
42. How have these support groups
influenced you in dealing with
CLD?
43. What kind of activities are you
involved in that affect you
positively living with CLD?
44. What inspires and motivates you
to recover from CLD?
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Research Question 6
To what degree does self-efficacy impact
the lives and decision-making processes of
different ethnic groups with average
levels of socio-economic status, education,
and third-party coverage?

45. What can public health do more
effectively to care for patients
living with CLD?
46. How has the health care system
impacted your CLD recovery?
47. What can your family and
friends do to best support you
with CLD?
48. How can your community
(neighbors, church, businesses,
health care practitioners, etc.)
support you living with CLD?

At the end of the interview ask if the participant has any comments to add or any
questions to be further clarified. Remind the participant that he/she may receive a follow
up phone call if any clarification of any question response is needed. Thank the
participant for his/her time spent and the information provided for this important and
significant study.
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Data Collection Process and Data Transcription
1. Record all interviews using an Olympus WS-321M digital voice recorder.
2. Send recorded interview to the selected transcription services within 24-48
hours. The researcher selected the transcription services provided by Kongo
Isaac <isaac@academictranscription-services.com>
3. Upload the interviews into the secure drop box account via the link provided
by the transcription service. The link that the researcher will be using will be
https://goo.gl/5xkZl9
4. Receive transcribed interview and check for accuracy of the recording by
checking the transcription against the tape.
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Data Analysis
1. Read and reread the transcript becoming familiar with the content and write
notes on the data quality. Identify any gaps in the information, contradictory
and ambiguous responses, and if the research questions have been answered.
2. Organize the data into a list of significant statements grouped in meaning
units or themes.
3. Identify meaning units, words, sentences, and paragraphs conveying similar
meanings.
4. Begin coding by combing the data for themes, ideas, concepts, keywords, and
categories and marking similar text passages with a code label which can be
easily retrieved later for further comparison and analysis.
5. Create a new code if a theme is identified from the data that does not fit the
existing codes.
6. Use a coding sort to collect similar coding texts using a qualitative software
package such as NVivo 10 for Windows. The researcher will use NVivo from
QSR International set of tools to assist the researcher analyze, manage, and
shape the data.
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Interpretation of Findings
1. Synthesize the data.
2. Answer the following questions: What is important in the data? Why is it
important? What can be learned from it?
3. Explain how all the different themes fit together.
4. Explain the overall meaning of the responses supplied by the participants.
5. Contextualize findings in the research.
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Appendix Q: The National Institutes of Health Certificate of Completion
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Appendix R: Non-Disclosure Agreement for Transcription Services

